Amedeo Smart

Free Medical Literature Service

 

Amedeo

Dermatology
  Free Subscription

Articles published in
Br J Dermatol
    October 2026
  1. LEONARD G, Emdin A, McSweeney SM, Smith C, et al
    Phenome-wide Longitudinal Association Study of Hospital-recorded Comorbidity in Psoriasis.
    Br J Dermatol. 2026 Oct 30:ljag450. doi: 10.1093.
    >> Share

  2. MCGRATH JA
    The Science of Skin Ageing Comes of Age: Molecular Insights, Precision Targets and Emerging Therapeutics.
    Br J Dermatol. 2026 Oct 26:ljag467. doi: 10.1093.
    >> Share

  3. HOPLEY GG, Walker SL
    Cercarial Dermatitis.
    Br J Dermatol. 2026 Oct 24:ljag479. doi: 10.1093.
    >> Share

  4. JOLY P, Murrell DF, Aoyama Y, Caux F, et al
    Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.
    Br J Dermatol. 2026;195:750-762.
    >> Share

  5. AUBERT H, Mahlaoui N, Barbarot S, Alligon M, et al
    Eczema in inborn errors of immunity with atopy: frequency, timing and phenotypic clustering.
    Br J Dermatol. 2026;195:840-851.
    >> Share

  6. LEE S, Kim YH, Park Y, Lee Y, et al
    Objective and quantitative assessment of facial vitiligo via artificial intelligence-powered three-dimensional analysis for diagnostic support.
    Br J Dermatol. 2026;195:830-839.
    >> Share

  7. EASTON S, Essery R, Steele M, Pollet S, et al
    Views and experiences of young people and their parents of managing acne: qualitative interview study.
    Br J Dermatol. 2026;195:782-792.
    >> Share

  8. WAN S, Li Y, Liu X, Song X, et al
    Soluble CD83 reverses alopecia areata via indoleamine 2,3-dioxygenase-mediated regulatory T cell activation.
    Br J Dermatol. 2026;195:806-817.
    >> Share

  9. KIM M, Nam J, Lee J, Kang S, et al
    Long-term particulate matter exposure and risk of alopecia areata: a nationwide epidemiological study with preliminary in vitro evidence.
    Br J Dermatol. 2026;195:763-771.
    >> Share

  10. MERHAND S, Halioua B, Taieb C
    Shadow Report on Atopic Dermatitis: a Patient-Led Assessment of Multidimensional Burden From 15 Years of French Real-world Evidence.
    Br J Dermatol. 2026 Oct 19:ljag459. doi: 10.1093.
    >> Share

  11. DE BENEDETTO A, Lally JS
    Beyond TEWL: Toward a Multidimensional Assessment of Barrier Dysfunction in Atopic Dermatitis.
    Br J Dermatol. 2026 Oct 16:ljag461. doi: 10.1093.
    >> Share

  12. ZENG X, Huang F, Chen J, Tong Z, et al
    Proteomic Profiling Differentiates Erythrodermic Atopic Dermatitis from Erythrodermic Psoriasis: A Novel insight of CD99 molecule.
    Br J Dermatol. 2026 Oct 16:ljag451. doi: 10.1093.
    >> Share

  13. LI Y, Wang Y, Huang X, Yang L, et al
    Skin Microbiome Metabolism in Cutaneous Microenvironments: Implications for Skin Health and Disease.
    Br J Dermatol. 2026 Oct 15:ljag463. doi: 10.1093.
    >> Share

  14. MASSELLA PATSEA AAL, Nelemans PJ, Mosterd K
    Comment on 'Health-related quality of life in patients with basal cell naevus syndrome and high-frequency basal cell carcinoma: a questionnaire study': reply from authors.
    Br J Dermatol. 2026 Oct 14:ljag456. doi: 10.1093.
    >> Share

  15. ROCHMAH NZ, Hanif MI, Sholihah MM
    Comment on 'Health-related Quality of Life in Patients With Basal Cell Naevus Syndrome and High-frequency Basal Cell Carcinoma: a Questionnaire Study'.
    Br J Dermatol. 2026 Oct 14:ljag455. doi: 10.1093.
    >> Share

  16. ABBAD-JAIME DE ARAGON C, Berna-Rico E, Neria F, Perez-Bootello J, et al
    Distinct Gut Microbiota Signatures are Associated With Progression of Atherosclerosis in Patients With Psoriasis: Results From the EDSAP Study.
    Br J Dermatol. 2026 Oct 14:ljag449. doi: 10.1093.
    >> Share

  17. SHARONI E, Ishtewy R, Arad M, Khair L, et al
    An ADAR1 variant as a candidate modifier of cutaneous disease severity in familial psoriasis.
    Br J Dermatol. 2026 Oct 12:ljag452. doi: 10.1093.
    >> Share

  18. SAITO S, Yoshioka A, Suzuki H, Saito Y, et al
    Biallelic deficiencies of FDPS are required for skin lesion formation in FDPS-associated porokeratosis.
    Br J Dermatol. 2026 Oct 12:ljag446. doi: 10.1093.
    >> Share

  19. SHARKEY T, Eisner M, Common J, Rajan N, et al
    Towards Personalised Therapeutics for Epidermal Differentiation Disorders: Integrating Host Genetics, Immuno-Endotypes and the Skin Microbiome.
    Br J Dermatol. 2026 Oct 9:ljag447. doi: 10.1093.
    >> Share

  20. HASEGAWA T, Kabashima K
    Releasing the brake: lipid control of CD1a-autoreactive T cells in atopic dermatitis.
    Br J Dermatol. 2026 Oct 8:ljag448. doi: 10.1093.
    >> Share

  21. RAMAMURTHY SRINIVASAN M, de Berker D, Venables ZC, Levell NJ, et al
    The environmental burden of melanoma: a national stage-specific carbon footprint analysis.
    Br J Dermatol. 2026 Oct 8:ljag440. doi: 10.1093.
    >> Share

  22. TRAN HGN, Afach S, Guelimi R, Sbidian E, et al
    Secondary Publications From Biologic or Small-molecule Trials in Psoriasis: A Methodological Systematic Review.
    Br J Dermatol. 2026 Oct 8:ljag441. doi: 10.1093.
    >> Share

  23. ADALSTEINSSON JA, Karadottir HL
    Surviving stage IV melanoma: the unfinished task of survivorship care.
    Br J Dermatol. 2026 Oct 5:ljag438. doi: 10.1093.
    >> Share

  24. TANG J, Wen Y, Chen K, Sun M, et al
    Effect of Biologic Therapy on Depression and Anxiety Symptoms in Patients With Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis.
    Br J Dermatol. 2026 Oct 3:ljag435. doi: 10.1093.
    >> Share

  25. NAKANO J, Barroso LF, de Carvalho Mesquita K, Gomes CM, et al
    Assessment of the Sustained Response to Systemic Treatment for Atopic Dermatitis in Patients Who Achieved Disease Remission: A Systematic Review and Network Meta-Analysis Comparing Withdrawal, Dose Reduction and Dosing Interval Extension Versus Contin
    Br J Dermatol. 2026 Oct 3:ljag436. doi: 10.1093.
    >> Share

  26. KAWASHITA M, Lim CH, Hibbard T, Andriollo P, et al
    A UV-Free Strategy for Vitamin D Synthesis in Skin: Concept Verification and a Randomised Double-Blind Placebo-Controlled Clinical Trial of a Cholecalciferol Phosphate Patch (TransVitD).
    Br J Dermatol. 2026 Oct 1:ljag421. doi: 10.1093.
    >> Share

  27. RIVERA-DIAZ R, Perez-Jacoiste Asin M
    Infection risk in psoriasis: not all biologics are the same.
    Br J Dermatol. 2026 Oct 1:ljag434. doi: 10.1093.
    >> Share

  28. BELL KJL, Adamson AS, Parker L, van Akkooi ACJ, et al
    Goals of melanoma surveillance: focusing on outcomes that matter most.
    Br J Dermatol. 2026 Oct 1:ljag430. doi: 10.1093.
    >> Share

  29. SHAH VK, Wei E, Neely S, Ogunsanya ME, et al
    Longitudinal Validation of the Cutaneous Lupus Erythematosus Quality of Life Index.
    Br J Dermatol. 2026 Oct 1:ljag432. doi: 10.1093.
    >> Share

    September 2026
  30. FARRUGIA S, Scerri L
    Dental Sinus: Cutaneous Clues to a Root Cause.
    Br J Dermatol. 2026 Sep 30:ljag428. doi: 10.1093.
    >> Share

  31. BALADO-SIMO P, Podlipnik S
    Low-risk lesion, increased-risk patient: separating lesion prognosis from future melanoma risk.
    Br J Dermatol. 2026 Sep 30:ljag427. doi: 10.1093.
    >> Share

  32. MAGNOLO N, Lara WL, Reich A, Lara-Corrales I, et al
    Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.
    Br J Dermatol. 2026 Sep 26:ljag403. doi: 10.1093.
    >> Share

  33. LUO H, Shen X, Lou J, Lin X, et al
    Generalized Cutaneous Hyperpigmentation and Lentigines due to KIT Variant.
    Br J Dermatol. 2026 Sep 22:ljag419. doi: 10.1093.
    >> Share

  34. THIRUGNANASAMPANTHAR SS, Fajardo RG, Boyle R, Leshem Y, et al
    Uptake and reporting of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set in randomized clinical trials for topical anti-inflammatory treatments in Atopic Dermatitis.
    Br J Dermatol. 2026 Sep 21:ljag415. doi: 10.1093.
    >> Share

  35. WRIGHT AK, de Fatima Cobre A, Dimmock PW, Reeves D, et al
    Incidence, prevalence, and life expectancy of patients with generalised pustular psoriasis in England: a population-based cohort study exploring ethnic and sex variations.
    Br J Dermatol. 2026 Sep 21:ljag417. doi: 10.1093.
    >> Share

  36. REITMAJER M, Livingstone E, Schaffeler N, Borger S, et al
    Beyond the Surface of Long-term Survival in Stage IV Melanoma: A Multicenter Cross-sectional Study.
    Br J Dermatol. 2026 Sep 19:ljag374. doi: 10.1093.
    >> Share

  37. DADZIE OE, Petit A
    What Constitutes Expertise in Skin of Colour Dermatology?
    Br J Dermatol. 2026 Sep 19:ljag413. doi: 10.1093.
    >> Share

  38. GAN C, Wee E, Johnson D, Kelly R, et al
    Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy: case series of 36 patients.
    Br J Dermatol. 2026;195:656-664.
    >> Share

  39. FLORES-MUNOZ C, Diaz P, Fuentes I, Calvo M, et al
    Disrupted Skin-Nerve Homeostasis in Recessive Dystrophic Epidermolysis Bullosa: a Neurocutaneous Unit Perspective on Pain.
    Br J Dermatol. 2026 Sep 18:ljag411. doi: 10.1093.
    >> Share

  40. NAKANO E, Fujisawa Y, Masuzawa M, Mori S, et al
    Evaluation of Multimodal Treatment and Maintenance Chemotherapy in Localised Cutaneous Angiosarcoma of the Head and Neck: A Multicentre Retrospective Study.
    Br J Dermatol. 2026 Sep 16:ljag407. doi: 10.1093.
    >> Share

  41. ISHIZAKI J, Yoshida S, Takenaka K
    Unilateral Gottron Papules in a Hemiparetic Patient with Dermatomyositis.
    Br J Dermatol. 2026 Sep 15:ljag404. doi: 10.1093.
    >> Share

  42. BRIGHT HRB, Smith CH, Laws P, Reynolds NJ, et al
    Risks of tuberculosis, meningitis, candidiasis, and fungal infections among patients receiving systemic treatments for psoriasis: a nationwide cohort study from BADBIR data.
    Br J Dermatol. 2026 Sep 15:ljag397. doi: 10.1093.
    >> Share

  43. MA Y, Han T
    Less inflammation, greater photoprotection? Rethinking the role of the skin microbiome after ultraviolet exposure.
    Br J Dermatol. 2026 Sep 10:ljag400. doi: 10.1093.
    >> Share

  44. EGGERMONT CJ, Cruts EC, van Lee CB, de Vijlder HC, et al
    Five-year Recurrence Rate of Cutaneous Squamous Cell Carcinoma After Mohs Micrographic Surgery Versus Standard Excision: a Prospective Multicentre Cohort Study.
    Br J Dermatol. 2026 Sep 10:ljag399. doi: 10.1093.
    >> Share

  45. ROLAND-MCGOWAN J, Simpson EL, Leclair CM, Foster EL, et al
    Health Domains and Outcome Measurement Instruments in Adult Vulvovaginal Lichen Planus Studies: A Scoping Review.
    Br J Dermatol. 2026 Sep 10:ljag371. doi: 10.1093.
    >> Share

  46. OTTAKANDATHIL BABU R, Nahler J, Dooley K, Naidoo K, et al
    CD1a-autoreactive T cell sensing of skin barrier compromise.
    Br J Dermatol. 2026 Sep 8:ljag391. doi: 10.1093.
    >> Share

  47. CALVAO J, Lourenco M, Martins F, Coutinho I, et al
    Primary cutaneous lymphomas: diagnostic burden and determinants of diagnostic delay across the disease spectrum.
    Br J Dermatol. 2026 Sep 8:ljag392. doi: 10.1093.
    >> Share

  48. LU S, Micevic G, McGrath JA
    Personalised mRNA Therapy Comes of Age in Melanoma.
    Br J Dermatol. 2026 Sep 8:ljag378. doi: 10.1093.
    >> Share

  49. LIU M, Dong P, Yang C, Xu X, et al
    Immune-Epidermal Dual Targeting in Psoriasis: Emerging Technologies and Translational Therapeutic Strategies.
    Br J Dermatol. 2026 Sep 8:ljag390. doi: 10.1093.
    >> Share

  50. MORITA A, Zheng M, Zhang F, Shi YL, et al
    Real-world safety profile of spesolimab in generalised pustular psoriasis: expanded access programmes in Japan, China and Argentina.
    Br J Dermatol. 2026 Sep 6:ljag338. doi: 10.1093.
    >> Share

  51. CARROLL E, Visan M, Herlihy M, Tobin AM, et al
    Insulin resistance in psoriasis: beyond comorbidity?
    Br J Dermatol. 2026 Sep 5:ljag383. doi: 10.1093.
    >> Share


  52. Correction to: Incidence of skin cancer versus overall de novo malignancies among living donor liver transplantation recipients in Taiwan: a cohort study.
    Br J Dermatol. 2026 Sep 3:ljag359. doi: 10.1093.
    >> Share

  53. AHN SB, Furtmuller C, Guenova E, Hoetzenecker W, et al
    Does time matter? Rethinking the Temporal Dimension of Psoriasis.
    Br J Dermatol. 2026 Sep 3:ljag370. doi: 10.1093.
    >> Share

  54. YANG B, Li Y, Wang Y, Yang L, et al
    Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.
    Br J Dermatol. 2026 Sep 3:ljag369. doi: 10.1093.
    >> Share

  55. PAN L, Yi S, Bu Z
    Inguinal allergic contact dermatitis caused by benzalkonium chloride.
    Br J Dermatol. 2026 Sep 3:ljag372. doi: 10.1093.
    >> Share

    August 2026
  56. WOUTERS D, Voeten LM, Ebisch R, de Vos van Steenwijk PJ, et al
    Low-dose methotrexate in therapy-resistant lichen sclerosus: first clinical experience with recurrence-free interval extension in HPV-independent vulvar intraepithelial neoplasia (HPVi VIN).
    Br J Dermatol. 2026 Aug 28:ljag364. doi: 10.1093.
    >> Share

  57. MCGRATH JA
    Faecal microbiota transplantation for skin disease: intriguing biology, premature therapy?
    Br J Dermatol. 2026 Aug 27:ljag366. doi: 10.1093.
    >> Share

  58. ZHONG D
    Can a Treatment-Responsive Molecular Clock Independently Timestamp Psoriatic Skin?
    Br J Dermatol. 2026 Aug 27:ljag360. doi: 10.1093.
    >> Share

  59. YANG G, Lee HK, Kennedy H
    Topical Steroid Withdrawal Syndrome and Adverse Effects of Topical Corticosteroids in Vulval Lichen Sclerosus: a Single-centre Retrospective Study in New Zealand.
    Br J Dermatol. 2026 Aug 27:ljag362. doi: 10.1093.
    >> Share

  60. HE W
    Reply to 'Can a Treatment-Responsive Molecular Clock Independently Timestamp Psoriatic Skin?'.
    Br J Dermatol. 2026 Aug 27:ljag361. doi: 10.1093.
    >> Share

  61. SCARISBRICK JJ, Geskin L, Rozati S, Morsia E, et al
    Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.
    Br J Dermatol. 2026 Aug 26:ljag266. doi: 10.1093.
    >> Share

  62. FANG MM, Gillespie J, Okereke R, Morris CD, et al
    Remote identification of new onset pediatric atopic dermatitis - a comparison of diagnostic methods from a post-hoc analysis of the CASCADE prevention trial.
    Br J Dermatol. 2026 Aug 26:ljag347. doi: 10.1093.
    >> Share

  63. ZHANG J, Wang H, Zheng Q, Liu M, et al
    High-dimensional overfitting and noisy diagnostic labels: reconsidering the role of BRAF copy number in primary dermal melanoma.
    Br J Dermatol. 2026 Aug 24:ljag348. doi: 10.1093.
    >> Share

  64. WAN L, Hu Y, Wang F
    Methodological discussion regarding the independent evaluation of a CE-marked AI smartphone application for skin cancer screening.
    Br J Dermatol. 2026 Aug 24:ljag325. doi: 10.1093.
    >> Share

  65. KAPLAN F
    Does the higher asthma prevalence in preterm children with atopic dermatitis indicate a distinct allergic pathway?
    Br J Dermatol. 2026 Aug 22:ljag352. doi: 10.1093.
    >> Share


  66. Retraction and removal of: PA04 Porcelain papules in paediatrics: a case of systemic Degos disease.
    Br J Dermatol. 2026 Aug 21:ljag340. doi: 10.1093.
    >> Share

  67. DOURS L, Plasson A, Le Vilain-Abraham F, Hoarau C, et al
    Over-the-counter Products and Complementary Therapies in Childhood Atopic Dermatitis: a National Survey of Pharmacists.
    Br J Dermatol. 2026 Aug 21:ljag349. doi: 10.1093.
    >> Share

  68. ZHAO P, Papenfuss AT, Shackleton M
    Reply to 'High-dimensional overfitting and noisy diagnostic labels: reconsidering the role of BRAF copy number in primary dermal melanoma'.
    Br J Dermatol. 2026 Aug 21:ljag346. doi: 10.1093.
    >> Share

  69. BYERS RA, Andrew PV, Sahib S, Katibi O, et al
    Non-Invasive Biomarker Models for Objective Severity Assessment and Detection of Subclinical Inflammation in Non-Lesional Atopic Dermatitis.
    Br J Dermatol. 2026 Aug 20:ljag343. doi: 10.1093.
    >> Share

  70. MCPOLIN-HALL E, Stephen AS, Pardieu C, Georgeu G, et al
    Engineering microbial symbiosis and dysbiosis reveals a new aryl hydrocarbon receptor-mediated mechanism underlying dandruff pathogenesis.
    Br J Dermatol. 2026;195:483-495.
    >> Share

  71. MENSE SA, Hopkins T, Chovatiya R
    Cardiovascular comorbidities and risk in hidradenitis suppurativa: a systematic review and meta-analysis.
    Br J Dermatol. 2026;195:407-420.
    >> Share

  72. LEFEBVRE A, Gillibert A, Tancrede-Bohin E, Loridon L, et al
    Incidence and mortality of mucous membrane pemphigoid in France.
    Br J Dermatol. 2026;195:441-450.
    >> Share

  73. DUAN W, Farrar MD, Chandidzura AN, Peake M, et al
    Commensal Skin Microbiota Modulate Responses to Ultraviolet Radiation in Humans.
    Br J Dermatol. 2026 Aug 17:ljag334. doi: 10.1093.
    >> Share

  74. BELL KJL, Wu Z, Boroumand F, Parker L, et al
    Alternative diagnostic labels for melanoma in-situ: a randomised online experiment.
    Br J Dermatol. 2026 Aug 17:ljag341. doi: 10.1093.
    >> Share

  75. AKTAS H, Celik MS, Gunes K
    Long-term cutaneous and systemic manifestations at the 70th anniversary of the porphyria turcica outbreak: a three-case series.
    Br J Dermatol. 2026 Aug 14:ljag337. doi: 10.1093.
    >> Share

  76. LIN Y, Su H, Lin J, Chen Y, et al
    Lifetime Risk of Cutaneous Melanoma in 185 Countries: Decomposing its Difference From Cumulative Risk into Methodological and Longevity Effects.
    Br J Dermatol. 2026 Aug 14:ljag336. doi: 10.1093.
    >> Share

  77. YUKI A, Takatsuka S, Takenouchi T
    Age-specific Incidence Patterns and Latitude-associated Variation of Skin Cancer in Japan: A Nationwide Registry Study.
    Br J Dermatol. 2026 Aug 12:ljag333. doi: 10.1093.
    >> Share

  78. MILLETTE D
    Durability of response to Icotrokinra in the ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 Trials: a potential new novel oral treatment for psoriasis.
    Br J Dermatol. 2026 Aug 7:ljag323. doi: 10.1093.
    >> Share

  79. SMAK GREGOOR AM, Wehrens R, van der Vall N, Benning T, et al
    Willingness to pay among individuals from the Dutch general population for artificial intelligence based apps for skin cancer detection: a survey-based mixed-methods study.
    Br J Dermatol. 2026 Aug 7:ljag327. doi: 10.1093.
    >> Share

  80. SU Y, Wang T, Li L, Fang X, et al
    Proteomic Profiling Reveals a Cytokine-Chemokine Axis Involving CXCL10, CD40, and CCL17 in Dermatitis Herpetiformis Pathogenesis and Treatment Response.
    Br J Dermatol. 2026 Aug 3:ljag319. doi: 10.1093.
    >> Share

    July 2026
  81. MOSHUTZ A, Kanou M, Dababneh S, Hasbani A, et al
    "It's not just skin": Emotional impact of eczema in Inuit Communities of Northern Quebec.
    Br J Dermatol. 2026 Jul 30:ljag298. doi: 10.1093.
    >> Share


  82. Correction to: LY21 A rare case of cutaneous CD4-positive cytotoxic T-cell lymphoma.
    Br J Dermatol. 2026 Jul 29:ljag304. doi: 10.1093.
    >> Share

  83. ZHAN Q, Wang P, Li Z, Shen Z, et al
    Time-of-day-dependent immune dynamics are associated with disease severity and therapeutic response in psoriasis.
    Br J Dermatol. 2026 Jul 28:ljag314. doi: 10.1093.
    >> Share

  84. MISTRY K, Levell NJ, Karponis D, Wakkee M, et al
    Trends in keratinocyte cancers in England, 2013-2022: basal cell carcinoma incidence, cutaneous squamous cell carcinoma incidence, and non-melanoma skin cancer mortality.
    Br J Dermatol. 2026 Jul 28:ljag315. doi: 10.1093.
    >> Share

  85. MCGRATH JA
    What the animal kingdom teaches us about skin: lessons from nature's own experiments.
    Br J Dermatol. 2026 Jul 27:ljag313. doi: 10.1093.
    >> Share

  86. LODDE G, Livingstone E, Stang A
    Melanoma of unknown primary: UV-driven genomics and the need for era-adjusted outcomes: reply from authors.
    Br J Dermatol. 2026 Jul 23:ljag292. doi: 10.1093.
    >> Share

  87. SILVERBERG JI, Beck LA, Gooderham M, Murrell DF, et al
    Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial.
    Br J Dermatol. 2026 Jul 22:ljag296. doi: 10.1093.
    >> Share

  88. BRIGHT HRB, McPherson T, Smith CH, Laws P, et al
    Serious infections in children and young people with psoriasis on systemic treatments.
    Br J Dermatol. 2026 Jul 22:ljag306. doi: 10.1093.
    >> Share

  89. MURAT DE MONTAI Q, Bourrat E, Battesti G, Hickman G, et al
    Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases.
    Br J Dermatol. 2026 Jul 22:ljag302. doi: 10.1093.
    >> Share

  90. RICHARD MA, Bulai Livideanu C, Fougerousse AC, Staumont-Salle D, et al
    Real-world Clinical Effectiveness of Guselkumab and Its Impact on Quality of Life and Sexual Quality of Life in Patients with Genital Psoriasis: Results from the CASSIOPEE Study.
    Br J Dermatol. 2026 Jul 21:ljag291. doi: 10.1093.
    >> Share

  91. LI M, Huang HY
    Disseminated Cutaneous Gout in a Young Man.
    Br J Dermatol. 2026 Jul 21:ljag294. doi: 10.1093.
    >> Share

  92. XU G, Liu Y, Ge J, Cai C, et al
    Comment on 'Burden and risk of asthma and rhinitis in people with atopic dermatitis: global estimates from a hierarchical Bayesian model': reply from authors.
    Br J Dermatol. 2026 Jul 20:ljag299. doi: 10.1093.
    >> Share

  93. CAO Z, Kong S, Ye J, Hu W, et al
    A clinically actionable stratification of bullous pemphigoid using a disease activity score reveals a targetable inflammatory endotype.
    Br J Dermatol. 2026;195:293-303.
    >> Share

  94. WANG S, Wang R, Yang Y, Dong Y, et al
    Transcriptome profiling reveals that cellular composition contributes to the hyaline-vascular variant in unicentric Castleman disease-associated paraneoplastic pemphigus.
    Br J Dermatol. 2026;195:304-315.
    >> Share

  95. KING B, Ehst B, Foley P, Reygagne P, et al
    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial.
    Br J Dermatol. 2026;195:211-221.
    >> Share

  96. YAO X, Liu Y, Luo Y, Liu X, et al
    Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in patients with moderate-to-severe chronic spontaneous urticaria with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-cont
    Br J Dermatol. 2026;195:222-231.
    >> Share

  97. HADDADIN OM, Jacobson ME, Becker SL, Chen D, et al
    Minimum dataset for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus.
    Br J Dermatol. 2026;195:270-279.
    >> Share

  98. RUNGER A, Geusau A, Nageli M, Ferrandiz-Pulido C, et al
    Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.
    Br J Dermatol. 2026 Jul 15:ljag286. doi: 10.1093.
    >> Share

  99. YILMAZ E, Ozer NK, Topal E
    Comment on 'Burden and risk of asthma and rhinitis in people with atopic dermatitis: global estimates from a hierarchical Bayesian model'.
    Br J Dermatol. 2026 Jul 15:ljag287. doi: 10.1093.
    >> Share

  100. MISKY AT, Paiva M, Woltynski C, Bagirathan S, et al
    Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2026 Jul 6:ljag269. doi: 10.1093.
    >> Share

  101. ELYAS A, Mohareb AM, Rossoni I, Shahla WA, et al
    Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.
    Br J Dermatol. 2026 Jul 6:ljag267. doi: 10.1093.
    >> Share

  102. BJURLING J, Forsberg LA
    Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?
    Br J Dermatol. 2026 Jul 4:ljag270. doi: 10.1093.
    >> Share

  103. STEIN GOLD L, Armstrong AW, Soung J, Vender RB, et al
    Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.
    Br J Dermatol. 2026 Jul 3:ljag264. doi: 10.1093.
    >> Share

  104. RAN NA, Ruiz ES
    Improving Prognostication for Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2026 Jul 2:ljag271. doi: 10.1093.
    >> Share

  105. SIEGFRIED EC, Baselga E, de Graaf M, Simpson EL, et al
    Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.
    Br J Dermatol. 2026 Jul 1:ljag261. doi: 10.1093.
    >> Share

    June 2026
  106. PERKIN MR, Ussher M, Goldsmith LP, Flohr C, et al
    Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing.
    Br J Dermatol. 2026 Jun 26:ljag248. doi: 10.1093.
    >> Share

  107. AGELOPOULOS K, Nattkemper L, Witte F, Zeidler C, et al
    Dupilumab treatment restores skin nerve fibre density in patients with moderate-to-severe atopic dermatitis: results from DIFFERENSTAD, an open-label exploratory study.
    Br J Dermatol. 2026 Jun 23:ljag256. doi: 10.1093.
    >> Share

  108. YANG L, Li L, Mao J, Liang Q, et al
    Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.
    Br J Dermatol. 2026 Jun 22:ljag258. doi: 10.1093.
    >> Share

  109. MAO G, Lan H
    Comment on 'Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20'.
    Br J Dermatol. 2026 Jun 22:ljag168. doi: 10.1093.
    >> Share

  110. XIA J, Kuzyakov Y, Krutmann J
    Microbial diversity as a proxy for skin health: an ecological framework misapplied.
    Br J Dermatol. 2026 Jun 17:ljag251. doi: 10.1093.
    >> Share

  111. CHENG HC, Cheng JB, Cho RJ, McGrath JA, et al
    Dermatopathology in 4D: in situ spatial transcriptomics maps the cellular and molecular architecture of skin.
    Br J Dermatol. 2026 Jun 15:ljag246. doi: 10.1093.
    >> Share

  112. DEMIREL S, McPherson T, Rajan N, Affleck A, et al
    When less is more: The role of dermatologists in promoting societal and self-acceptance of skin health and disease.
    Br J Dermatol. 2026 Jun 13:ljag239. doi: 10.1093.
    >> Share

  113. STEIJLEN OFM, Rentroia-Pacheco B, Tokez S, Amir AL, et al
    Expanding histopathological assessment may provide limited prognostic value for metastatic cutaneous squamous cell carcinoma: insights from two nationwide nested case-control studies.
    Br J Dermatol. 2026 Jun 12:ljag227. doi: 10.1093.
    >> Share

  114. CHEUNG S, Wang H, Wu J, Zhang L, et al
    Insulin resistance in psoriasis: metabolic recalibration and therapeutic prediction; a prospective cohort study at a tertiary referral centre.
    Br J Dermatol. 2026 Jun 12:ljag198. doi: 10.1093.
    >> Share

  115. ASSAN F, Miskinyte S, Sylvain S, Masson Regnault M, et al
    Psoriasis flare-ups in non syndromic autosomal recessive epidermal differentiation disorders.
    Br J Dermatol. 2026 Jun 11:ljag244. doi: 10.1093.
    >> Share

  116. KNOPS E, Spuls PI
    Comparing narrowband and broadband ultraviolet B for atopic dermatitis: new knowledge about an "old" therapy.
    Br J Dermatol. 2026 Jun 10:ljag230. doi: 10.1093.
    >> Share

  117. CHIU YC, Ma SH, Chen TL
    Treatments for Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Critical Appraisal and Systematic Review.
    Br J Dermatol. 2026 Jun 10:ljag237. doi: 10.1093.
    >> Share

  118. NIE Y, Waller H, Caley MP, Peters DT, et al
    Engineered Caf1 Constructs Encoding Laminin-332 Motifs: A Novel Approach for Enhanced Cutaneous Wound Healing.
    Br J Dermatol. 2026 Jun 9:ljag235. doi: 10.1093.
    >> Share

  119. YIU ZZN, Wilson ECF
    The US-UK pharmaceutical deal - do dermatologists have skin in the game?
    Br J Dermatol. 2026 Jun 8:ljag236. doi: 10.1093.
    >> Share

  120. BOADA A, Tejera-Vaquerizo A
    Melanoma diagnosis during COVID-19: delay, disruption and the question of overdiagnosis.
    Br J Dermatol. 2026 Jun 7:ljag234. doi: 10.1093.
    >> Share

  121. FORCEY DS, Rosales BM, Wyld ML, De La Mata N, et al
    Skin cancer mortality in Australian and New Zealand kidney transplant recipients: A population-based cohort study using linked health data, 1990-2019.
    Br J Dermatol. 2026 Jun 4:ljag232. doi: 10.1093.
    >> Share

  122. BUI T, Hong D, Rozati S
    Folliculotropism in CTCL Is Associated with Increased Risk of Skin-Origin Infection and Distinct Infection-Mortality Relationships.
    Br J Dermatol. 2026 Jun 4:ljag231. doi: 10.1093.
    >> Share

  123. KIM M, Han S, Choi CW, Youn SW, et al
    Association of ketotifen use with cutaneous and neural tumor diagnoses in neurofibromatosis type 1.
    Br J Dermatol. 2026 Jun 2:ljag225. doi: 10.1093.
    >> Share

  124. YANG K, Wang X, Zhang M, Tian Z, et al
    Lesional sweat IL-17A reflects local inflammatory activity and treatment response in plaque psoriasis.
    Br J Dermatol. 2026 Jun 2:ljag226. doi: 10.1093.
    >> Share

  125. AETHALSTEINSSON JA, Gislasson GK, Hallsson S, Sharp K, et al
    Monoclonal gammopathy of undetermined significance is not associated with increased risk of skin cancer.
    Br J Dermatol. 2026 Jun 2:ljag119. doi: 10.1093.
    >> Share

  126. DE GIORGI V, Perillo G, Cecchi G, Fazzari F, et al
    Melanoma of unknown primary: UV-driven genomics and the need for era-adjusted outcomes.
    Br J Dermatol. 2026 Jun 1:ljag224. doi: 10.1093.
    >> Share

    May 2026
  127. BLAUVELT A, Bagel J, Pinter A, Thaci D, et al
    Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability.
    Br J Dermatol. 2026 May 29:ljag218. doi: 10.1093.
    >> Share

  128. LI Y, Li Q, Cao Z, Liang Y, et al
    Association of hematopoietic mosaic loss of chromosome Y with dermatitis and eczema risk: an analysis in a large-scale prospective cohort study.
    Br J Dermatol. 2026 May 28:ljag219. doi: 10.1093.
    >> Share

  129. KABASHIMA K, Vocanson M, Eidsmo L, Eyerich K, et al
    From legacy subsets to auditable descriptors: implementing the 2025 T-cell nomenclature guidelines for inflammatory skin diseases.
    Br J Dermatol. 2026 May 26:ljag201. doi: 10.1093.
    >> Share

  130. MASSELLA PATSEA AAL, Moermans MMG, Verkouteren BJA, Nelemans PJ, et al
    Health-related quality of life in patients with basal cell nevus syndrome and high-frequency basal cell carcinoma: a questionnaire study.
    Br J Dermatol. 2026 May 25:ljag212. doi: 10.1093.
    >> Share

  131. MACKENDER E, Frost B, Shipman AR
    Comment on 'Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility and renal function impact'.
    Br J Dermatol. 2026 May 23:ljag202. doi: 10.1093.
    >> Share

  132. TAI MC, Wang JY, Yang CC, Tsai SJ, et al
    Comment on 'Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility and renal function impact': reply from authors.
    Br J Dermatol. 2026 May 22:ljag205. doi: 10.1093.
    >> Share


  133. Correction to: A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021.
    Br J Dermatol. 2026 May 21:ljag197. doi: 10.1093.
    >> Share

  134. THOMAS NE, Kanetsky PA
    Enhanced Polygenic Risk Scores for Melanoma Prediction.
    Br J Dermatol. 2026 May 21:ljag185. doi: 10.1093.
    >> Share

  135. D'ORIA F, Costanzo A
    Unmasking PA2G4 as a keratinocyte hub in psoriasis pathogenesis.
    Br J Dermatol. 2026 May 20:ljag192. doi: 10.1093.
    >> Share

  136. COLLARD MK, Belkadi-Sadou D, Cavalcanti A, Lesourd R, et al
    Immune checkpoint inhibitors in anorectal melanoma: has it changed the outcomes?
    Br J Dermatol. 2026 May 20:ljag204. doi: 10.1093.
    >> Share

  137. ZHU Z, Zhu Y, Xuan Y, Wu Y, et al
    Clinical and molecular markers of vitiligo: a narrative review of early-stage insights into disease activity and treatment response.
    Br J Dermatol. 2026;194:1006-1023.
    >> Share

  138. JOHANSEN C, Emmanuel T
    p75NTR and psoriasis: a new inflammatory pathway?
    Br J Dermatol. 2026 May 18:ljag195. doi: 10.1093.
    >> Share

  139. LI B, Han Y, Sun C, Shi M, et al
    Risk of type 2 inflammation-related diseases during Interleukin-17-inhibitors treatment for psoriasis patients-A retrospective cohort study.
    Br J Dermatol. 2026 May 16:ljag186. doi: 10.1093.
    >> Share

  140. VENABLES ZC, van Bodegraven B, Ahmed S
    Comment on 'Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20': reply from authors.
    Br J Dermatol. 2026 May 13:ljag183. doi: 10.1093.
    >> Share

  141. EL BANNA G, Wishner S, Baker N, Peacker BL, et al
    Risk of skin and subcutaneous diseases in paediatric HIV-exposed uninfected individuals in the United States.
    Br J Dermatol. 2026 May 11:ljag144. doi: 10.1093.
    >> Share

  142. MCGRATH JA, Olsen CM
    Mole counts, melanoma, and the dermatologist's next "vital sign".
    Br J Dermatol. 2026 May 9:ljag178. doi: 10.1093.
    >> Share

  143. KARPONIS D, Nikolaou V, Stratigos AJ, Mistry K, et al
    Epidemiology of lentigo maligna and lentigo maligna melanoma in England between 2013-2023.
    Br J Dermatol. 2026 May 8:ljag177. doi: 10.1093.
    >> Share

  144. MARJANOVIC M, Claeson M
    Type 2 diabetes in melanoma patients: a potential prognostic risk factor?
    Br J Dermatol. 2026 May 7:ljag173. doi: 10.1093.
    >> Share

  145. BRIGHT HRB, Smith CH, Laws P, Reynolds NJ, et al
    Serious infection risk with systemic treatments for psoriasis: A cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Br J Dermatol. 2026 May 5:ljag174. doi: 10.1093.
    >> Share

  146. SAND C, Jayasinghe D, Wolfe R, Mar V, et al
    Evaluating COVID-19 Pandemic Impact on Melanoma Incidence and factors in Regions with Different Infection Control Strategies.
    Br J Dermatol. 2026 May 4:ljag172. doi: 10.1093.
    >> Share

  147. VIELMUTH F
    The skin under mechanical stress - the evolving importance of mechanical stress in autoimmune skin diseases such as vitiligo.
    Br J Dermatol. 2026 May 2:ljag169. doi: 10.1093.
    >> Share

    April 2026
  148. BRIGHT HRB, Smith CH, Laws P, Reynolds NJ, et al
    Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis.
    Br J Dermatol. 2026 Apr 30:ljag170. doi: 10.1093.
    >> Share

  149. MIKIVER R, Marjanovic M, Nielsen K, Isaksson K, et al
    Impact of occult metastasis size on mortality in stage IIIA melanoma: A Swedish population-based registry study.
    Br J Dermatol. 2026 Apr 30:ljag171. doi: 10.1093.
    >> Share

  150. RUGE IF, Nielsen ML, Halling AS, Gerner T, et al
    Preterm Birth Is Associated with Reduced Risk of Atopic Dermatitis and a Distinct Allergic Comorbidity Profile in Early Childhood.
    Br J Dermatol. 2026 Apr 28:ljag167. doi: 10.1093.
    >> Share

  151. RAMESSUR R, Arham AGA, Saklatvala J, Thomas L, et al
    Genetic proxies of GLP1R expression are associated with lower risk of psoriasis and psoriatic arthritis.
    Br J Dermatol. 2026 Apr 28:ljag163. doi: 10.1093.
    >> Share

  152. DRUCKER AM, Zhong Y, Tomlinson G, Lau KPL, et al
    Narrowband vs broadband ultraviolet B phototherapy for adults with moderate-to-severe atopic dermatitis: a randomized controlled trial.
    Br J Dermatol. 2026 Apr 24:ljag161. doi: 10.1093.
    >> Share

  153. RAUNEGGER T, Wasserer S, Eigemann J, Hillig C, et al
    Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis.
    Br J Dermatol. 2026 Apr 20:ljag154. doi: 10.1093.
    >> Share

  154. BOUADI N, Ayoub A, Croitoru D, Piguet V, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnancy.
    Br J Dermatol. 2026 Apr 20:ljag128. doi: 10.1093.
    >> Share

  155. BAI J, Qiao J
    Cutaneous angiosarcoma.
    Br J Dermatol. 2026 Apr 18:ljag155. doi: 10.1093.
    >> Share

  156. MORGAN HJ, Deorukhkar RA, Tuckwell W, Shorning BY, et al
    Presence of koilocytes in actinic keratosis identifies those at high risk of developing keratinocyte carcinoma.
    Br J Dermatol. 2026;194:914-922.
    >> Share

  157. BOUAZZI D, Lophaven S, Hagan PG, Botvid S, et al
    Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study.
    Br J Dermatol. 2026;194:869-878.
    >> Share

  158. ZOUTENDIJK J, Hollestein LM, Mooyaart AL, Wakkee M, et al
    A nationwide study of treatment of lentigo maligna and its recurrence rate in the Netherlands.
    Br J Dermatol. 2026;194:862-868.
    >> Share

  159. NAKAMURA M, Ogata D, Kato J, Ko YW, et al
    Spatial proteomics of tertiary lymphoid structures reveals correlation with immunotherapy response in Merkel cell carcinoma.
    Br J Dermatol. 2026;194:888-898.
    >> Share

  160. SHIH HY, Han-Wen L, Tsai TF, Lai YJ, et al
    Recurrence and relapse in nonsegmental vitiligo: phenotypic and autoimmune predictors from a large retrospective cohort.
    Br J Dermatol. 2026;194:854-861.
    >> Share

  161. SILENO S, D'Agostino M, Farina L, Kosta A, et al
    The nerve growth factor receptor p75NTR interacts with toll like receptor 4 and the alarmins high mobility group box-1 and nucleophosmin: a novel inflammatory mechanism in psoriasis.
    Br J Dermatol. 2026 Apr 17:ljag152. doi: 10.1093.
    >> Share

  162. SIMMONDS F, Petukhova L
    Lichen sclerosus GWAS meta-analysis reveals immune pathways and drug repurposing opportunities.
    Br J Dermatol. 2026 Apr 16:ljag145. doi: 10.1093.
    >> Share

  163. KHOSHNIYATI S, Fleischli A, Niknejad K, Weiner J, et al
    The prognostic impact of prior atopic dermatitis on cutaneous T-cell lymphoma: a single-center retrospective cohort study.
    Br J Dermatol. 2026 Apr 16:ljag143. doi: 10.1093.
    >> Share

  164. SILVERBERG JI, Dodiuk-Gad R, Takaoka R, Tan J, et al
    More than a symptom: itch as an independent clinical contributor in atopic dermatitis - a global-scale study on 15,223 patients.
    Br J Dermatol. 2026 Apr 11:ljag142. doi: 10.1093.
    >> Share

  165. HAQ Z, Abdi P, Tran JT, Diaz MJ, et al
    Assessment of mental health disorders among patients with lichen simplex chronicus.
    Br J Dermatol. 2026 Apr 10:ljag125. doi: 10.1093.
    >> Share

  166. WANG H, Ghajari H, Jayasinghe GJMSR, Seviiri M, et al
    Genetics vs clinical risk scores for melanoma prediction.
    Br J Dermatol. 2026 Apr 10:ljag126. doi: 10.1093.
    >> Share

  167. PHILLIPS PF, Bourke JF
    Spectacles Cleaning Products: a hidden source of direct isothiazolinone exposure on facial skin.
    Br J Dermatol. 2026 Apr 10:ljag139. doi: 10.1093.
    >> Share

  168. PORTER EMI, White C, Tucker E, Morgan H, et al
    Clinically relevant recurrence of basal cell carcinoma following primary treatment with hypofractionated kilovoltage radiotherapy: A single-centre retrospective review.
    Br J Dermatol. 2026 Apr 10:ljag127. doi: 10.1093.
    >> Share

  169. VALENZUELA F, Davalos M
    Early biologic therapy in psoriasis: challenging the stepwise paradigm.
    Br J Dermatol. 2026 Apr 9:ljag131. doi: 10.1093.
    >> Share

    March 2026
  170. LEE EJ, Kwon IJ, Kim JY, Park S, et al
    Unanchored by two hits: IFNgamma and mechanical stress synergize to undermine melanocyte adhesion and promote vitiligo.
    Br J Dermatol. 2026 Mar 31:ljag113. doi: 10.1093.
    >> Share

  171. ARHAM AGA, Sharma A, Thomas LF, Ramessur R, et al
    Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: A cross-sectional study of 470,352 participants.
    Br J Dermatol. 2026 Mar 30:ljag116. doi: 10.1093.
    >> Share

  172. HSU H, Yang CC, Huang SM, Wu MS, et al
    Topical Probiotics in Soybean Concentrate for Diabetic Foot Ulcers: A Randomised Controlled Trial.
    Br J Dermatol. 2026 Mar 27:ljag115. doi: 10.1093.
    >> Share

  173. REBIKOVA B
    "It was good that you came": A patient perspective on prevention, fear, and supportive decision-making in basal cell carcinoma.
    Br J Dermatol. 2026 Mar 27:ljag110. doi: 10.1093.
    >> Share

  174. FLOHR C, Corkerry E, Burton T, Mackenzie T, et al
    Guiding the way to unmet needs in atopic dermatitis.
    Br J Dermatol. 2026 Mar 27:ljag107. doi: 10.1093.
    >> Share

  175. RICAR J, Cetkovsky M, Cetkovska P
    Effective treatment of alopecia areata and psoriasis with baricitinib.
    Br J Dermatol. 2026 Mar 21:ljag106. doi: 10.1093.
    >> Share


  176. Correction to: Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma: a nationwide population-based registry study from Sweden.
    Br J Dermatol. 2026 Mar 21:ljag096. doi: 10.1093.
    >> Share

  177. HARTLEY S, Judson-Torres RL
    How benign tumors grow: insights from melanocytic naevi.
    Br J Dermatol. 2026 Mar 20:ljag108. doi: 10.1093.
    >> Share

  178. BASKURT D, Altiner S, Atci T, Akay BN, et al
    Genotype-phenotype associations in a robust cohort of 69 patients with xeroderma pigmentosum across Turkiye: a multicentre study.
    Br J Dermatol. 2026;194:758-767.
    >> Share

  179. DAND N, Rayinda T, Silz E, Thomas LF, et al
    Genome-wide meta-analysis in lichen sclerosus identifies 14 genomic risk loci.
    Br J Dermatol. 2026 Mar 19:ljag088. doi: 10.1093.
    >> Share

  180. PHAN DB, Laws P, Smith CH, Griffiths CEM, et al
    Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Br J Dermatol. 2026 Mar 16:ljag098. doi: 10.1093.
    >> Share

  181. LYNGSTRAND JE, Rossell EL, Bonnelykke-Behrndtz ML, Laurberg T, et al
    The impact of type 2 diabetes on sex- and stage-specific melanoma recurrence and mortality: A Danish cohort study, 2004 to 2024.
    Br J Dermatol. 2026 Mar 15:ljag097. doi: 10.1093.
    >> Share

  182. FAN B, Song X, Meng X, Sheng Y, et al
    Severity assessment agreement in atopic dermatitis and association with short-term response: a patient-partner cohort.
    Br J Dermatol. 2026 Mar 7:ljag091. doi: 10.1093.
    >> Share

  183. HODGSON K, Inns J, Reynolds G, Stephenson E, et al
    Targeting non-canonical NF-kappaB signalling in CYLD cutaneous syndrome by selective inhibition of IkappaB kinase alpha.
    Br J Dermatol. 2026 Mar 4:ljag044. doi: 10.1093.
    >> Share

  184. HOLLATZ AR, Eggermont CJ, Rentroia-Pacheco B, Louwman M, et al
    Predicting a metachronous cutaneous squamous cell carcinoma: a competing-risk model based on nationwide linked registries.
    Br J Dermatol. 2026 Mar 4:ljag076. doi: 10.1093.
    >> Share

  185. OASHI K, Ogata D, Yokoyama M, Sano Y, et al
    Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).
    Br J Dermatol. 2026 Mar 3:ljag071. doi: 10.1093.
    >> Share

    February 2026
  186. WEI B, Zhu D, Jin J, Lai B, et al
    Multilineage differentiation drives hamartoma formation in large-to-giant congenital melanocytic naevi: evidence for naevocyte multipotency.
    Br J Dermatol. 2026 Feb 26:ljaf497. doi: 10.1093.
    >> Share

  187. BOOTH L, Chen X, Stoker K, McCraw A, et al
    Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping review.
    Br J Dermatol. 2026 Feb 26:ljag074. doi: 10.1093.
    >> Share

  188. MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
    Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden': reply from authors.
    Br J Dermatol. 2026 Feb 25:ljag059. doi: 10.1093.
    >> Share

  189. LIN Z, Yang L, Han Y, Qi C, et al
    Microbiota-fibroblast crosstalk represents the missing link in skin barrier dysfunction and fibrosis.
    Br J Dermatol. 2026 Feb 23:ljag068. doi: 10.1093.
    >> Share

  190. TORRANO J, Oey HM, Smit DJ, Kao YC, et al
    Differential expression of HRK regulates proliferation of acquired melanocytic naevi.
    Br J Dermatol. 2026 Feb 20:ljag063. doi: 10.1093.
    >> Share

  191. LODDE G, Dollani J, Galetzka W, Mohr P, et al
    Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanoma.
    Br J Dermatol. 2026 Feb 20:ljaf499. doi: 10.1093.
    >> Share

  192. BA W, Zhang G, Tian X, Sun Z, et al
    Disseminated myofibroblastic papulosis in young individuals - a newly identified entity: a clinicopathological study from a case series of eight patients.
    Br J Dermatol. 2026;194:559-565.
    >> Share

  193. HIEL MAJ, Tedbirt B, Korte EWH, Bolling MC, et al
    Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments.
    Br J Dermatol. 2026;194:429-440.
    >> Share

  194. YANG Y, Zhang J, Zhou S, Chen Q, et al
    Germline and somatic second-hit changes in porokeratosis: comprehensive variant spectrum and genotype-phenotype correlation analysis.
    Br J Dermatol. 2026;194:551-558.
    >> Share

  195. GUO Z, Luo Z, Zhang S, Yu Y, et al
    Sleep patterns and the risk of psoriatic disease: genetic predisposition and metabonomics.
    Br J Dermatol. 2026;194:489-498.
    >> Share

  196. BRADSHAW L, Howells LM, Muller I, Mitchell EJ, et al
    Weekly versus daily bathing for people with eczema: results of the Eczema Bathing online randomized controlled trial.
    Br J Dermatol. 2026;194:450-460.
    >> Share

  197. PENG X, Ran Y, Wang S, Zhu Y, et al
    Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) is associated with inflammation and disease severity in pemphigus.
    Br J Dermatol. 2026;194:540-550.
    >> Share

  198. ZHAO F, Guo Y, Jiao Y, Zou W, et al
    Mitochondrial Metabolism in Neutrophils: Emerging Roles in Inflammatory Skin Diseases.
    Br J Dermatol. 2026 Feb 18:ljag060. doi: 10.1093.
    >> Share

  199. DONI SN, Mohammed FS, Mohammed AB, Zewdu FT, et al
    Clinical and patient-reported outcomes of cutaneous leishmaniasis treatment in Ethiopia: A prospective, observational cohort study in two referral hospitals.
    Br J Dermatol. 2026 Feb 17:ljag061. doi: 10.1093.
    >> Share

  200. KIPS J, Papeleu J, Shen A, Mylle S, et al
    Artificial intelligence-based smartphone application for skin cancer detection: A prospective diagnostic accuracy study.
    Br J Dermatol. 2026 Feb 17:ljag057. doi: 10.1093.
    >> Share

  201. ZHOU C, Zhao Y, Zhu G, Wu L, et al
    Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
    Br J Dermatol. 2026 Feb 16:ljag052. doi: 10.1093.
    >> Share

  202. PASTUKHOVA E, Miller-Monthrope Y, Croitoru D
    Rubella vaccine-induced cutaneous granulomas.
    Br J Dermatol. 2026 Feb 10:ljag042. doi: 10.1093.
    >> Share

  203. DAI X, Hu Y, Huang D, Xu Z, et al
    A tRNA-derived RNA fragment protects skin from photoaging by preserving collagen and mRNA stability.
    Br J Dermatol. 2026 Feb 8:ljag046. doi: 10.1093.
    >> Share

  204. LIU Y, Ge J, Xu G, Cai C, et al
    Burden and Risk of Asthma and Rhinitis in Atopic Dermatitis: Global Estimates from a Hierarchical Bayesian Model.
    Br J Dermatol. 2026 Feb 5:ljag025. doi: 10.1093.
    >> Share

  205. YUANBO Z, Huishu L, Qianyang Z, Yaping H, et al
    Spatial Proteomics Reveals Layer-Specific Molecular Landscapes and KRT17-Mediated Inflammatory Crosstalk in Tongue Oral Lichen Planus.
    Br J Dermatol. 2026 Feb 5:ljag040. doi: 10.1093.
    >> Share

  206. O'REILLY P, Fortune DG, Ingen-Housz-Oro S, Hannigan A, et al
    Development of a health-related quality of life outcome measure for adults with Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) - QoLTEN: An international multidisciplinary DELPHI consensus survey.
    Br J Dermatol. 2026 Feb 3:ljag037. doi: 10.1093.
    >> Share

  207. BEAGLES E, Khattab S, Burke OM, Nguyen N, et al
    The Impact of Clinicopathologic Features on the Prognosis of Thin Melanomas: A Retrospective Cohort Analysis.
    Br J Dermatol. 2026 Feb 2:ljag034. doi: 10.1093.
    >> Share

    January 2026
  208. PICARDO M, Chen Q
    Metabolic approach to counteract skin aging.
    Br J Dermatol. 2026 Jan 29:ljag026. doi: 10.1093.
    >> Share

  209. QI J, Nie G
    Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden'.
    Br J Dermatol. 2026 Jan 28:ljag030. doi: 10.1093.
    >> Share

  210. BRIGHT HRB, Smith CH, Laws P, Reynolds NJ, et al
    Serious infection risk in people treated with infliximab for severe psoriasis.
    Br J Dermatol. 2026 Jan 28:ljag032. doi: 10.1093.
    >> Share

  211. REDMOND LC, Higgins CA
    Not quite naked: the bare necessities of human body hair evolution.
    Br J Dermatol. 2026;194:205-212.
    >> Share

  212. GUO W, Li Z, Xu D, Li T, et al
    CCL19+ fibroblast-CCR7+ T-cell crosstalk coordinates immunofibrotic signalling networks in systemic sclerosis.
    Br J Dermatol. 2026;194:326-339.
    >> Share

  213. JOSHY J, Sheern C, Mistry K, Venables ZC, et al
    A multiple-methods study of the SKCIN Sun Safe Schools international programme 2012-23: promoting sun safety and empowering behavioural change in primary education.
    Br J Dermatol. 2026;194:292-300.
    >> Share

  214. KORTELAINEN S, Hieta N, Rissanen T, Paltta J, et al
    Localized scleroderma and related comorbidities: a single-centre cohort study.
    Br J Dermatol. 2026;194:351-358.
    >> Share

  215. BRANDTZAEG KH, von der Lippe C, Vestengen IK, Holtan JP, et al
    Clinical and genetic findings in 103 individuals in Norway with basal cell naevus syndrome.
    Br J Dermatol. 2026;194:264-272.
    >> Share

  216. FU Y, Wu C, Pang Z, Liu T, et al
    Spatiotemporal transcriptomics deciphered neutrophil-activated interleukin-36 as driver and effective therapeutic target in Sweet syndrome.
    Br J Dermatol. 2026;194:311-325.
    >> Share

  217. GIAMARELLOS-BOURBOULIS EJ, Jemec GBE, Prens EP, Riedemann NC, et al
    Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial.
    Br J Dermatol. 2026;194:254-263.
    >> Share

  218. BRODERICK C, Poulsen CS, Hjelmso MH, Marrs T, et al
    Associations between early-life exposures and the infant skin microbiome.
    Br J Dermatol. 2026 Jan 16:ljaf524. doi: 10.1093.
    >> Share

  219. CUI X, Wang Y, Liu S, Zhang Q, et al
    A novel fusion gene identified in metastatic melanoma associated with malignant transformation of a giant congenital melanocytic naevus.
    Br J Dermatol. 2026 Jan 14:ljag015. doi: 10.1093.
    >> Share

  220. MORTAGY M, Cliff-Patel N, Askary R, Bologan AM, et al
    Evaluation and Enhancement of the Prognostic Ability of the Eighth Edition of TNM Staging in Cutaneous Malignant Melanoma: A Population-Based Study of 111,871 Cases Using Machine Learning.
    Br J Dermatol. 2026 Jan 13:ljag018. doi: 10.1093.
    >> Share

  221. MCGRATH JA
    High-resolution biology and the evolving nature of skin biopsy analysis in translational dermatology.
    Br J Dermatol. 2026 Jan 9:ljag014. doi: 10.1093.
    >> Share

  222. REYES-MARCELINO G, Salam RA, Espinoza D, Watts CG, et al
    Real-world evaluation of the use of melanoma risk prediction tools by clinicians in Australia: a mixed methods study.
    Br J Dermatol. 2026 Jan 8:ljag003. doi: 10.1093.
    >> Share

  223. ELAHMAR HA, Barnett-Tapia C
    Ask and you will find: the importance of measuring stigma due to cutaneous neurofibromas in Neurofibromatosis type 1.
    Br J Dermatol. 2026 Jan 8:ljag002. doi: 10.1093.
    >> Share

  224. GRAIER T, Bordag N, Weger W, Laschober N, et al
    Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study.
    Br J Dermatol. 2026;194:77-85.
    >> Share

  225. TALAGAS M, Le Garrec R, Le Bon-Jego M, Le Gall-Ianotto C, et al
    Alloknesis: a severe form of itch.
    Br J Dermatol. 2026;194:18-24.
    >> Share

  226. KASPERKIEWICZ M, Pigors M, Holtsche MM, Goletz S, et al
    Anti-p200 pemphigoid.
    Br J Dermatol. 2026;194:10-17.
    >> Share

  227. DIDONA D, Hudemann C, Garn H, Krzikalla D, et al
    Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus.
    Br J Dermatol. 2026;194:86-98.
    >> Share

  228. BLUME-PEYTAVI U, Piraccini BM, Reygagne P, Guiraud J, et al
    Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial.
    Br J Dermatol. 2026;194:37-46.
    >> Share

  229. GHIASVAND R
    High-Risk Stage II Melanoma: AJCC Staging anomaly or understaging dilemma?
    Br J Dermatol. 2026 Jan 3:ljaf523. doi: 10.1093.
    >> Share

    December 2025
  230. TROIN L, Adamski H, Rousset P, Poizeau F, et al
    Use of mogamulizumab in cutaneous T-cell lymphomas among people living with HIV: insights from a nationwide French cohort.
    Br J Dermatol. 2025 Dec 30:ljaf534. doi: 10.1093.
    >> Share

  231. SCARDAMAGLIA L
    Evolving approaches to atopic dermatitis in the JAK inhibitor era.
    Br J Dermatol. 2025 Dec 30:ljaf528. doi: 10.1093.
    >> Share

  232. KIM JC, Park TJ, Kim Y, Myeong SY, et al
    ATG7 dysfunction in senescent melanocytes and hypopigmented skin: Reversal by metformin.
    Br J Dermatol. 2025 Dec 26:ljaf529. doi: 10.1093.
    >> Share

  233. O'REILLY S
    Targeting the cGAS STING pathway for therapeutic gain in autoimmune inflammatory cutaneous diseases with a focus on systemic lupus erythematosus and systemic sclerosis.
    Br J Dermatol. 2025 Dec 26:ljaf526. doi: 10.1093.
    >> Share

  234. MARIE-LUCE S, Dugourd PM, Cardot-Leccia N, Audidier S, et al
    Characterization of basal cell carcinoma using dermoscopy-guided high-frequency ultrasound: a single-centre pilot study.
    Br J Dermatol. 2025 Dec 26:ljaf501. doi: 10.1093.
    >> Share

  235. BOTTOMLEY MJ
    Skin Cancer in Transplant Recipients: time to revisit immunosuppression trials?
    Br J Dermatol. 2025 Dec 24:ljaf527. doi: 10.1093.
    >> Share

  236. ZAMAN S, Dear K, Morar N, Wilsher M, et al
    P21 A rare case of eosinophilic pustular folliculitis presenting with pustules and bullae at birth.
    Br J Dermatol. 2025;193.
    >> Share

  237. AL JUAIDI F, Balasch Carulla M, Martinez AE, Petrof G, et al
    O01 Infantile bullous pemphigoid: when autoimmunity hides an immunodeficiency.
    Br J Dermatol. 2025;193.
    >> Share

  238. RAMWANI M, Solman L
    P13 The cellulitis that wasn't: a case of subcutaneous panniculitis-like T-cell lymphoma in a toddler.
    Br J Dermatol. 2025;193.
    >> Share

  239. HERD E, Gardner L, Leech S, Weiand D, et al
    P02 A single-centre, retrospective study of paediatric tinea capitis in the United Kingdom.
    Br J Dermatol. 2025;193.
    >> Share

  240. KROUZKOVA D, McPherson T
    P12 An audit of the psychological morbidity of children and young people on systemic medications for atopic eczema or psoriasis.
    Br J Dermatol. 2025;193.
    >> Share

  241. KHAN J, Godor D, Ramaiya A, Yakuub A, et al
    P23 Scurvy presenting as an unusual petechial rash in a patient with anorexia nervosa.
    Br J Dermatol. 2025;193.
    >> Share

  242. DODEIN R, Abdul-Wahab A
    P24 Congenital milium of the nipple: a rare presentation.
    Br J Dermatol. 2025;193.
    >> Share

  243. JASSAL-PRIOR P, Carson L, Leech S, Dubois A, et al
    O08 The elemental clue: a case series of Acrodermatitis enteropathica in a tertiary centre.
    Br J Dermatol. 2025;193.
    >> Share

  244. FRENEAT M, McPherson T, Davison J, Dennis C, et al
    P10 Treatment-refractory psoriasiform dermatitis resulting from a rare genetic alteration in MSMO1 with marked improvement with combined cholesterol and statin use.
    Br J Dermatol. 2025;193.
    >> Share

  245. POUDEL P, Moss C, Ogboli M
    P18 ZMPSTE24 variant with the lethal phenotype of restrictive dermopathy.
    Br J Dermatol. 2025;193.
    >> Share

  246. HOWELLS L, Ravenscroft J, Roberts A, Thomas K, et al
    O03 Rapid eczema trials: generating evidence that patients need.
    Br J Dermatol. 2025;193.
    >> Share

  247. KUNNUMPURATH A, Agarwal V, Zahoor M, Bogucki P, et al
    P20 Erythroderma in a newborn: an atypical presentation of Incontinentia Pigmenti.
    Br J Dermatol. 2025;193.
    >> Share

  248. KING STOKES N, O'Neill C, Glover M, Martinez A, et al
    O05 Incontinentia pigmenti: clinical heterogeneity and the role of early dermatological recognition.
    Br J Dermatol. 2025;193.
    >> Share

  249. SOFELA J, Cookson H
    P08 A case of a 7-year-old female with SAPHO and CRMO treated successfully with IL-17A inhibitor after failure with Anti-TNFalpha biologic.
    Br J Dermatol. 2025;193.
    >> Share

  250. POUDEL P, Parajuli N, Pandey P, Acharya B, et al
    P15 Scabies in pediatric population in Nepal: a study from tertiary-care referral children's hospital.
    Br J Dermatol. 2025;193.
    >> Share

  251. OYEDEPO J, Kadam G, Solman L
    O09 Improving referral quality for infantile haemangiomas: audit of 76 cases and proposal for a standardised national form.
    Br J Dermatol. 2025;193.
    >> Share

  252. RAMWANI M, Glover M
    P14 Bilateral plantar nodules in toddlers: a case series highlighting diagnostic nuances and a reassuring clinical course.
    Br J Dermatol. 2025;193.
    >> Share

  253. BAGETA ML, Lopez Balboa P, Bursnall M, Wilson I, et al
    O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial.
    Br J Dermatol. 2025;193.
    >> Share

  254. FOSTIER W, Gardner L, Charlton F, Dubois A, et al
    P06 Adenosine deaminase deficient-severe combined immunodeficiency and multicentric dermatofibrosarcoma protuberans: an emerging association.
    Br J Dermatol. 2025;193.
    >> Share

  255. PEEVA D, Kinsler V
    O06 Complete spontaneous resolution of NRAS-mosaic multiple congenital melanocytic naevi: proof of principle for therapeutic mole reversal.
    Br J Dermatol. 2025;193.
    >> Share

  256. PUGH R, McPherson T
    P05 The efficacy and safety of isotretinoin in transgender males receiving gender-affirming hormonal therapy with youth subgroup analysis: a systematic review.
    Br J Dermatol. 2025;193.
    >> Share

  257. KATIBI OS, Andrew P, Pinnock A, Brown K, et al
    P16 Effect of moisturisers on allergen-induced inflammation and skin barrier.
    Br J Dermatol. 2025;193.
    >> Share

  258. BAIRD J, Murrell D
    P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases.
    Br J Dermatol. 2025;193.
    >> Share

  259. BARON S, Ali R, Akinde M, Kanji A, et al
    O02 Kids in control: development and assessment of a 3 part virtual behavioural intervention programme to reduce scratching in children with atopic eczema.
    Br J Dermatol. 2025;193.
    >> Share

  260. BOGUSZEWSKA Z, O'Higgins L, Alachkar H, Johnson O, et al
    P04 Hidden hazards: prevalence of food allergens in paediatric leave-on skincare products in the UK.
    Br J Dermatol. 2025;193.
    >> Share

  261. POUDEL P, Moss C, Ogboli M
    P11 Prolonged diagnostic journey in infantile bullous pemphigoid.
    Br J Dermatol. 2025;193.
    >> Share

  262. GAN WK, Fong G, Ravenscroft J, Burden-Teh E, et al
    O07 To test or not to test? Isotretinoin blood test monitoring in children and adolescents in a teaching hospital over 2 years.
    Br J Dermatol. 2025;193.
    >> Share

  263. DATSENKO A, Beck-Sander K, Riches S, Olechowska M, et al
    P17 Distinguishing familial generalized multiple glomangiomas from blue rubber bleb naevus syndrome: a case discussion.
    Br J Dermatol. 2025;193.
    >> Share

  264. HOLCROFT L, Doolan A, O'Sullivan A
    P09 Skin injury and treatment in a sample of preterm infants in the NICU.
    Br J Dermatol. 2025;193.
    >> Share

  265. KATIBI OS, Ogunbiyi A, Cork M, Danby S, et al
    P07 Recommendation and practices on infant skin care among health workers in Nigeria.
    Br J Dermatol. 2025;193.
    >> Share

  266. SMITH A, Chow C
    Patient-Centred Perspectives - Empowerment, Engagement, and the Future of Cardiovascular Prevention in Psoriasis.
    Br J Dermatol. 2025 Dec 13:ljaf513. doi: 10.1093.
    >> Share

  267. HAS C
    Skin fragility or epidermal differentiation disorder: the devil is in the details.
    Br J Dermatol. 2025 Dec 11:ljaf514. doi: 10.1093.
    >> Share

  268. PETUKHOVA L, Dand N, Watts K, Saklatvala J, et al
    The Skin Genetics Consortium.
    Br J Dermatol. 2025 Dec 11:ljaf496. doi: 10.1093.
    >> Share

  269. KAHLER S, Yan S, Mothershaw A, Leo F, et al
    Automated classification of site-specific cutaneous photodamage using a convolutional neural network and 3D total body photography.
    Br J Dermatol. 2025 Dec 10:ljaf516. doi: 10.1093.
    >> Share

  270. WITKAM WCAM, Mathieu A, Dal Belo SE, Moreau M, et al
    Distinct Bacterial Facial Cutaneous Microbiota Compositions in Adolescents with Acne Vulgaris: A Population-Based Cross-Sectional Observational Study.
    Br J Dermatol. 2025 Dec 10:ljaf508. doi: 10.1093.
    >> Share

  271. RAMESSUR R, Loset M
    Sleep and psoriasis: an emerging modifiable risk factor?
    Br J Dermatol. 2025 Dec 9:ljaf502. doi: 10.1093.
    >> Share

  272. ZHAO P, Chew C, Szeto P, Berry W, et al
    Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma.
    Br J Dermatol. 2025 Dec 9:ljaf507. doi: 10.1093.
    >> Share

  273. REFSUM E, Furu K, Cesta CE, Norgaard M, et al
    Topical retinoid use in women of reproductive age and risk of major congenital malformations in exposed pregnancies - a Nordic cohort study.
    Br J Dermatol. 2025 Dec 9:ljaf500. doi: 10.1093.
    >> Share

  274. ACENCIO ML, Lopata O, Hemedan AA, Dand N, et al
    The inflammatory skin disease map: an interactive computational resource focused on psoriasis and atopic dermatitis molecular mechanisms.
    Br J Dermatol. 2025 Dec 2:ljaf491. doi: 10.1093.
    >> Share

  275. XU X, Li W, Sun K, Hu F, et al
    scRNA-seq and Proteomics Uncover Glycolytic Dysregulation Linking Skin and Systemic Inflammation in Dermatomyositis.
    Br J Dermatol. 2025 Dec 2:ljaf486. doi: 10.1093.
    >> Share

  276. GAN X, Wu Y, Sun X, Zhao A, et al
    Chimeric antigen receptor T-cell therapy for relapsed/refractory primary cutaneous B-lymphoblastic lymphoma with rapid and durable systemic regression.
    Br J Dermatol. 2025 Dec 2:ljaf484. doi: 10.1093.
    >> Share

  277. VAN ROOIJ N, Sparkes A
    Biologic and Small-Molecule Therapies for Chronic Plaque Psoriasis in People Living with HIV: Current Evidence and Clinical Practical Considerations.
    Br J Dermatol. 2025 Dec 1:ljaf493. doi: 10.1093.
    >> Share

    November 2025
  278. WANG D, Wu J, Guo Q, Li Z, et al
    Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial.
    Br J Dermatol. 2025 Nov 29:ljaf482. doi: 10.1093.
    >> Share

  279. MILTNER LA, Loman L, Ortiz JA, Zhang J, et al
    Multimorbidity and Atopic Dermatitis in a Population-Based Cohort: Severity-Dependent Association With Distinct Non-Atopic Multimorbidity Patterns.
    Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093.
    >> Share

  280. KNOPFEL N, Barberan-Martin S, Polubothu S, Sauvadet A, et al
    Gene discovery in extensive dermal melanocytosis reveals multiple mosaic causes.
    Br J Dermatol. 2025 Nov 27:ljaf481. doi: 10.1093.
    >> Share

  281. GOMEZ-TOMAS A, Gonzalez-Cruz C, Garcia-Patos V, Ferrandiz-Pulido C, et al
    Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients.
    Br J Dermatol. 2025 Nov 27:ljaf483. doi: 10.1093.
    >> Share

  282. MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
    Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden.
    Br J Dermatol. 2025 Nov 26:ljaf478. doi: 10.1093.
    >> Share

  283. FERTITTA L, Sarin KY, Romo CG, Bergqvist C, et al
    Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-D.
    Br J Dermatol. 2025 Nov 26:ljaf479. doi: 10.1093.
    >> Share

  284. STERN R
    Cancer and Psoriasis: Known Risk factors explain the Association.
    Br J Dermatol. 2025 Nov 25:ljaf477. doi: 10.1093.
    >> Share

  285. CHENG AY, Lin CC, Cheng AT, Chou MP, et al
    Incidence of skin cancer versus overall de novo malignancies among living donor liver transplant recipients in Taiwan: a cohort study.
    Br J Dermatol. 2025 Nov 24:ljaf472. doi: 10.1093.
    >> Share

  286. XIANG Z, Chen G, Yin L, Xi X, et al
    Cutaneous toxicity and management in CEA-targeted Chimeric Antigen Receptor T-cell therapy for solid tumors.
    Br J Dermatol. 2025 Nov 24:ljaf473. doi: 10.1093.
    >> Share

  287. ZHAO M, Xu Z, Wu L, Wei Z, et al
    Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial.
    Br J Dermatol. 2025 Nov 24:ljaf455. doi: 10.1093.
    >> Share

  288. CHEN J, Francis P, Martinez A, Marre E, et al
    Exploring sexual health in patients with cutaneous T-cell lymphoma: a mixed methods study.
    Br J Dermatol. 2025 Nov 20:ljaf466. doi: 10.1093.
    >> Share

  289. FRANZ A, Constantinou A, Hillmann K, Chasapi V, et al
    Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study.
    Br J Dermatol. 2025;193:1165-1173.
    >> Share

  290. INGRAM JR, Wozniak MB, Passera A, Uhlmann L, et al
    The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.
    Br J Dermatol. 2025;193:1155-1164.
    >> Share

  291. MEHTA H, Bishnoi A, Vinay K, Kumaran MS, et al
    Comparative efficacy of topical tofacitinib versus topical tacrolimus in the treatment of localized vitiligo: a randomized investigator-blinded intraindividual trial.
    Br J Dermatol. 2025;193:1112-1119.
    >> Share

  292. ZHANG H, Paus R, Dai Y, Song X, et al
    Transient receptor potential channels in hair follicle biology: physiological significance and translational relevance.
    Br J Dermatol. 2025;193:1065-1074.
    >> Share

  293. AKAIKE T, Ch'en PY, Hippe DS, Gilmour MW, et al
    Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy.
    Br J Dermatol. 2025;193:1221-1231.
    >> Share

  294. KINSLER VA
    Mosaic disorders affecting pigmentation - part 2: how to make a genetic diagnosis.
    Br J Dermatol. 2025;193:1047-1055.
    >> Share

  295. KUMAR S, Ralser DJ, Wenzel J, Frank J, et al
    Beneath the surface: delineating the subtypes of Dowling-Degos disease.
    Br J Dermatol. 2025;193:1075-1089.
    >> Share

  296. BOUDHABHAY I, Bellon N, Avramescu M, Bataille P, et al
    Prevalence of kidney complications in a large cohort of patients with recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2025;193:1204-1213.
    >> Share

  297. CHEN HW, Barber G, Foster J, Zigler CK, et al
    Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis.
    Br J Dermatol. 2025;193:1174-1181.
    >> Share

  298. BARBAROT S, Aubert H, Boivin M, Foureau A, et al
    Evaluation of antenatal prebiotic intake in infants at risk of atopy: the double-blind PREGRALL randomized clinical trial.
    Br J Dermatol. 2025 Nov 18:ljaf414. doi: 10.1093.
    >> Share

  299. SCHMITT T, Haneberg J, Egu D, Sebastia Moron C, et al
    The role of PKC subtype-specific signaling in the regulation of adhesion in human keratinocytes and skin in pemphigus.
    Br J Dermatol. 2025 Nov 15:ljaf458. doi: 10.1093.
    >> Share

  300. MALEKAN M, Rahmatpour Rokni G, Gholizadeh N, Mollapour Sisakht M, et al
    Efficacy and Safety of Baricitinib Versus Azathioprine Combined with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Single-Center, Randomized, Open-Label Trial.
    Br J Dermatol. 2025 Nov 14:ljaf456. doi: 10.1093.
    >> Share

  301. VAN HOUT NE, Nevot G, Jansen PAM, Mannan AA, et al
    From prebiotics to engineered microbes: microbe-inspired therapies for atopic dermatitis.
    Br J Dermatol. 2025 Nov 13:ljaf451. doi: 10.1093.
    >> Share

  302. DYANKOVA-PEEVA D, Kinsler VA
    Complete spontaneous resolution of NRAS-mosaic multiple congenital melanocytic naevi - proof of principle for therapeutic mole reversal.
    Br J Dermatol. 2025 Nov 11:ljaf447. doi: 10.1093.
    >> Share

  303. LISLE TL, Weis-Banke SE, Ahmad SM, Holmstrom MO, et al
    Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.
    Br J Dermatol. 2025 Nov 10:ljaf450. doi: 10.1093.
    >> Share

  304. LOFT N, Zachariae C, Kaur-Knudsen D, Bunick CG, et al
    Pustular psoriasis following treatment with biologics among patients with plaque psoriasis: a nationwide cohort study.
    Br J Dermatol. 2025 Nov 8:ljaf448. doi: 10.1093.
    >> Share

  305. STAVE SDW, Nymand LK, Ferrucci SM, Ribero S, et al
    Patient preferences for treatment of atopic dermatitis: findings from the Danish Skin Cohort.
    Br J Dermatol. 2025 Nov 7:ljaf388. doi: 10.1093.
    >> Share

  306. YEUNG K, Weber JF, Stegenborg-Grathwohl SM, Bischofberger N, et al
    Heterogeneous generation and expansion of epidermal-resident memory T cells in individuals allergic to nickel.
    Br J Dermatol. 2025 Nov 6:ljaf427. doi: 10.1093.
    >> Share

  307. SIEBORG J, Zwahlen D, Maul JT, Haedersdal M, et al
    Psychological distress and unmet supportive care needs in melanoma-survivors and high-risk patients for melanoma: A Swiss cross-sectional study.
    Br J Dermatol. 2025 Nov 5:ljaf439. doi: 10.1093.
    >> Share

  308. FOURMOUND S, Dumonteil S, Akil H, Couraud A, et al
    Specific serum and skin immunological profiles of patients with bullous pemphigoid requiring biologic therapies.
    Br J Dermatol. 2025 Nov 4:ljaf430. doi: 10.1093.
    >> Share

  309. TSAKOK T, Yiu ZZN, Smith CH
    Psoriasis at high-impact sites: shifting the paradigm.
    Br J Dermatol. 2025 Nov 4:ljaf404. doi: 10.1093.
    >> Share

  310. MI Z, Yu Y, Wang Z, Bai F, et al
    Excessive Glycine Loop Variations in the Keratin 10 Tail Domain and Implications for Skin Fragility.
    Br J Dermatol. 2025 Nov 4:ljaf436. doi: 10.1093.
    >> Share

  311. AGATHANGELIDI TA, Carson L, Doolan BJ, Dubois A, et al
    An ontological analysis of a dataset of curated dermatological gene disease associations (G2P-Skin).
    Br J Dermatol. 2025 Nov 3:ljaf438. doi: 10.1093.
    >> Share

  312. KAHLER S, Primiero C, Mothershaw A, Jayasinghe D, et al
    3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk.
    Br J Dermatol. 2025 Nov 3:ljaf440. doi: 10.1093.
    >> Share

  313. LIU Y, Tan L
    A Missing Piece in the Cutaneous Melanoma Puzzle: Metabolic Reprogramming Driven by Loss of TET2/5hmC.
    Br J Dermatol. 2025 Nov 3:ljaf442. doi: 10.1093.
    >> Share

  314. JAMES ML, Freeman A, Haider A, Kravvas G, et al
    Perianal melanosis, benign genital melanosis and lichen sclerosus.
    Br J Dermatol. 2025 Nov 3:ljaf443. doi: 10.1093.
    >> Share

  315. BRUGRAND O, O'Shea S
    From Flare to Freedom: A Young Woman's Guttate Psoriasis Journey.
    Br J Dermatol. 2025 Nov 1:ljaf433. doi: 10.1093.
    >> Share

    October 2025
  316. THIMJO J, Das D, Enerback C, Ludvigsson J, et al
    Infections during childhood as predisposing factors to develop Psoriasis Vulgaris into early adulthood.
    Br J Dermatol. 2025 Oct 31:ljaf416. doi: 10.1093.
    >> Share

  317. MCPHERSON T, Ravenscroft JC, Fazel M, Nancarrow R, et al
    Reframing 'Dermatitis Artefacta' in Children and Young People as a Functional Skin Disorder: building trust, improving communication and enhancing recovery.
    Br J Dermatol. 2025 Oct 29:ljaf426. doi: 10.1093.
    >> Share

  318. LEE KJ, Kao YC, Jiang A, Prokofyeva A, et al
    Subclinical Fields of BRAF V600E-Mutant Melanocytes Populate Human Skin and Are Enriched Around Melanoma and Naevi.
    Br J Dermatol. 2025 Oct 28:ljaf412. doi: 10.1093.
    >> Share

  319. YOSHINO K, Fujisawa Y, Yoshikawa S, Maekawa T, et al
    Nivolumab in the treatment of non-melanoma skin cancer: multi-center, retrospective analysis of 46 cases.
    Br J Dermatol. 2025 Oct 27:ljaf420. doi: 10.1093.
    >> Share

  320. SINGH J, Korevaar JC, van Houten KM, Vondenhoff MFR, et al
    Exploring patients' views on a more proactive role for allied healthcare professionals in the identification of suspicious skin lesions: a qualitative study.
    Br J Dermatol. 2025 Oct 27:ljaf421. doi: 10.1093.
    >> Share

  321. IVERT LU, Anveden-Berglind I, Gembert K, Eriksson J, et al
    The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study.
    Br J Dermatol. 2025 Oct 24:ljaf418. doi: 10.1093.
    >> Share

  322. ZHAO S, Xie J, He Y, Li L, et al
    Unveiling the TBX2-driven molecular landscape of large/giant congenital melanocytic nevi: from single-cell sequencing to targeted therapy.
    Br J Dermatol. 2025 Oct 23:ljaf415. doi: 10.1093.
    >> Share

  323. GRAIER T, Lwin SM, Griffiths CEM
    Breaking the Cycle of Psoriasis: The Role for Early Intervention.
    Br J Dermatol. 2025 Oct 22:ljaf403. doi: 10.1093.
    >> Share

  324. MISTRY K, Bagdatoglou G, Daniels S, Lorigan P, et al
    The economic burden of melanoma in the UK: A stage-specific cost analysis underscoring the importance of prevention and early diagnosis.
    Br J Dermatol. 2025 Oct 22:ljaf393. doi: 10.1093.
    >> Share

  325. LIANG B, Pu M, Xu YN, Li Y, et al
    Dandruff scalp microbiome exhibits flake severity and sex-related differences.
    Br J Dermatol. 2025;193.
    >> Share

  326. XU YN, Salgaonkar N, Pu M, Hawkins S, et al
    Unveiling acne microbiome signatures: the role of the microbiome and the impact of a facewash formula containing plant-derived monoterpenes.
    Br J Dermatol. 2025;193.
    >> Share

  327. YUE X, Wang H, Xu YN, Chu CC, et al
    Microbiome network: a robust biomarker of skin health.
    Br J Dermatol. 2025;193.
    >> Share

  328. CHEVITI B, Cawley A, Malviya S, Murphy B, et al
    Mild skin cleansers strengthen microbiome networks without affecting the skin microbiome.
    Br J Dermatol. 2025;193.
    >> Share

  329. ARIAS-MERINO G, Benito-Lozano J, Gomez-Martinez M, Villaverde-Hueso A, et al
    Health-related quality-of-life evaluation in epidermolysis bullosa: a scoping review.
    Br J Dermatol. 2025;193:856-864.
    >> Share

  330. ITO S, Kolbe L, Weets G, Rogers T, et al
    Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone.
    Br J Dermatol. 2025;193:959-967.
    >> Share

  331. BROADAWAY KA, Sun Q, Edmiston SN, Currin KW, et al
    Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.
    Br J Dermatol. 2025;193:948-958.
    >> Share

  332. KINSLER VA, Knopfel N, Polubothu S
    Segmental macular hyperpigmentation: new genes, new clinical implications.
    Br J Dermatol. 2025;193:987-995.
    >> Share

  333. KINSLER VA
    Mosaic disorders affecting pigmentation - part 1: how to make a clinical diagnosis.
    Br J Dermatol. 2025;193:819-829.
    >> Share

  334. SWIDERSKI M, Lewis S, Vinogradova Y, Ridd MJ, et al
    Incidence rates of bullous pemphigoid, herpes zoster and urticaria following the start of the COVID-19 vaccination programme in the UK: a population-based cohort study.
    Br J Dermatol. 2025;193:889-897.
    >> Share

  335. ZHU G, Gordon S, Green AC, Martin NG, et al
    Halving of Australian children's naevus counts during 1992-2016 and change in sun behaviour.
    Br J Dermatol. 2025;193:898-906.
    >> Share

  336. SZONDI DC, Crompton RA, Oon L, Subramaniam N, et al
    Keratinocyte arginase 1 regulates proinflammatory responses and drives re-epithelialization via lipocalin 2.
    Br J Dermatol. 2025;193:924-935.
    >> Share

  337. DASKALOPOULOU A, Assrawi E, Diab F, Louvrier C, et al
    Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3-related disorders and therapeutic implications.
    Br J Dermatol. 2025;193:914-923.
    >> Share

  338. SILVERBERG JI, Skayem C, Le Floc'h C, Begolka WS, et al
    Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by Parents.
    Br J Dermatol. 2025 Oct 17:ljaf411. doi: 10.1093.
    >> Share

  339. TAI MC, Wang JY, Yang CC, Tsai SJ, et al
    Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility, and renal function impact.
    Br J Dermatol. 2025 Oct 16:ljaf408. doi: 10.1093.
    >> Share

  340. MCGRATH JA
    From connective tissue builders to cellular architects: the journey of the skin fibroblast.
    Br J Dermatol. 2025 Oct 16:ljaf407. doi: 10.1093.
    >> Share

  341. PARK JJ, Nguyen CV, Choi JN, Guitart J, et al
    Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestations.
    Br J Dermatol. 2025 Oct 15:ljaf297. doi: 10.1093.
    >> Share

  342. LAI P, Cao M, Li M, Jiang Y, et al
    Atopic dermatitis shares a distinct T helper 2 subset with mycosis fungoides that exhibits autonomous proliferative potential.
    Br J Dermatol. 2025 Oct 14:ljaf362. doi: 10.1093.
    >> Share

  343. LEBWOHL MG, Blauvelt A, Bagel J, Gogineni R, et al
    Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over five years in patients living with obesity.
    Br J Dermatol. 2025 Oct 14:ljaf392. doi: 10.1093.
    >> Share

  344. MELCHIONDA V, van Bodegraven B, Archer CMG, Perkins W, et al
    National epidemiology of dermatofibromasarcoma protuberans, England 2013-2022.
    Br J Dermatol. 2025 Oct 14:ljaf401. doi: 10.1093.
    >> Share

  345. AKINSHEMOYIN VAUGHN OL
    The Long Road to Standardization in Vulvar Lichen Sclerosus Research.
    Br J Dermatol. 2025 Oct 13:ljaf405. doi: 10.1093.
    >> Share

  346. TRAFFORD AM, Schonmann Y, Chen TC, Egeberg A, et al
    Psoriasis and the risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel, and Taiwan.
    Br J Dermatol. 2025 Oct 12:ljaf399. doi: 10.1093.
    >> Share

  347. LIPNICK MS, Chen D, Law T, Moore K Jr, et al
    Comparison of methods for characterizing skin pigment diversity in research cohorts.
    Br J Dermatol. 2025 Oct 10:ljaf397. doi: 10.1093.
    >> Share

  348. HO G, Smith AL, Collgros H, Sinz C, et al
    Clinician and patient perspectives on implementation of a remote interpretation model of reflectance confocal microscopy for skin cancer diagnosis: a qualitative study using an acceptability framework.
    Br J Dermatol. 2025 Oct 9:ljaf348. doi: 10.1093.
    >> Share

  349. WEHKAMP U, Assaf C
    Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder - a truly "benign" disease?
    Br J Dermatol. 2025 Oct 5:ljaf389. doi: 10.1093.
    >> Share

  350. WRIGHT AK, Swan R, Xu J, Lwin SM, et al
    Skin disease in the Eastern Cape (SKINSCAPE): a Global Psoriasis Atlas point prevalence study in rural South Africa.
    Br J Dermatol. 2025 Oct 3:ljaf386. doi: 10.1093.
    >> Share

  351. SVEDBOM A
    Potential additional benefits of glucagon-like peptide-1 receptor agonists in psoriasis.
    Br J Dermatol. 2025 Oct 1:ljaf382. doi: 10.1093.
    >> Share

    September 2025
  352. KEDDIE SH, Griffiths CEM, Jemec GBE, Ezzedine K, et al
    Grand Challenges for Skin Health Revisited: The International League of Dermatological Societies (ILDS) Skin Disease Atlases.
    Br J Dermatol. 2025 Sep 30:ljaf358. doi: 10.1093.
    >> Share

  353. FISCHER GM, Fang R, Xu S, Karkempetzaki AI, et al
    Loss of TET2 Facilitates Aggressive Behavior in Cutaneous Melanoma by Inducing PGC1alpha/Oxidative Phosphorylation (OXPHOS).
    Br J Dermatol. 2025 Sep 27:ljaf378. doi: 10.1093.
    >> Share

  354. AFTAB Y, Moloney S, Ho B, Raymond B, et al
    Four decades of stagnation: A qualitative exploration of the lived experience of Atopic Dermatitis across ethnically and sexually diverse adults in the United Kingdom.
    Br J Dermatol. 2025 Sep 26:ljaf377. doi: 10.1093.
    >> Share

  355. DRUCKER AM, Williams E, Kaffenberger B, Dodiuk-Gad RP, et al
    Long-term morbidity and quality of life among survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Br J Dermatol. 2025 Sep 26:ljaf380. doi: 10.1093.
    >> Share

  356. WANG SP, Myers E, Arents BWM, Flohr C, et al
    Caution regarding interpretation of trends for the global burden of atopic dermatitis and asthma.
    Br J Dermatol. 2025 Sep 26:ljaf369. doi: 10.1093.
    >> Share

  357. YIU ZZN
    Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis.
    Br J Dermatol. 2025 Sep 23:ljaf316. doi: 10.1093.
    >> Share

  358. WARREN RB, de Bruin-Weller M, Tsianakas A, Khemis A, et al
    Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).
    Br J Dermatol. 2025 Sep 22:ljaf285. doi: 10.1093.
    >> Share

  359. FOSTER EL, Davis MI, Li AX, Kottner J, et al
    Identification of key symptoms for a core outcome set for research in vulvar lichen sclerosus: a CORALS symptom domain initiative.
    Br J Dermatol. 2025 Sep 22:ljaf374. doi: 10.1093.
    >> Share

  360. TAN W, Chen Z, Xu M, Chen J, et al
    Single-cell RNA sequencing reveals transcriptomic landscape and potential targets for large/giant congenital melanocytic nevi.
    Br J Dermatol. 2025 Sep 20:ljaf360. doi: 10.1093.
    >> Share

  361. MAI JZ, Kitahara CM, Sargen MR, Little MP, et al
    Residential ambient ultraviolet B and ultraviolet A and incidence of keratinocyte carcinoma in the nationwide US Radiologic Technologists cohort.
    Br J Dermatol. 2025;193:678-686.
    >> Share

  362. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
    ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.
    Br J Dermatol. 2025;193:653-661.
    >> Share

  363. JOPP H, Kraft A, Hoffmann B, Merkel R, et al
    Preclinical validation of PKC412 as a therapy candidate for epidermolysis bullosa simplex across multiple keratin pathogenic variants.
    Br J Dermatol. 2025;193:741-757.
    >> Share

  364. AKIYAMA M, Choate K, Hernandez-Martin A, Aldwin-Easton M, et al
    Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
    Br J Dermatol. 2025;193:619-641.
    >> Share

  365. PALLER AS, Teng J, Mazereeuw-Hautier J, Hernandez-Martin A, et al
    Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
    Br J Dermatol. 2025;193:592-618.
    >> Share

  366. ZHANG L, Wang M, Zhang L, Liang Y, et al
    Efficacy and Safety of Pumecitinib Gel for Treating Mild-to-moderate Atopic Dermatitis: a Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Phase IIb Clinical Trial.
    Br J Dermatol. 2025 Sep 18:ljaf363. doi: 10.1093.
    >> Share

  367. FOSTER J, Sarlashkar P, Lu G, Teske N, et al
    Disparities in online patient education materials for rheumatic skin diseases.
    Br J Dermatol. 2025 Sep 15:ljaf371. doi: 10.1093.
    >> Share

  368. WHITEMAN DC
    BRAF testing for melanoma in England.
    Br J Dermatol. 2025 Sep 12:ljaf373. doi: 10.1093.
    >> Share

  369. HE H, Xiao M, Song L, Tian Y, et al
    Lipidome-microbiome crosstalk as an outer niche in the skin: regulatory networks in health and disease.
    Br J Dermatol. 2025 Sep 11:ljaf353. doi: 10.1093.
    >> Share

  370. AHMED S, van Bodegraven B, Proby C, Harwood CA, et al
    Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20.
    Br J Dermatol. 2025 Sep 10:ljaf352. doi: 10.1093.
    >> Share

  371. SAMOTIJ D, Reich A
    Could TYK2 inhibition be a breakthrough in the effective treatment of cutaneous lupus erythematosus?
    Br J Dermatol. 2025 Sep 9:ljaf357. doi: 10.1093.
    >> Share

  372. BASHALL SEL, Thomas BR, Sim V, Wain M, et al
    Primary Cutaneous CD4+ Small Medium T Cell Lymphoproliferative Disorder - 20 years of experience from a specialist centre.
    Br J Dermatol. 2025 Sep 8:ljaf338. doi: 10.1093.
    >> Share

  373. BOULANGER KP, McCuaig C, Roy AA, Kokta V, et al
    Striking improvement with targeted therapy in an ALK-positive atypical giant congenital melanocytic naevus of the right lower limb: a case report.
    Br J Dermatol. 2025 Sep 8:ljaf334. doi: 10.1093.
    >> Share

  374. WANG Y, Xin X, Xu Z
    Primary Annular Psoriasis.
    Br J Dermatol. 2025 Sep 5:ljaf340. doi: 10.1093.
    >> Share

  375. GHOSH S, Pavlova O, Latshaw A, Kim D, et al
    Multi-Harmonic Imaging-Based Automated Recognition of Cutaneous T-Cell Lymphoma.
    Br J Dermatol. 2025 Sep 4:ljaf345. doi: 10.1093.
    >> Share

  376. HAFERKAMP S, Schilling B, Berking C, Drexler K, et al
    Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II study.
    Br J Dermatol. 2025 Sep 4:ljaf350. doi: 10.1093.
    >> Share

  377. MISTRY K, Jeffrey P, Levell NJ, Kennedy O, et al
    A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21.
    Br J Dermatol. 2025 Sep 3:ljaf351. doi: 10.1093.
    >> Share

  378. LIU Z, Zheng DQ, Fan YM
    Recurrent eczematous dermatitis in a port-wine stain: Meyerson phenomenon.
    Br J Dermatol. 2025 Sep 3:ljaf342. doi: 10.1093.
    >> Share

  379. OLBRICH H, Kridin K, Zirpel H, Hernandez G, et al
    GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study.
    Br J Dermatol. 2025 Sep 3:ljaf346. doi: 10.1093.
    >> Share

  380. TENG YS, Wang HJ
    Kaposi varicelliform eruption.
    Br J Dermatol. 2025 Sep 2:ljaf343. doi: 10.1093.
    >> Share

  381. ZHANG J, Silverberg JI, Guo J, Yun J, et al
    Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing.
    Br J Dermatol. 2025 Sep 2:ljaf347. doi: 10.1093.
    >> Share

    August 2025
  382. GU Y, Zhang B
    Stink bug-induced cutaneous chromatosis.
    Br J Dermatol. 2025 Aug 29:ljaf336. doi: 10.1093.
    >> Share

  383. REICH K, Langley RG, Salvador JFS, Staumont-Salle D, et al
    Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of 8 clinical trials.
    Br J Dermatol. 2025 Aug 29:ljaf309. doi: 10.1093.
    >> Share

  384. STEIN GOLD L, Gottlieb AB, Armstrong AW, Alkousakis T, et al
    SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement.
    Br J Dermatol. 2025 Aug 28:ljaf327. doi: 10.1093.
    >> Share

  385. XU YN, Pu M, Raut J, Du Y, et al
    Skin microbiome as a signature of premature ageing appearance: Manipulation through by use of topical products.
    Br J Dermatol. 2025 Aug 27:ljaf098. doi: 10.1093.
    >> Share

  386. MAUBEC E
    Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.
    Br J Dermatol. 2025 Aug 21:ljaf331. doi: 10.1093.
    >> Share

  387. MOSS C
    Dermatitis artefacta explains haematohidrosis.
    Br J Dermatol. 2025 Aug 21:ljaf329. doi: 10.1093.
    >> Share

  388. MATSUDA KM, Harada T, Doi M, Io T, et al
    An open-label randomized parallel-group phase I study of the oral Bruton tyrosine kinase inhibitor tirabrutinib in systemic sclerosis.
    Br J Dermatol. 2025;193:434-441.
    >> Share

  389. CHUNG HY, Chen CB, Lee HE, Lu CW, et al
    Janus kinase/signal transducer and activator of transcription signalling pathway is involved in the immune mechanism of bullous pemphigoid.
    Br J Dermatol. 2025;193:521-531.
    >> Share

  390. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
    ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging.
    Br J Dermatol. 2025;193:405-414.
    >> Share

  391. EL HACHEM M, Caldaro T, Lara-Corrales I, Pope E, et al
    Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline.
    Br J Dermatol. 2025;193:394-404.
    >> Share

  392. CHRISTOU E, Lalagianni N, McSweeney SM, Cotter C, et al
    Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study.
    Br J Dermatol. 2025;193:458-467.
    >> Share

  393. MALOVITSKI K, Feller Y, Giladi M, Janagond AB, et al
    Loss-of-function variants in DUSP1 encoding dual specificity phosphatase 1 cause palmoplantar keratoderma.
    Br J Dermatol. 2025;193:532-543.
    >> Share

  394. FUCHS M, Mochel M, Radeva MY, Schmitt T, et al
    Direct inhibition precedes p38 mitogen activated protein kinase-mediated uncoupling in desmosomes to reduce desmoglein 3 adhesion by pemphigus autoantibodies.
    Br J Dermatol. 2025;193:468-479.
    >> Share

  395. QIAN Q, Gu Y, Luo J, Wu S, et al
    Genetic and environmental factors affecting hair density in East Asian populations.
    Br J Dermatol. 2025;193:502-513.
    >> Share

  396. BONE M, Schreyer D, Treanor-Taylor M, Proby CM, et al
    The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression.
    Br J Dermatol. 2025;193:490-501.
    >> Share

  397. SPRECHER E, Ishida-Yamamoto A, Schwartz J, Akiyama M, et al
    Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
    Br J Dermatol. 2025;193:364-380.
    >> Share

  398. BABER C, Busch L, Klein AL, Infante VHP, et al
    Mechanistic in vivo studies of secondary skin-to-skin peanut allergen transfer to determine the impact of hand washing in reducing the risk of cutaneous sensitization.
    Br J Dermatol. 2025 Aug 16:ljaf214. doi: 10.1093.
    >> Share

  399. SHIMOMURA Y
    Unravelling the molecular basis for premature diffuse familial sebaceous hyperplasia.
    Br J Dermatol. 2025 Aug 12:ljaf320. doi: 10.1093.
    >> Share

  400. WASSERER S, Seiringer P, Kurzen N, Jargosch M, et al
    TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupus.
    Br J Dermatol. 2025 Aug 8:ljaf293. doi: 10.1093.
    >> Share

  401. WILLEMZE R, Assaf C, Bagot M, Beylot-Barry M, et al
    EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.
    Br J Dermatol. 2025 Aug 6:ljaf312. doi: 10.1093.
    >> Share

    July 2025
  402. PALLER AS, Fiorillo L, Becker E, Armesto S, et al
    Efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial.
    Br J Dermatol. 2025 Jul 30:ljaf305. doi: 10.1093.
    >> Share

  403. KELLY ASV, Moustaqim-Barrette A, Xie C, Shah A, et al
    Under the arctic sun: assessment of skin cancer risk and sun protection behaviors in Indigenous communities in Nunavik, an emerging at-risk population for skin cancers.
    Br J Dermatol. 2025 Jul 30:ljaf290. doi: 10.1093.
    >> Share

  404. BECKER JC, Gesierich AH, Leiter U, Zimmer L, et al
    Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial.
    Br J Dermatol. 2025 Jul 26:ljaf303. doi: 10.1093.
    >> Share

  405. LIANG L, Wang S, Huang S, Sun Y, et al
    A gain-of-function variant in NNT causes premature diffuse familial sebaceous hyperplasia.
    Br J Dermatol. 2025 Jul 25:ljaf294. doi: 10.1093.
    >> Share

  406. FOLKMANN CL, Pinborg EH, Iversen M, Ronnstad ATM, et al
    The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis.
    Br J Dermatol. 2025;193:212-220.
    >> Share

  407. HIEL MAJ, Korte EWH, Tedbirt B, Bolling MC, et al
    Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitions.
    Br J Dermatol. 2025;193:221-231.
    >> Share

  408. TORRELO A, Colmenero I, Alvarez-Twose I
    Childhood mastocytosis: challenges and potential shortfalls in current disease classification.
    Br J Dermatol. 2025;193:203-211.
    >> Share

  409. HUANG Z, Zhao W, Xu C, Zheng J, et al
    Interleukin (IL)-34 promotes the inflammatory role of IL-1beta-producing myeloid cells in pemphigus lesions.
    Br J Dermatol. 2025;193:287-297.
    >> Share

  410. NOCK MR, Griffiths D, Shields A, Michael K, et al
    Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites.
    Br J Dermatol. 2025;193:267-275.
    >> Share

  411. MOSTAGHIMI A, Craiglow B, King B, Shapiro J, et al
    Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib.
    Br J Dermatol. 2025;193:240-249.
    >> Share

  412. PARAGH G, Huss WJ
    Shedding new light on narrowband ultraviolet B phototherapy: balancing psoriasis treatment and carcinogenic risk.
    Br J Dermatol. 2025 Jul 16:ljaf218. doi: 10.1093.
    >> Share

  413. KWATRA SG, Pereira MP, Misery L, Mollanazar NK, et al
    Prurigo nodularis: disease burden, clinical features and approach to management.
    Br J Dermatol. 2025 Jul 16:ljaf213. doi: 10.1093.
    >> Share

  414. CREAMER D
    Quality of life assessment in Stevens-Johnson syndrome / toxic epidermal necrolysis (SJS/TEN): damage assessment guides damage limitation.
    Br J Dermatol. 2025 Jul 15:ljaf278. doi: 10.1093.
    >> Share

  415. GALILI E, Barzilai A, Lev A, Amit S, et al
    Genetic, immunological and clinical assessment of isolated chronic recalcitrant dermatophytosis: A prospective study.
    Br J Dermatol. 2025 Jul 15:ljaf269. doi: 10.1093.
    >> Share

  416. LIU D, Hu BD, Mishra A, Patel D, et al
    Tape Strips in Inflammatory Skin Disease: A Noninvasive Method for Molecular Insights and Personalized Care.
    Br J Dermatol. 2025 Jul 14:ljaf275. doi: 10.1093.
    >> Share

  417. NARDIN C, Cavalieri C, Lebbe C, Gerard E, et al
    Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).
    Br J Dermatol. 2025 Jul 14:ljaf268. doi: 10.1093.
    >> Share

  418. EPSTEIN Z, Epstein L, Rork J, Koo J, et al
    Skin Picking in Down syndrome: A Patient Speaks Out.
    Br J Dermatol. 2025 Jul 7:ljaf264. doi: 10.1093.
    >> Share

  419. KARPONIS D, Mistry K, Stratigos G, Levell NJ, et al
    Can the effects of the COVID-19 pandemic provide insights into the impact of melanoma under-diagnosis and delayed care?
    Br J Dermatol. 2025 Jul 3:ljaf263. doi: 10.1093.
    >> Share

  420. PAPADAVID E, Scarisbrick J
    The critical role of National Referral Centers of excellence in the accurate diagnosis and management of Cutaneous Lymphomas.
    Br J Dermatol. 2025 Jul 3:ljaf256. doi: 10.1093.
    >> Share

    June 2025
  421. AFACH S, Sbidian E
    Hormonal therapy and psoriasis risk: a new concern for women's health?
    Br J Dermatol. 2025 Jun 30:ljaf261. doi: 10.1093.
    >> Share

  422. KRISTYANTO H, Rey Torre S, Cunney A, Dunder K, et al
    The European Medicines Agency evaluation of nemolizumab (Nemluvio) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis.
    Br J Dermatol. 2025 Jun 28:ljaf259. doi: 10.1093.
    >> Share

  423. DOUSSET L, Khalife F, Chalopin-Fillot D, Dartigues B, et al
    Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumor features and responses to treatment by DHODH inhibitors.
    Br J Dermatol. 2025 Jun 27:ljaf253. doi: 10.1093.
    >> Share

  424. CAI ZR, Kim J, Rezaei SJ, Chen ML, et al
    Assessing the Performance of Artificial Intelligence Models in Evaluating Inflammatory Skin Disease Severity: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2025 Jun 26:ljaf250. doi: 10.1093.
    >> Share

  425. BAI X, Flaherty KT
    The Rise of New Targets in Melanoma.
    Br J Dermatol. 2025 Jun 26:ljaf251. doi: 10.1093.
    >> Share

  426. SEXTON F, O' Mahony J, Sumera S, Golchin R, et al
    Culprit allergens in diabetes technology-associated allergic contact dermatitis: investigation remains challenging.
    Br J Dermatol. 2025 Jun 26:ljaf245. doi: 10.1093.
    >> Share

  427. IMHOF RL, Yang E, Lehman J, Tekin B, et al
    Lichen planus pemphigoides - A retrospective single-center cohort over two decades and comparison of idiopathic vs. drug-induced cases.
    Br J Dermatol. 2025 Jun 25:ljaf240. doi: 10.1093.
    >> Share

  428. LEE EY, Ang YS, Leow SY, Koh MJA, et al
    Mobile Inpatient Care at Home: A Pilot Programme for Paediatric Patients with Atopic Dermatitis in Singapore.
    Br J Dermatol. 2025 Jun 24:ljaf246. doi: 10.1093.
    >> Share

  429. LIU T, Chang JM
    Clown Nose-Like Cutaneous Metastasis.
    Br J Dermatol. 2025 Jun 24:ljaf247. doi: 10.1093.
    >> Share

  430. ALANI O, Ahmed A, Haraldsdottir EL, Hoyt D, et al
    The Incidence and Impact of Melanoma Subtypes in Iceland 1955-2023.
    Br J Dermatol. 2025 Jun 23:ljaf248. doi: 10.1093.
    >> Share

  431. GOODERHAM M, Torres T, Imafuku S, Rademaker M, et al
    Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up).
    Br J Dermatol. 2025 Jun 23:ljaf236. doi: 10.1093.
    >> Share

  432. O'REILLY P, Savarimalai R, Walsh S, Barry LA, et al
    The impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: A mixed method systematic review.
    Br J Dermatol. 2025 Jun 21:ljaf229. doi: 10.1093.
    >> Share

  433. YUAN Y, Wang H, Pan M, Zheng J, et al
    Exome and transcriptome analysis link calcium channel pathway aberrations to botulinum toxin A resistance in Hailey-Hailey disease.
    Br J Dermatol. 2025;193:147-156.
    >> Share

  434. KIRBY JS, Thorlacius L, Lambert J, Ciaravino V, et al
    Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL(c)) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.
    Br J Dermatol. 2025;193:93-104.
    >> Share

  435. YOKOZEKI H, Murota H, Matsumura T
    Long-term (68 weeks) administration of nemolizumab and topical corticosteroids for prurigo nodularis in patients aged >/= 13 years: efficacy and safety data from a phase II/III study.
    Br J Dermatol. 2025;193:56-65.
    >> Share

  436. HOWELLS L, Leighton P, Thomas KS, Collier F, et al
    A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.
    Br J Dermatol. 2025;193:85-92.
    >> Share

  437. GAY-MIMBRERA J, Lozano-Ojalvo D, Gomez-Arias PJ, Rivera-Ruiz I, et al
    Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo.
    Br J Dermatol. 2025;193:115-124.
    >> Share

  438. CHANG CY, Chan K, Chen HC, Lai CC, et al
    Atopic dermatitis epidemiological research methodology: a global scoping review.
    Br J Dermatol. 2025 Jun 19:ljaf238. doi: 10.1093.
    >> Share

  439. KAHLER S, Primiero C, Jayasinghe D, Mothershaw A, et al
    Unpredictable interdependence of invasive and in situ melanoma.
    Br J Dermatol. 2025 Jun 19:ljaf235. doi: 10.1093.
    >> Share

  440. TAN JY, Marlow L, Phillips C, McPherson T, et al
    Chronic inflammatory skin conditions in adolescents and their impact on intimate relationships - a quantitative and qualitative study.
    Br J Dermatol. 2025 Jun 13:ljaf228. doi: 10.1093.
    >> Share

  441. XIAO H, Ding Y, Shen M, Chen X, et al
    Menopausal Age, Hormone Therapy, and Risk of Psoriasis: A Prospective Cohort Study applying Inverse Probability of Treatment Weighting Analysis.
    Br J Dermatol. 2025 Jun 10:ljaf222. doi: 10.1093.
    >> Share

  442. SIA T, Li S, Zhong X, Park C, et al
    Acitretin chemoprevention in non-melanoma skin cancer patients with chronic hematopoietic disease: findings from three independent databases.
    Br J Dermatol. 2025 Jun 10:ljaf221. doi: 10.1093.
    >> Share

  443. LIU Z, Zhang Y, Wang K, Xie F, et al
    Early diagnosis model of mycosis fungoides and five inflammatory skin diseases based on multi-modal data-based convolutional neural network.
    Br J Dermatol. 2025 Jun 4:ljaf212. doi: 10.1093.
    >> Share

  444. LIU X, McBride JD
    Unmethylated PRAME DNA in Tissue and Plasma: A Promising Marker for Melanoma.
    Br J Dermatol. 2025 Jun 3:ljaf217. doi: 10.1093.
    >> Share

  445. DANESH K, Adler BL, Vecerek N
    Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus.
    Br J Dermatol. 2025 Jun 3:ljaf215. doi: 10.1093.
    >> Share

    May 2025
  446. BRUSTAD N, Wang T, Chen L, Kaiser H, et al
    Prenatal high-dose vitamin D supplementation and childhood atopic dermatitis until age 6 years: A secondary analysis of a randomized clinical trial.
    Br J Dermatol. 2025 May 30:ljaf208. doi: 10.1093.
    >> Share

  447. BOOSTANI M, Wortsman X, Pellacani G, Cantisani C, et al
    Dermoscopy-guided high-frequency ultrasound for preoperative assessment of basal cell carcinoma lateral margins: A pilot study.
    Br J Dermatol. 2025 May 29:ljaf209. doi: 10.1093.
    >> Share

  448. LAIMER M, South AP, Mayr E, Kitzmueller S, et al
    Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2025 May 29:ljaf205. doi: 10.1093.
    >> Share

  449. TYSON-CARR J, Leng J, Scott M, Adams S, et al
    Body-site specific associations between human skin microbiome composition and psychological wellbeing.
    Br J Dermatol. 2025 May 26:ljaf177. doi: 10.1093.
    >> Share

  450. GARGIULO L, Costanzo A
    Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis.
    Br J Dermatol. 2025 May 23:ljaf186. doi: 10.1093.
    >> Share

  451. MCGRATH JA, Mellerio JE
    The classification of Ichthyosis morphs into Epidermal Differentiation Disorders.
    Br J Dermatol. 2025 May 23:ljaf197. doi: 10.1093.
    >> Share

  452. LEE JYW, Mahil SK
    Systemic inflammation and psoriasis: unpicking a complex relationship.
    Br J Dermatol. 2025 May 23:ljaf203. doi: 10.1093.
    >> Share

  453. ANDREW PV, Williams SF, Brown K, Chittock J, et al
    Topical supplementation with physiologic lipids rebalances the stratum corneum ceramide profile and strengthens skin barrier function in adults predisposed to atopic dermatitis.
    Br J Dermatol. 2025 May 23:ljaf200. doi: 10.1093.
    >> Share

  454. MAHO-VAILLANT M, Lemieux A, Arnoult C, Lebourgeois L, et al
    Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus.
    Br J Dermatol. 2025;192:1072-1082.
    >> Share

  455. KIM BR, Kim G, Jin SP, Choi CW, et al
    Causal association between polyunsaturated fatty acids and acne: a two-sample Mendelian randomization study.
    Br J Dermatol. 2025;192:1106-1114.
    >> Share

  456. MURRELL DF, Bodemer C, Bruckner AL, Cunningham T, et al
    Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study.
    Br J Dermatol. 2025;192:1007-1017.
    >> Share

  457. APFELBACHER C, Bewley A, Molin S, Fargnoli MC, et al
    Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK.
    Br J Dermatol. 2025;192:1047-1054.
    >> Share

  458. DIMITRION PM, Krevh R, Veenstra J, Ge J, et al
    High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa.
    Br J Dermatol. 2025;192:1063-1071.
    >> Share

  459. POWELL JB, Dhesi JK, Harwood CA, McGrath EJ, et al
    How do we avoid over-treating skin cancer in people with severe frailty and limited life expectancy?
    Br J Dermatol. 2025 May 15:ljaf174. doi: 10.1093.
    >> Share

  460. DA ROSA GP, Santos JV, Cerejeira A, Matos P, et al
    Patterns of hospitalizations due to bacterial skin and soft tissue infections: a retrospective observational study from a Portuguese national registry.
    Br J Dermatol. 2025 May 15:ljaf157. doi: 10.1093.
    >> Share

  461. DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
    Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
    Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
    >> Share

  462. CHEN JQ, Zheng M, Yin WH, Wang P, et al
    Safety and efficacy of the selective TYK2/JAK1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: A phase 1b, randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2025 May 14:ljaf185. doi: 10.1093.
    >> Share

  463. ARMSTRONG AW, Blauvelt A, Lebwohl M, Asahina A, et al
    Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis.
    Br J Dermatol. 2025 May 14:ljaf171. doi: 10.1093.
    >> Share

  464. YANG HW, Chen YH, To SY, Wen YL, et al
    Hormone Therapy and Increased Risk of Psoriasis in Reproductive-age and Postmenopausal Women: A Nationwide Cohort Study and Target Trial Emulation.
    Br J Dermatol. 2025 May 9:ljaf179. doi: 10.1093.
    >> Share

  465. WANG Y, Xu G, Xia H
    Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic.
    Br J Dermatol. 2025 May 9:ljaf178. doi: 10.1093.
    >> Share

  466. DRUCKER AM, Walwyn C, Chu C, Yiu ZZN, et al
    Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis.
    Br J Dermatol. 2025 May 7:ljaf166. doi: 10.1093.
    >> Share

  467. WHITEMAN DC
    Melanoma in England: incidence is up, mortality is down.
    Br J Dermatol. 2025 May 7:ljaf175. doi: 10.1093.
    >> Share

  468. MORTIMORE AM, McMeniman E
    Reassuring results from skin cancer risk in Swedish patients with vitiligo and alopecia areata.
    Br J Dermatol. 2025 May 6:ljaf118. doi: 10.1093.
    >> Share

  469. FOWLER JC, Sood RK, Coltart G, Lai C, et al
    The mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin; relevance to NB-UVB lifetime exposures and skin cancer surveillance.
    Br J Dermatol. 2025 May 3:ljaf173. doi: 10.1093.
    >> Share

  470. KIRCIK L, Tsianakas A, Valenzuela F, Mikol V, et al
    Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical Trial.
    Br J Dermatol. 2025 May 3:ljaf156. doi: 10.1093.
    >> Share

  471. ZHANG WW, Ke LF, Chen Y, Wu CY, et al
    Methylation-Based Test for Diagnosis of Benign and Malignant Melanocytoma.
    Br J Dermatol. 2025 May 2:ljaf169. doi: 10.1093.
    >> Share

  472. GILLESPIE J, Bash GN, Jacobson ME, Latour E, et al
    Harmonizing Measurement of Eczema Control- Mapping Scores Between the Atopic Dermatitis Control Tool and The Recap of Atopic Eczema Instrument.
    Br J Dermatol. 2025 May 2:ljaf167. doi: 10.1093.
    >> Share

  473. LU G, Chambers S, Cepica T, Xie L, et al
    Erythema and scale in cutaneous lupus erythematosus significantly impacts patient quality of life and disease course impression.
    Br J Dermatol. 2025 May 2:ljaf165. doi: 10.1093.
    >> Share

    April 2025
  474. JIANG X, Mortlock RD, Lomakin IB, Zhou J, et al
    Autosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.
    Br J Dermatol. 2025;192:896-906.
    >> Share

  475. PATHMARAJAH P, Eid E, Nazaroff J, So J, et al
    Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2025;192:917-925.
    >> Share

  476. SCHELL SL, Sennett ML, Feehan RP, Wallace TE, et al
    Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa.
    Br J Dermatol. 2025;192:845-856.
    >> Share

  477. LIU Y, Liu Z, Li D, He X, et al
    Emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment.
    Br J Dermatol. 2025;192:796-806.
    >> Share

  478. SILVERBERG JI, Dodiuk-Gad R, Takaoka R, Tan J, et al
    Atopic dermatitis starting in childhood has a stronger impact on adults: results from the "Scars of Life" international project in 27 countries.
    Br J Dermatol. 2025 Apr 26:ljaf158. doi: 10.1093.
    >> Share

  479. LEMARCQ L, Reynaert V, Van den Steen E, Evers-Lebrun C, et al
    Outcome Measures for Interdisciplinary Care in Immune-mediated Inflammatory Skin Diseases (skIMIDs): A Scoping Review.
    Br J Dermatol. 2025 Apr 18:ljaf153. doi: 10.1093.
    >> Share

  480. NASLUND-KOCH C, Kvist-Hansen A, Bojesen SE, Skov L, et al
    Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100,000 individuals.
    Br J Dermatol. 2025 Apr 18:ljaf147. doi: 10.1093.
    >> Share

  481. DUGOURD PM, Guardoli D, Fontas E, Marie-Luce S, et al
    Promoting Repigmentation after Epidermal cell suspension grafting and preVENTing the loss of melanocytes using topical ruxolitinib for vitiligo in resistant areas (PREVENT). A prospective monocentric interventional double-blind study.
    Br J Dermatol. 2025 Apr 17:ljaf143. doi: 10.1093.
    >> Share

  482. FARIYIKE O, Johnson NA, Van Bodegraven B, Quirke K, et al
    The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England.
    Br J Dermatol. 2025 Apr 15:ljaf135. doi: 10.1093.
    >> Share

  483. ZHU J, Abuabara K
    Complex comorbidities: Could a diabetes drug help prevent atopic dermatitis?
    Br J Dermatol. 2025 Apr 15:ljaf131. doi: 10.1093.
    >> Share

  484. CHEN J, Liu X, Bai Y, Tang X, et al
    Tonsillar Microbiota Alterations Contribute to Immune Responses in Psoriasis by Skewing Aged Neutrophils.
    Br J Dermatol. 2025 Apr 15:ljaf134. doi: 10.1093.
    >> Share

  485. KARPONIS D, van Bodegraven B, Mistry K, Nikolaou V, et al
    Incidence and mortality of melanoma in situ and malignant melanoma in England between 2001 and 2020.
    Br J Dermatol. 2025 Apr 15:ljaf136. doi: 10.1093.
    >> Share

  486. PILERI A, Zengarini C
    Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
    Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
    >> Share

  487. HUAI P, Xing P, Yang Y, Kong Y, et al
    Global burden of skin and subcutaneous diseases: an update from the Global Burden of Disease Study 2021.
    Br J Dermatol. 2025 Apr 11:ljaf071. doi: 10.1093.
    >> Share

  488. FALTOT L, Donzel M, Chidiac G, Balme B, et al
    Evaluation of the anti-CCR4 monoclonal antibody Mogamulizumab in advanced cutaneous T-cell lymphomas and with large cell transformation.
    Br J Dermatol. 2025 Apr 7:ljaf125. doi: 10.1093.
    >> Share

  489. MAZEREEUW-HAUTIER J, Paller AS, O'Toole E, Dreyfus I, et al
    Management of congenital ichthyoses: Guidelines of care: Part Two: 2024 Update.
    Br J Dermatol. 2025 Apr 7:ljaf077. doi: 10.1093.
    >> Share

  490. WANG J, Hennessey D, Iyer A, O'Keefe S, et al
    Transcriptomic skin niches in systemic sclerosis underpins a role for mitochondrial dysfunction.
    Br J Dermatol. 2025 Apr 2:ljaf119. doi: 10.1093.
    >> Share

  491. ISKANDAR RJ, Tadrous M, Nguyen P, Dolovich L, et al
    Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: A population-based cross-sectional study.
    Br J Dermatol. 2025 Apr 2:ljaf092. doi: 10.1093.
    >> Share

  492. SARASWAT N, Tripathy DM, Adhau RW, Tripathy A, et al
    Furuncular Myiasis in the skin of colour.
    Br J Dermatol. 2025 Apr 1:ljaf114. doi: 10.1093.
    >> Share

    March 2025
  493. MAZEREEUW-HAUTIER J, Paller AS, Dreyfus I, Sprecher E, et al
    Management of congenital ichthyoses: Guidelines of care: Part One: 2024 Update.
    Br J Dermatol. 2025 Mar 28:ljaf076. doi: 10.1093.
    >> Share

  494. ALEXANDER H, Murryam S, Kezic S, Motazedi E, et al
    Methotrexate and Cyclosporin Improve Skin Biomarkers in Paediatric Atopic Dermatitis: Results from the TREatment of Severe Atopic Eczema Trial.
    Br J Dermatol. 2025 Mar 27:ljaf115. doi: 10.1093.
    >> Share

  495. VESTERGAARD C
    Air Pollution and Atopic Dermatitis: Critical Windows of Risk in Early Life.
    Br J Dermatol. 2025 Mar 24:ljaf109. doi: 10.1093.
    >> Share

  496. BAGOT M
    Therapeutic advances for Cutaneous T Cell Lymphoma.
    Br J Dermatol. 2025 Mar 22:ljaf105. doi: 10.1093.
    >> Share

  497. LACKNER A, Burner T, Brandner M, Dey S, et al
    Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
    Br J Dermatol. 2025 Mar 20:ljaf102. doi: 10.1093.
    >> Share

  498. LEE CN, Hsieh MH, Chen CY, Yang CC, et al
    Risk of Herpes Zoster and Postherpetic Neuralgia in Patients with Psoriasis Treated with Biologics: A nationwide study using target trial emulation framework.
    Br J Dermatol. 2025 Mar 20:ljaf101. doi: 10.1093.
    >> Share

  499. DE LA IGLESIA MARTIN J, Martin Vera J, Tubau Prims C
    Dermatitis cruris pustulosa et atrophicans.
    Br J Dermatol. 2025 Mar 20:ljaf103. doi: 10.1093.
    >> Share

  500. AHMADY S, Mosterd K, Jansen MHE, Kelleners-Smeets NWJ, et al
    Patient preferences for the treatment of Bowen disease.
    Br J Dermatol. 2025;192:653-659.
    >> Share

  501. KIMBALL AB, Bechara FG, Badat A, Giamarellos-Bourboulis EJ, et al
    Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial.
    Br J Dermatol. 2025;192:629-640.
    >> Share

  502. LEAR JT, Harwood CA, Hasan Z, Kentley J, et al
    Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial.
    Br J Dermatol. 2025;192:611-617.
    >> Share

  503. RASTRICK J, Edwards H, Ferecsko AS, Le Friec G, et al
    The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.
    Br J Dermatol. 2025;192:660-671.
    >> Share

  504. HUA VK, Chang J, Laxer RM, Broderick L, et al
    Disabling pansclerotic morphoea: a century of discovery.
    Br J Dermatol. 2025;192:585-596.
    >> Share

  505. WALBURN J, Norton S, Sarkany R, Canfield M, et al
    A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trial.
    Br J Dermatol. 2025;192:728-737.
    >> Share

  506. NAKAMIZO S, Kabashima K
    Cutaneous Granulomas: Mechanisms, Cellular Interactions, and Therapeutic Insights.
    Br J Dermatol. 2025 Mar 13:ljaf096. doi: 10.1093.
    >> Share

  507. MIRANDA BH, Shahid S, Correiro A, Zhang J, et al
    St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.
    Br J Dermatol. 2025 Mar 13:ljaf097. doi: 10.1093.
    >> Share

  508. LI T, Tao R, Yang L, Wan Z, et al
    Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.
    Br J Dermatol. 2025 Mar 12:ljaf095. doi: 10.1093.
    >> Share

  509. SU T, Yu Y, Su Z, Lu Y, et al
    Rapid improvements in Kaposi sarcoma with metformin: a report of two cases.
    Br J Dermatol. 2025 Mar 11:ljaf090. doi: 10.1093.
    >> Share

  510. ZHANG Q, Liu G, Jing L, Aghayants S, et al
    The Landscape of m6A RNA Methylation in Skin Diseases.
    Br J Dermatol. 2025 Mar 10:ljaf087. doi: 10.1093.
    >> Share

  511. WEN YL, Hsu WT, Chen YH, Kao HH, et al
    Sodium-glucose Cotransporter 2 Inhibitors and Inverse Risk of New-onset Atopic Dermatitis in Diabetic Population: a Nationwide, Active-comparator Study.
    Br J Dermatol. 2025 Mar 4:ljaf086. doi: 10.1093.
    >> Share

  512. KOCHI Y, Togawa Y, Yamazaki Y, Yamamoto Y, et al
    Anatomical distribution of acral lentiginous melanoma in the hand and nail among Japanese individuals.
    Br J Dermatol. 2025 Mar 4:ljaf070. doi: 10.1093.
    >> Share

  513. VON SCHUCKMANN LA, Khosrotehrani K
    Haematological cancers and skin cancer: statistics from the Netherlands.
    Br J Dermatol. 2025 Mar 1:ljaf081. doi: 10.1093.
    >> Share

    February 2025
  514. COSTANZA M, Giordano C, von Brunneck AC, Zhao J, et al
    Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas.
    Br J Dermatol. 2025 Feb 27:ljaf001. doi: 10.1093.
    >> Share

  515. ACKERMANN DM, Bell KJL
    Setting the melanoma research agenda for all end-users: the need to include patient, clinician, and policy perspectives.
    Br J Dermatol. 2025 Feb 27:ljaf082. doi: 10.1093.
    >> Share

  516. NARDIN C, Vernerey D, Aubin F
    Ipilimumab + nivolumab combination or nivolumab monotherapy as first-line treatment in patients with metastatic melanoma: conclusions from a real-world French national cohort.
    Br J Dermatol. 2025 Feb 27:ljaf080. doi: 10.1093.
    >> Share

  517. MISTRY K, Srimudkul O, Patel M, Ragan J, et al
    Patient research priorities in melanoma: a national qualitative interview study.
    Br J Dermatol. 2025 Feb 27:ljaf048. doi: 10.1093.
    >> Share

  518. ROY SF, Agim NG, Mir A, Couts KL, et al
    Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stroma.
    Br J Dermatol. 2025 Feb 27:ljaf061. doi: 10.1093.
    >> Share

  519. LIN LH, Lee CC, Hwang MM, Jung CR, et al
    Fine particulate matter exposure and incident atopic dermatitis: A birth cohort study.
    Br J Dermatol. 2025 Feb 26:ljaf075. doi: 10.1093.
    >> Share

  520. KROAH-HARTMAN M, Lee JYW, Dooley N, Tan WR, et al
    Environmental triggers of psoriasis: insights from a UK patient-reported cohort (mySkin).
    Br J Dermatol. 2025 Feb 25:ljaf073. doi: 10.1093.
    >> Share

  521. DELCOIGNE B, Lysell J, Askling J
    Incidence, stage and outcome of melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?
    Br J Dermatol. 2025 Feb 25:ljaf074. doi: 10.1093.
    >> Share

  522. OTTEVANGER R, Vermeer MH
    Cutaneous T-cell lymphoma in Australia: what drives geospatial?
    Br J Dermatol. 2025 Feb 22:ljaf026. doi: 10.1093.
    >> Share

  523. WANG Z, Liu J, Wechsberg O, Liang L, et al
    Variants in KLF4 affecting residue Asp441 cause an autosomal dominant syndromic ichthyosis.
    Br J Dermatol. 2025 Feb 19:ljaf062. doi: 10.1093.
    >> Share

  524. PERIS K
    Patidegib: a novel, promising treatment for basal cell carcinoma lesions in patients with Gorlin syndrome.
    Br J Dermatol. 2025 Feb 19:ljae515. doi: 10.1093.
    >> Share

  525. GNIADECKI R, Guenova E, Querfeld C, Nicolay JP, et al
    Haematogenous seeding in mycosis fungoides and Sezary syndrome: current evidence and clinical implications.
    Br J Dermatol. 2025;192:381-389.
    >> Share

  526. PHILIPP-DORMSTON WG, Bruckner M, Hoffmann M, Bae M, et al
    Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.
    Br J Dermatol. 2025;192:510-519.
    >> Share

  527. WEHKAMP U, Pietzka S, Kotrova M, Jost M, et al
    Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.
    Br J Dermatol. 2025;192:492-500.
    >> Share

  528. DONHAUSER T, Gabes M, Masur C, Kamudoni P, et al
    Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL(c)) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change.
    Br J Dermatol. 2025;192:450-457.
    >> Share

  529. SWIDERSKI M, Vinogradova Y, Knaggs RD, Harman K, et al
    Association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case-control study.
    Br J Dermatol. 2025;192:440-449.
    >> Share

  530. KIM SR, Koh SJ, Park H
    Association of childhood obesity or weight change with early-onset follicular occlusion triad in children.
    Br J Dermatol. 2025;192:430-439.
    >> Share

  531. PLANELLA-FONTANILLAS N, Bosch-Amate X, Jimenez Anton A, Moreno-Vilchez C, et al
    Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series.
    Br J Dermatol. 2025;192:501-509.
    >> Share

  532. SZONDI DC, Crompton RA, Oon L, Subramaniam N, et al
    A role for Arginase in skin epithelial differentiation and anti-microbial peptide production.
    Br J Dermatol. 2025 Feb 14:ljaf057. doi: 10.1093.
    >> Share

  533. ZOUBOULIS CC, Deloche C, Skayem C, Leclerc-Mercier S, et al
    Global study of 17,009 women reveal significant skin condition changes associated with irregular menstrual cycles.
    Br J Dermatol. 2025 Feb 11:ljae484. doi: 10.1093.
    >> Share

  534. LOPEZ S, Thakker S, Minkis K
    Beyond the Diagnosis: A Skin of Color Patient's Journey with Acral Lentiginous Melanoma.
    Br J Dermatol. 2025 Feb 6:ljaf047. doi: 10.1093.
    >> Share

  535. VON KOBYLETZKI L, Svensson A
    Patient-reported outcome measures are highly needed for patients with skin of colour with atopic dermatitis.
    Br J Dermatol. 2025 Feb 4:ljaf043. doi: 10.1093.
    >> Share

  536. FREW JW
    Unravelling the complex pathogenesis of hidradenitis suppurativa.
    Br J Dermatol. 2025;192.
    >> Share

  537. PETUKHOVA L, Colvin A, Koerts NDK, Horvath B, et al
    Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management.
    Br J Dermatol. 2025;192.
    >> Share

  538. SAYED CJ, Shams RB, Midgette B, Garg A, et al
    An evolutionary tale on clinical trials in hidradenitis suppurativa.
    Br J Dermatol. 2025;192.
    >> Share

    January 2025
  539. LEDUCQ S, Fong WCG, Williams HC, Bradshaw L, et al
    Reporting of concomitant and rescue topical therapies in atopic dermatitis randomised controlled trials evaluating a systemic treatment: a scoping review.
    Br J Dermatol. 2025 Jan 30:ljaf031. doi: 10.1093.
    >> Share

  540. ALVES C
    Orismilast for moderate-to-severe atopic dermatitis: the potential therapeutic value of a new oral pharmacological alternative.
    Br J Dermatol. 2025 Jan 30:ljaf042. doi: 10.1093.
    >> Share

  541. GNIADECKI R
    Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
    Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
    >> Share

  542. KANEDA E, Koguchi-Yoshioka H, Nimura K, Hattori S, et al
    Genotype-phenotype correlation for skin and neuropsychiatric features in tuberous sclerosis complex.
    Br J Dermatol. 2025 Jan 28:ljaf038. doi: 10.1093.
    >> Share

  543. WARREN RB, Lebwohl M, Thaci D, Gooderham M, et al
    Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE RADIANT phase 3b trial open-label extension period.
    Br J Dermatol. 2025 Jan 25:ljaf032. doi: 10.1093.
    >> Share

  544. PILIANG M, Soung J, King B, Shapiro J, et al
    Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alop
    Br J Dermatol. 2025;192:215-227.
    >> Share

  545. GARG A, Burge R, Cohee A, Wallinger H, et al
    Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.
    Br J Dermatol. 2025;192:261-268.
    >> Share

  546. ZHU Z, Zhong X, Luo Z, Liu M, et al
    Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis.
    Br J Dermatol. 2025;192:228-237.
    >> Share

  547. PERALS C, le Jan S, Muller C, Le Naour R, et al
    Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity.
    Br J Dermatol. 2025;192:283-292.
    >> Share

  548. EGGERMONT CJ, Hollatz A, Wakkee M, Louwman M, et al
    Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a nationwide population-based study in the Netherlands.
    Br J Dermatol. 2025 Jan 24:ljaf027. doi: 10.1093.
    >> Share


  549. Correction to: Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
    Br J Dermatol. 2025 Jan 24:ljaf029. doi: 10.1093.
    >> Share

  550. BARKER JN, Casanova E, Choon SE, Foley P, et al
    Global Delphi consensus on treatment goals for generalised pustular psoriasis.
    Br J Dermatol. 2025 Jan 23:ljae491. doi: 10.1093.
    >> Share

  551. SMITH MJ, Peach H, Keohane S, Lear J, et al
    Melanoma: Assessment and Management summary of 2022 update of the NICE guidelines.
    Br J Dermatol. 2025 Jan 21:ljaf016. doi: 10.1093.
    >> Share

  552. ANDERSON ADG, Shirwac HF, Morgan H, Greenish H, et al
    Real-World Melanoma Miss-Rate In An NHS Hospital Dermatology Service. A Retrospective Study.
    Br J Dermatol. 2025 Jan 16:ljaf024. doi: 10.1093.
    >> Share

  553. ALABAS OA, Mason KJ, Yiu ZZN, Smith CH, et al
    Age and biologic survival in patients with moderate-to-severe psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Br J Dermatol. 2025 Jan 10:ljaf017. doi: 10.1093.
    >> Share

  554. HARTFORD C, Alexis A, Wang Z, Levit NA, et al
    Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colour.
    Br J Dermatol. 2025 Jan 10:ljae494. doi: 10.1093.
    >> Share

  555. PUIG L
    Post-switching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases.
    Br J Dermatol. 2025 Jan 7:ljaf003. doi: 10.1093.
    >> Share

  556. CHENG JW, Li JH
    Squamous cell carcinoma arising from lichen planus.
    Br J Dermatol. 2025 Jan 7:ljaf007. doi: 10.1093.
    >> Share

  557. MCGRATH JA, Kabashima K
    Unlocking the skin's immunological secrets: antibodies and new topical vaccination strategies.
    Br J Dermatol. 2025 Jan 7:ljaf014. doi: 10.1093.
    >> Share

  558. SILVERBERG JI, Eichenfield LF, Blauvelt A, Irvine AD, et al
    Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS).
    Br J Dermatol. 2025 Jan 7:ljae507. doi: 10.1093.
    >> Share

    December 2024
  559. PLACKE JM, Bottek J, Varaljai R, Shannan B, et al
    Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.
    Br J Dermatol. 2024 Dec 31:ljae433. doi: 10.1093.
    >> Share

  560. PATRA V, Wolf P
    Skin microbiome and polymorphous light eruption.
    Br J Dermatol. 2024 Dec 26:ljae513. doi: 10.1093.
    >> Share

  561. TAKASE K, Komatsu-Fujii T, Kogame T, Otsuka A, et al
    Tinea corporis at the injection site of interleukin-17 inhibitor in psoriasis vulgaris.
    Br J Dermatol. 2024 Dec 26:ljae511. doi: 10.1093.
    >> Share

  562. CHEN Z, Wang Y, Wang R
    Generalized granulomatous slack skin.
    Br J Dermatol. 2024 Dec 25:ljae508. doi: 10.1093.
    >> Share

  563. CARRASCOSA JM
    Optimizing dosing in atopic dermatitis therapy: Looking for the cream of the crop.
    Br J Dermatol. 2024 Dec 25:ljae514. doi: 10.1093.
    >> Share

  564. IWASAWA O, Ikegami M, Miyagawa T, Morita H, et al
    Association of genetic alterations with prognosis in extramammary Paget disease: insights into the involvement of somatic CDKN2A variants in patients with a poor prognosis.
    Br J Dermatol. 2024;192:46-54.
    >> Share

  565. BONTOUX C, Badrignans M, Afach S, Sbidian E, et al
    Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
    Br J Dermatol. 2024;192:125-134.
    >> Share

  566. ELEFTHERIADOU V, Ahmed A, Nesnas J, Nagra R, et al
    The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study.
    Br J Dermatol. 2024;192:63-71.
    >> Share

  567. LI J, Wang Y, Niu X, Xing J, et al
    Downregulation of lysine 2-hydroxyisobutyrylation of ErbB3 binding protein 1 at amino acid 210 promotes keratinocyte proliferation via induction of transcription initiation factor IA-mediated rRNA synthesis.
    Br J Dermatol. 2024;192:92-103.
    >> Share


  568. Correction to: Severity rating of specific skin lesions in hidradenitis suppurativa: the patient perspective.
    Br J Dermatol. 2024 Dec 23:ljae474. doi: 10.1093.
    >> Share

  569. PRAJAPATI VH, Seyger MMB, Wilsmann-Theis D, Szakos E, et al
    Guselkumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients: results of the phase 3, randomized, placebo-controlled PROTOSTAR study.
    Br J Dermatol. 2024 Dec 21:ljae502. doi: 10.1093.
    >> Share

  570. PREIS S, Biedermann T, Zink A
    Unseen Spaces: Psoriasis Inversa Between the Toes.
    Br J Dermatol. 2024 Dec 21:ljae500. doi: 10.1093.
    >> Share

  571. BADAWY H, Harvey J, Rajan N, Stuart B, et al
    Changes in skin research funding: the emergence of environmental sustainability criteria in the research competition assessment process.
    Br J Dermatol. 2024 Dec 20:ljae503. doi: 10.1093.
    >> Share

  572. CHEN L, Tan M, Li T, Zhu L, et al
    Rapid and sustained response of stubborn guttate psoriasis to ustekinumab: A 52-week, two-center, one-arm, observational study.
    Br J Dermatol. 2024 Dec 18:ljae481. doi: 10.1093.
    >> Share

  573. WHITEMAN DC, Pandeya N, Olsen CM
    Differences in mean age at diagnosis of invasive melanoma for men and women, by anatomic site, thickness, and subtype.
    Br J Dermatol. 2024 Dec 17:ljae482. doi: 10.1093.
    >> Share

  574. MITRA R, Hale TK, Fitzsimons HL, Gray C, et al
    A novel three-dimensional model of Infantile Haemangioma.
    Br J Dermatol. 2024 Dec 17:ljae483. doi: 10.1093.
    >> Share

  575. LYNCH M
    Beyond the Algorithm: Ethical Challenges in AI-Driven Skin Cancer Diagnosis.
    Br J Dermatol. 2024 Dec 16:ljae490. doi: 10.1093.
    >> Share

  576. MORTATO E, Talamonti M, Paganini C, Belcastro A, et al
    Comment on "A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council"- A case of Rhabdomyolysis Induced by Upadacitinib.
    Br J Dermatol. 2024 Dec 13:ljae485. doi: 10.1093.
    >> Share

  577. LOUVEAU B, Jouenne F, Ram-Wolff C, Mancini M, et al
    Comment on 'Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder' by Wobser et al.
    Br J Dermatol. 2024 Dec 13:ljae487. doi: 10.1093.
    >> Share

  578. DOUSSET L, Khosrotehrani K
    A new frontier in drug discovery for skin cancer through electronic medical records.
    Br J Dermatol. 2024 Dec 13:ljae489. doi: 10.1093.
    >> Share

  579. BERESFORD-WYLIE B, Ashcroft S, Gaglani B, Green A, et al
    Integrating artificial intelligence into skin cancer pathways; the opportunities and obstacles.
    Br J Dermatol. 2024 Dec 11:ljae480. doi: 10.1093.
    >> Share

  580. CHO SI, Na JI
    Long-term observation to determine durable efficacy and safety of novel paediatric atopic dermatitis treatment, nemolizumab.
    Br J Dermatol. 2024 Dec 10:ljae479. doi: 10.1093.
    >> Share

  581. SINKKO H, Olah P, Yang Y, Maia G, et al
    Taxonomic and functional profiling of skin microbiome in psoriasis.
    Br J Dermatol. 2024 Dec 9:ljae471. doi: 10.1093.
    >> Share

  582. SHAH SFH, O'Toole EA
    Biologics in Congenital Ichthyosis - an Incomplete Fix.
    Br J Dermatol. 2024 Dec 6:ljae475. doi: 10.1093.
    >> Share

  583. CAMPBELL BA, Baade PD, Dasgupta P, Cameron JK, et al
    Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.
    Br J Dermatol. 2024 Dec 6:ljae476. doi: 10.1093.
    >> Share

  584. WEIDINGER S, Bewley A, Hong HC, Silvestre JF, et al
    Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2024 Dec 5:ljae439. doi: 10.1093.
    >> Share

  585. MCGRATH JA
    Recently discovered roles for macrophages in human skin development.
    Br J Dermatol. 2024 Dec 4:ljae473. doi: 10.1093.
    >> Share

    November 2024
  586. IGARASHI A, Katsunuma T, Nagano Y, Komazaki H, et al
    Long-term (68 weeks) administration of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: efficacy and safety data from a phase III study.
    Br J Dermatol. 2024 Nov 28:ljae458. doi: 10.1093.
    >> Share

  587. KARINE B, Mortier L, Dereure O, Dalac S, et al
    The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.
    Br J Dermatol. 2024 Nov 28:ljae470. doi: 10.1093.
    >> Share

  588. WOLBER AK, Jayasinghe D, Betz-Stablein B, Janda M, et al
    Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma.
    Br J Dermatol. 2024 Nov 26:ljae467. doi: 10.1093.
    >> Share

  589. LI CY, Wang WT, Ma SH, Lo LW, et al
    Association of PCSK9 inhibitors with risk of nonmelanoma skin cancer: a retrospective cohort study.
    Br J Dermatol. 2024 Nov 25:ljae438. doi: 10.1093.
    >> Share

  590. AMAR Y, Niedermeier S, Silva R, Kublik S, et al
    Skin microbiome dynamics in patients with polymorphic light eruption in response to UV radiations.
    Br J Dermatol. 2024 Nov 22:ljae464. doi: 10.1093.
    >> Share

  591. ZHANG B, Mei J, Liao Q, Zhou S, et al
    Multitranscriptome analysis revealed that stromal cells in the papillary dermis promote angiogenesis in psoriasis vulgaris.
    Br J Dermatol. 2024 Nov 21:ljae459. doi: 10.1093.
    >> Share

  592. PHAN DB, Jourdain H, Descalzo-Gallego MA, Gonzalez-Quesada A, et al
    Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study.
    Br J Dermatol. 2024 Nov 20:ljae454. doi: 10.1093.
    >> Share

  593. THOMPSON AR, Tziotzios C, Nesnas J, Randall R, et al
    Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study.
    Br J Dermatol. 2024;191:924-935.
    >> Share

  594. XIONG X, Cesarato N, Gossmann Y, Wehner M, et al
    A nonsense variant in KRT31 is associated with autosomal dominant monilethrix.
    Br J Dermatol. 2024;191:979-987.
    >> Share

  595. PATTINSON R, Trialonis-Suthakharan N, Pickles T, Austin J, et al
    Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure.
    Br J Dermatol. 2024;191:936-948.
    >> Share

  596. OUYANG F, Yang H, Di Z, Hu J, et al
    Life's Essential 8, genetic susceptibility and the risk of psoriatic disease: a prospective cohort study.
    Br J Dermatol. 2024;191:897-905.
    >> Share

  597. SINGH N, Schikowski T
    Interactive effect of genetic and environmental risk factors on Psoriasis: current evidence and future directives.
    Br J Dermatol. 2024 Nov 15:ljae450. doi: 10.1093.
    >> Share

  598. ZHENG DX, Jenkins RW
    Real-world data confirms limited efficacy of dual anti-PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma.
    Br J Dermatol. 2024 Nov 15:ljae445. doi: 10.1093.
    >> Share


  599. Correction to: COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
    Br J Dermatol. 2024 Nov 11:ljae440. doi: 10.1093.
    >> Share

  600. VAN DER WEYDEN L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, et al
    Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.
    Br J Dermatol. 2024 Nov 7:ljae432. doi: 10.1093.
    >> Share

  601. VAN VEEN FCAP, Rossel SVJ, Steijlen PM, Moser A, et al
    The perceived quality of life in adult patients with inherited ichthyosis: a qualitative interview study.
    Br J Dermatol. 2024 Nov 7:ljae436. doi: 10.1093.
    >> Share

  602. SHAH SFH, Arecco D, Draper H, Tiribelli S, et al
    Ethical implications of artificial intelligence in skin cancer diagnostics: use-case analyses.
    Br J Dermatol. 2024 Nov 6:ljae434. doi: 10.1093.
    >> Share

  603. CHIU TM, Chen CB, Lu CW, Hui RC, et al
    CCR8/CCL1 and CXCR3/CXCL10 axis mediated memory T cell activations in recalcitrant drug-induced hypersensitivity patients.
    Br J Dermatol. 2024 Nov 6:ljae375. doi: 10.1093.
    >> Share

  604. TAYLOR MA, Yuan M, Wang S, North JP, et al
    A Case of Biologic-Resistant Hand Dermatitis Demonstrates Dual T2/T17 Transcriptomic Abnormalities and Responds to JAK Inhibition.
    Br J Dermatol. 2024 Nov 5:ljae430. doi: 10.1093.
    >> Share

  605. SANGERS TE, van Doorn R
    The usefulness of large language models for patient information on melanoma: challenges and opportunities.
    Br J Dermatol. 2024 Nov 1:ljae429. doi: 10.1093.
    >> Share

    October 2024
  606. WELLER RB, Gu J
    Ultraviolet radiation is not the major cause of melanoma mortality in the UK and sun exposure advice should be revised.
    Br J Dermatol. 2024 Oct 30:ljae426. doi: 10.1093.
    >> Share

  607. MAZEREEUW-HAUTIER J, Granier Tournier C, Hernandez-Martin A, Milesi S, et al
    Biologics in congenital ichthyosis: are they effective?
    Br J Dermatol. 2024 Oct 29:ljae420. doi: 10.1093.
    >> Share

  608. RAUWERDINK DJW, Hoogland Y, Schrader AMR, Potjer TP, et al
    Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant.
    Br J Dermatol. 2024 Oct 29:ljae417. doi: 10.1093.
    >> Share

  609. CHEN M, Gao L
    Carcinoid syndrome presenting as diffuse violaceous cutaneous flushing.
    Br J Dermatol. 2024 Oct 26:ljae424. doi: 10.1093.
    >> Share

  610. BLAUVELT A, Papp K, Trivedi M, Barragan C, et al
    Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks.
    Br J Dermatol. 2024 Oct 23:ljae402. doi: 10.1093.
    >> Share

  611. KATOH N, Tanaka A, Takahashi H, Shimizu R, et al
    Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week, randomized, double-blind, placebo-controlled phase III trial in Japan (ADhere-J).
    Br J Dermatol. 2024 Oct 23:ljae394. doi: 10.1093.
    >> Share

  612. YANG X, Li L, Zhu M
    Primary cutaneous Alternaria alstroemeriae infection.
    Br J Dermatol. 2024 Oct 23:ljae409. doi: 10.1093.
    >> Share

  613. MCGILLIVRAY E, Ashouri K, Chatziioannou E, Gallegos JAO, et al
    Combined PD-1 and CTLA-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma.
    Br J Dermatol. 2024 Oct 23:ljae401. doi: 10.1093.
    >> Share

  614. SILVERBERG JI, Bunick CG, Hong HC, Mendes-Bastos P, et al
    Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up).
    Br J Dermatol. 2024 Oct 23:ljae404. doi: 10.1093.
    >> Share

  615. ZHANG J, Ding Y, Wang P, Li L, et al
    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial.
    Br J Dermatol. 2024 Oct 22:ljae406. doi: 10.1093.
    >> Share

  616. BLANCHARD G, Atallah I, Blanchard M, Fehrenbacher B, et al
    Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
    Br J Dermatol. 2024 Oct 21:ljae412. doi: 10.1093.
    >> Share

  617. BARBIERI JS
    Levelling up outcomes in atopic dermatitis through personalized dosing of upadacitinib.
    Br J Dermatol. 2024 Oct 19:ljae410. doi: 10.1093.
    >> Share

  618. KOBYLETZKI LBV, Svensson A
    Treatment for atopic dermatitis with JAK Inhibitors-useful recommendations from expert opinions.
    Br J Dermatol. 2024 Oct 19:ljae396. doi: 10.1093.
    >> Share

  619. WANG Q, Niu G, Liu Z, Toma MA, et al
    Circular RNA circASH1L(4,5) protects microRNA-129-5p from target-directed microRNA degradation in human skin wound healing.
    Br J Dermatol. 2024 Oct 18:ljae405. doi: 10.1093.
    >> Share

  620. CAMPBELL C, Mayatra JM, Neve AJ, Fletcher JM, et al
    Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?
    Br J Dermatol. 2024;191:670-679.
    >> Share

  621. KORTE EWH, Baardman R, Pool G, Duipmans JC, et al
    Navigating the diagnostic journey of epidermolysis bullosa: a qualitative study of the lived experiences and needs of parents and patients.
    Br J Dermatol. 2024;191:737-745.
    >> Share

  622. TSENG H, Stone C, Shulruf B, Murrell DF, et al
    Establishing minimal clinically important differences for the Pemphigus Disease Area Index.
    Br J Dermatol. 2024;191:823-831.
    >> Share

  623. SORENSEN SBT, Farkas DK, Vestergaard C, Schmidt SAJ, et al
    Urticaria and the risk of cancer: a Danish population-based cohort study.
    Br J Dermatol. 2024;191:706-712.
    >> Share

  624. YOSIPOVITCH G, Skayem C, Aroman MS, Taieb C, et al
    International study on prevalence of itch: examining the role of itch as a major global public health problem.
    Br J Dermatol. 2024;191:713-718.
    >> Share

  625. RUTKOWSKI D, Scholey R, Davies J, Pye D, et al
    Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege.
    Br J Dermatol. 2024;191:791-804.
    >> Share

  626. BETTUZZI T, Welfringer-Morin A, Ingen-Housz-Oro S, Bataille P, et al
    Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study.
    Br J Dermatol. 2024;191:698-705.
    >> Share

  627. XIONG Y, Xia Y, Zhang X, Jiang B, et al
    Joint exposure to multiple air pollutants, genetic risk, and incident psoriasis: a large-scale prospective cohort study.
    Br J Dermatol. 2024 Oct 12:ljae391. doi: 10.1093.
    >> Share

  628. KUMARI R, Apfelbacher CJ, Nelson-Piercy C, Flohr C, et al
    The management of atopic dermatitis in women of childbearing age: confused terminology, lack of evidence and resulting clinical inertia.
    Br J Dermatol. 2024 Oct 12:ljae398. doi: 10.1093.
    >> Share

  629. LAI C, Fuggle NR, Matin RN, Tanaka RJ, et al
    Artificial Intelligence and Machine Learning in Dermatological Research and Healthcare: British Society for Investigative Dermatology Skin Club Report - Southampton April 2024.
    Br J Dermatol. 2024 Oct 12:ljae395. doi: 10.1093.
    >> Share

  630. VAN DER WEYDEN L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, et al
    Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.
    Br J Dermatol. 2024 Oct 11:ljae386. doi: 10.1093.
    >> Share


  631. Correction to: Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Oct 11:ljae374. doi: 10.1093.
    >> Share

  632. EJEZIE CL, Ayieko S, Anunobi P, Oladoyin J, et al
    Skin Bleaching: A Socio-ecological Perspective.
    Br J Dermatol. 2024 Oct 9:ljae368. doi: 10.1093.
    >> Share

  633. BLAUVELT A, Reckleff J, Zhao Y, Clark M, et al
    Content Evaluation of Pruritus, Skin Pain, and Sleep Disturbance Patient-Reported Outcome Measures in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Qualitative Interviews.
    Br J Dermatol. 2024 Oct 4:ljae346. doi: 10.1093.
    >> Share

  634. KAMMINGA NC, Kievits JE, Plaisier PW, Burgers JS, et al
    Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma.
    Br J Dermatol. 2024 Oct 4:ljae377. doi: 10.1093.
    >> Share

  635. ROMANI J, Roses C, Brillet F, Fernandez-Vela J, et al
    Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
    Br J Dermatol. 2024 Oct 1:ljae371. doi: 10.1093.
    >> Share

  636. PANDEYA N, Olsen CM, Neale RE, Whiteman DC, et al
    Melanoma as a detection-dependent cancer: proxy measures of screening and surveillance associated with 3-year incidence of detection procedures for skin cancer in a national prospective study.
    Br J Dermatol. 2024 Oct 1:ljae372. doi: 10.1093.
    >> Share

    September 2024
  637. LAI CC, Shao SC, Tsai ET, Chi CC, et al
    Efficacy and safety of biologics and small molecule inhibitors in treating genital psoriasis: A systematic review of randomised controlled trials.
    Br J Dermatol. 2024 Sep 30:ljae370. doi: 10.1093.
    >> Share

  638. SOUTH AP
    Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2024;191:482-483.
    >> Share

  639. CHEN ML, Kim J, Naik HB, Aleshin MA, et al
    Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach.
    Br J Dermatol. 2024;191:633-635.
    >> Share

  640. CARRASCOSA JM, Munera-Campos M
    Prurigo nodularis: the difference between knowing the path and walking the path.
    Br J Dermatol. 2024;191:480-481.
    >> Share

  641. KIM J, Kim JH
    Clinical relevance of circulating autoantigen-specific T-follicular regulatory cells in pemphigus vulgaris.
    Br J Dermatol. 2024;191:485-486.
    >> Share

  642. BERTOLD C, Delaunay P, Cathelineau AC, Chassang M, et al
    Efficacy of hypnotherapy in chronic idiopathic pruritus: a single-arm prospective pilot study.
    Br J Dermatol. 2024;191:644-645.
    >> Share

  643. AMBER KT, Feldman RJ
    The safety of topical vs. oral steroids in bullous pemphigoid: considerations for retrospective analyses.
    Br J Dermatol. 2024;191:479-480.
    >> Share

  644. HEBERT V, Novarino J, Maho-Vaillant M, Perals C, et al
    The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.
    Br J Dermatol. 2024;191:605-615.
    >> Share

  645. BAHLOUL D, Hudson R, Balogh O, Mathias E, et al
    Prevalence, incidence and treatment patterns of prurigo nodularis in England: a retrospective database analysis.
    Br J Dermatol. 2024;191:548-555.
    >> Share

  646. BESSIS D, Poujade L, Cossee M, Boursier G, et al
    Mosaic EGFR exon 20 in-frame insertion pathogenic variants are associated with papular epidermal naevus with 'skyline' basal cell layer (PENS).
    Br J Dermatol. 2024;191:641-644.
    >> Share

  647. HUBENTHAL M, Dai C, Brown SJ, Heinrich L, et al
    Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data.
    Br J Dermatol. 2024;191:637-639.
    >> Share

  648. PRIMERANO A, De Domenico E, Cianfarani F, De Luca N, et al
    Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2024;191:568-579.
    >> Share

  649. JOHNS JR, Vyas J, Ali FM, Ingram JR, et al
    The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review.
    Br J Dermatol. 2024;191:497-507.
    >> Share

  650. GARATE D, Thang CJ, Schmidt M, Ravanassa S, et al
    Granuloma annulare and the risk of autoimmune conditions: a multicentre retrospective cohort analysis.
    Br J Dermatol. 2024;191:626-627.
    >> Share

  651. KRIDIN K, Bieber K, Vorobyev A, Moderegger EL, et al
    Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids.
    Br J Dermatol. 2024;191:539-547.
    >> Share

  652. LYONS D, Louly Nathan A, Pender E, Murray G, et al
    Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life.
    Br J Dermatol. 2024;191:631-633.
    >> Share

  653. LONG A, O'Malley S, Collins S
    The sunbed trend in Ireland.
    Br J Dermatol. 2024;191:630-631.
    >> Share

  654. ALAVI A, Prens EP, Kimball AB, Frew JW, et al
    Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial.
    Br J Dermatol. 2024;191:508-518.
    >> Share

  655. CARR DF, Hanson A
    Stevens-Johnson syndrome/toxic epidermal necrolysis: international consensus, advances and opportunities.
    Br J Dermatol. 2024 Sep 16:ljae358. doi: 10.1093.
    >> Share

  656. TENSEN CP, Vermeer MH
    Single cell analyses of cutaneous T-cell lymphoma biopsies.
    Br J Dermatol. 2024 Sep 13:ljae351. doi: 10.1093.
    >> Share

  657. GALENTINE E, Powers CM, McAleer L, Rivera S, et al
    Hidden hurts: life with lichen sclerosus - a patient perspective.
    Br J Dermatol. 2024 Sep 12:ljae357. doi: 10.1093.
    >> Share

  658. STEVENS HP, Pampena R, Farnetani F, Pellicani G, et al
    The use of Reflectance Confocal Microscopy to diagnose Basal Cell Carcinoma in the United Kingdom: A Prospective Observational Trial at a Single Centre.
    Br J Dermatol. 2024 Sep 11:ljae356. doi: 10.1093.
    >> Share

  659. STEVENS HP, Pellacani G, Angus C, El-Jabbour JN, et al
    The use of Reflectance Confocal Microscopy to diagnose Malignant Melanoma and Lentigo Maligna in the United Kingdom: A Prospective Observational Trial at a Single Centre.
    Br J Dermatol. 2024 Sep 10:ljae354. doi: 10.1093.
    >> Share

  660. HAAG C, Alexis A, Aoki V, Bissonnette R, et al
    A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.
    Br J Dermatol. 2024 Sep 10:ljae342. doi: 10.1093.
    >> Share

  661. MAHUMUD RA
    The emerging burden of melanoma overdiagnosis in Australia: Who bears the cost-patients or the healthcare system?
    Br J Dermatol. 2024 Sep 9:ljae339. doi: 10.1093.
    >> Share

  662. POSADA V, Toland AE
    Role of albinism and pigment-related genes in amelanotic melanoma formation.
    Br J Dermatol. 2024 Sep 9:ljae353. doi: 10.1093.
    >> Share

  663. SIMPSON C, Leducq S, Venables Z, Yiu ZZN, et al
    The association between prescribed oral anti-diabetic medication for type 2 diabetes mellitus and skin cancer risk: a systematic review and meta-analysis.
    Br J Dermatol. 2024 Sep 6:ljae341. doi: 10.1093.
    >> Share

  664. ARDERN-JONES MR, Brown SJ, Flohr C, Hossain P, et al
    An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024.
    Br J Dermatol. 2024 Sep 5:ljae344. doi: 10.1093.
    >> Share

  665. GELLER AC, Stratigos AJ
    Exploring sex and site- specific differences in melanoma.
    Br J Dermatol. 2024 Sep 4:ljae345. doi: 10.1093.
    >> Share

    August 2024
  666. YAMAZAKI E, Fujimura T, Takahashi-Watanabe M, Tada S, et al
    Decreased serum levels of IL-4 correlate with the efficacy of the PAI-1 inhibitor TM5614 in patients with malignant melanoma refractory to anti-PD-1 antibodies: post hoc study of TM5614-MM trial.
    Br J Dermatol. 2024 Aug 31:ljae343. doi: 10.1093.
    >> Share

  667. WEI L, Fitzgerald ME, Yan L, Murakami M, et al
    Photodynamic therapy reduces the burden of small ultraviolet-induced epidermal clones in human and mouse skin.
    Br J Dermatol. 2024 Aug 27:ljae314. doi: 10.1093.
    >> Share

  668. AHMED A, Mohandas P, Taylor R, Assalman I, et al
    'Psycholag': a new term to describe the delay between physical and psychological improvement in patients with skin disease.
    Br J Dermatol. 2024 Aug 22:ljae333. doi: 10.1093.
    >> Share

  669. GIPPLE MO, Dhami RK, Latour E, Keller JJ, et al
    Morgellons disease shows a lower quality of life than psoriasis, atopic dermatitis, and prurigo nodularis.
    Br J Dermatol. 2024 Aug 21:ljae335. doi: 10.1093.
    >> Share

  670. STURM RA, Smit DJ, Duffy DL, McLean C, et al
    Uncovering molecular mechanisms for amelanotic/hypopigmented primary cutaneous melanoma.
    Br J Dermatol. 2024 Aug 21:ljae336. doi: 10.1093.
    >> Share

  671. SERVATTALAB SE, Lee M, Hlobik M, Song H, et al
    Examining racial and ethnic disparities in diagnosis and access to care in infantile atopic dermatitis in the United States: a retrospective cohort study.
    Br J Dermatol. 2024 Aug 20:ljae322. doi: 10.1093.
    >> Share

  672. O'REILLY P, Walsh S, Bunker CB, Ryan S, et al
    The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: An interpretative descriptive qualitative study.
    Br J Dermatol. 2024 Aug 20:ljae334. doi: 10.1093.
    >> Share

  673. KPENOU FC, Paul C, Seneschal J, Andreu N, et al
    The Atopic Dermatitis Patient Journey: Insights from a Qualitative Study.
    Br J Dermatol. 2024 Aug 18:ljae329. doi: 10.1093.
    >> Share

  674. CHIESA FUXENCH ZC, Mitra N, Grice E, Hoffstad O, et al
    Is seborrhoeic dermatitis of infancy and childhood related to maternal history of seborrhoeic dermatitis? A large population-based cohort study from the UK.
    Br J Dermatol. 2024 Aug 18:ljae331. doi: 10.1093.
    >> Share

  675. KORTE EWH, Pasmooij AMG, Bolling MC, Hickey S, et al
    Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.
    Br J Dermatol. 2024;191:463-465.
    >> Share

  676. OH BH, Kim KH
    Applying a novel optical technique for residual cancer detection with accuracy evaluation: a cornerstone for field implementation.
    Br J Dermatol. 2024;191:322-323.
    >> Share

  677. EHIZOGIE E, Maghari I, Lo S, Albrecht J, et al
    Hidradenitis suppurativa, systemic inflammatory response syndrome and sepsis: a database study.
    Br J Dermatol. 2024;191:451-453.
    >> Share

  678. CURMAN P, Jebril W, Larsson H, Bachar-Wikstrom E, et al
    Increased risk of depression and anxiety in individuals with Darier disease.
    Br J Dermatol. 2024;191:462-463.
    >> Share

  679. YIU D, Aguilar-Duran S, Edwards C, Chauhan D, et al
    Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
    Br J Dermatol. 2024;191:465-467.
    >> Share

  680. DALE C, Hewitt RM, Purcell C, Pandya N, et al
    'Feeling like a second-class citizen': exploring the impact, self-management and existing support for adults living with acne and/or post-inflammatory hyperpigmentation and scarring.
    Br J Dermatol. 2024;191:469-470.
    >> Share

  681. HAS C
    MiTES: itch or pain?
    Br J Dermatol. 2024;191:323-324.
    >> Share

  682. RHODES LE
    Vitamin D status in patients with erythropoietic protoporphyria taking the systemic photoprotective agent afamelanotide.
    Br J Dermatol. 2024;191:317-318.
    >> Share

  683. STADLER R
    The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2024;191:321-322.
    >> Share

  684. DEKKERS C, de Bruin-Weller M
    The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitis.
    Br J Dermatol. 2024;191:316-317.
    >> Share

  685. MAGHARI I, Abiad H, Griffin T, Albrecht J, et al
    Hidradenitis suppurativa (HS), systemic inflammatory response syndrome and sepsis, sepsis caused by HS: an empty systematic review.
    Br J Dermatol. 2024;191:449-450.
    >> Share

  686. KLUIJVER LG, Nekouei Shahraki M, Wagenmakers MAEM, Hanssen BE, et al
    The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study.
    Br J Dermatol. 2024;191:357-364.
    >> Share

  687. MITSUNAGA K, Bagot M, Ram-Wolff C, Guenova E, et al
    Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
    Br J Dermatol. 2024;191:419-427.
    >> Share

  688. COHN E, Palma G, Mastacouris N, Strunk A, et al
    Incidence of anxiety disorder in adults with hidradenitis suppurativa.
    Br J Dermatol. 2024;191:351-356.
    >> Share

  689. NOCHAIWONG S, Ruengorn C, Thavorn K, Noppakun K, et al
    Psychometric evaluation of the multidimensional Uraemic Pruritus in Dialysis patients (UP-Dial) scale: comparison of haemodialysis and peritoneal dialysis patients with chronic pruritus.
    Br J Dermatol. 2024;191:375-384.
    >> Share

  690. SIBBALD C, Castelo-Soccio L
    Review of global epidemiology data for alopecia areata highlights gaps and a call for action.
    Br J Dermatol. 2024;191:315-316.
    >> Share

  691. JEON JJ, Jung SW, Kim YH, Parisi R, et al
    Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study.
    Br J Dermatol. 2024;191:325-335.
    >> Share

  692. BANERJEE A, Ezzedine K, Shore R, Peeva E, et al
    An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo.
    Br J Dermatol. 2024;191:453-454.
    >> Share

  693. HAMA N, Aoki S, Chen CB, Hasegawa A, et al
    Recent progress of Stevens-Johnson syndrome/toxic epidermal necrolysis: Diagnosis criteria, pathogenesis and therapy.
    Br J Dermatol. 2024 Aug 14:ljae321. doi: 10.1093.
    >> Share

  694. CHENNAREDDY S, Rindler K, Ruggiero JR, Alkon N, et al
    Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Aug 12:ljae313. doi: 10.1093.
    >> Share

  695. KIM SR, Choi YG, Jo SJ
    Duration of smoking cessation for the prevention of psoriasis vulgaris and palmoplantar pustulosis.
    Br J Dermatol. 2024 Aug 6:ljae317. doi: 10.1093.
    >> Share

  696. FANG Y, Qi J, Jiang Y, Lin Z, et al
    Fish oil supplementation protects skin from yellowness induced by fine particulate matter through anti-inflammatory mechanism: a randomized, double-blind, placebo-controlled clinical trial.
    Br J Dermatol. 2024 Aug 5:ljae311. doi: 10.1093.
    >> Share

    July 2024
  697. RAYMUNDO C, Cella D, Wagner L, Hippe DS, et al
    Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
    Br J Dermatol. 2024 Jul 30:ljae308. doi: 10.1093.
    >> Share

  698. WILLEMZE R
    Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder: a benign or malignant process?
    Br J Dermatol. 2024 Jul 26:ljae303. doi: 10.1093.
    >> Share

  699. DE BRITO M, O'Toole EA
    Exploring the role of cytokeratin-17 in skin tumourigenesis and HPV persistence.
    Br J Dermatol. 2024 Jul 25:ljae294. doi: 10.1093.
    >> Share

  700. ALEXANDER H, Malek R, Prieto-Merino D, Gribaleva E, et al
    A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register.
    Br J Dermatol. 2024 Jul 24:ljae287. doi: 10.1093.
    >> Share

  701. VAN DOORN R
    Supplemental vitamin D on trial: no evidence of benefit as an adjuvant treatment for melanoma.
    Br J Dermatol. 2024 Jul 23:ljae302. doi: 10.1093.
    >> Share

  702. LINDSAY D, Bell KJL, Olsen CM, Whiteman DC, et al
    Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.
    Br J Dermatol. 2024 Jul 19:ljae296. doi: 10.1093.
    >> Share

  703. OLSEN CM, Pandeya N, Neale RE, Law MH, et al
    Phenotypic and genotypic risk factors for invasive melanoma by sex and body site.
    Br J Dermatol. 2024 Jul 19:ljae297. doi: 10.1093.
    >> Share

  704. HARRISON SR, Campbell F, Bennett H, De Marco G, et al
    High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study.
    Br J Dermatol. 2024 Jul 19:ljae292. doi: 10.1093.
    >> Share

  705. RENTROIA-PACHECO B, Shain AH
    Cutaneous squamous cell carcinoma progression: what does a meta-analysis of transcriptomic studies tell us?
    Br J Dermatol. 2024 Jul 17:ljae293. doi: 10.1093.
    >> Share

  706. MACAULAY ARK, Yang J, Price MA, Forster CL, et al
    Chondroitin sulfate proteoglycan 4 (CSPG4) increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying TGFbeta signaling.
    Br J Dermatol. 2024 Jul 17:ljae295. doi: 10.1093.
    >> Share


  707. Correction to: Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study.
    Br J Dermatol. 2024 Jul 17:ljae285. doi: 10.1093.
    >> Share


  708. New British Skin Foundation/Skin Health Alliance Psychodermatology Research Award now available.
    Br J Dermatol. 2024;191:309.
    >> Share

  709. BATTISTELLA M
    Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
    Br J Dermatol. 2024;191:158-159.
    >> Share

  710. DOOLAN BJ, Thomas BR
    Bursting the bubble on diagnostics: artificial intelligence in autoimmune bullous disease.
    Br J Dermatol. 2024;191:160-161.
    >> Share

  711. ANDRADE LF, Haq Z, Abdi P, Diaz MJ, et al
    Impact of pruritus on patient fatigue: a cross-sectional study.
    Br J Dermatol. 2024;191:292-293.
    >> Share

  712. REICH A
    Nemolizumab: a new key player in the treatment of prurigo nodularis.
    Br J Dermatol. 2024;191:154-155.
    >> Share

  713. THEIN D, Maul JT, Schmid-Grendelmeier P, Thyssen JP, et al
    Prevalence of ichthyoses in Denmark: a nationwide registry-based study.
    Br J Dermatol. 2024;191:305-306.
    >> Share

  714. SAMUELOV L
    Dystrophic epidermolysis bullosa: from disease biology to biologic therapy.
    Br J Dermatol. 2024;191:159-160.
    >> Share

  715. GAMBICHLER T, Razeghpour F, Sorescu E, Stucker M, et al
    High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Br J Dermatol. 2024;191:295-296.
    >> Share

  716. GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
    'Substantial clinical benefit' and 'substantial clinical worsening' cutoff of Vitiligo Impact Scale (VIS)-22 change scores.
    Br J Dermatol. 2024;191:307-308.
    >> Share

  717. GRATTAN CEH, Kocaturk E
    How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab.
    Br J Dermatol. 2024;191:153-154.
    >> Share

  718. SARKOVICS K, Kolodney JA, Kolodney MS
    Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study.
    Br J Dermatol. 2024;191:299-300.
    >> Share

  719. YOKOZEKI H, Murota H, Matsumura T, Komazaki H, et al
    Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged >/= 13 years.
    Br J Dermatol. 2024;191:200-208.
    >> Share

  720. BRAZZELLI V, Michelerio A
    Use of a large patient database to analyse disease burden and treatment patterns among patients with vitiligo.
    Br J Dermatol. 2024;191:156-157.
    >> Share

  721. MCCARTHY RL, Schwartz J, Oldham J, Bodemer C, et al
    A cross-sectional study of erythromelalgia in patients with pachyonychia congenita.
    Br J Dermatol. 2024;191:300-302.
    >> Share

  722. CAPURRO N, Pastore VP, Touijer L, Odone F, et al
    A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.
    Br J Dermatol. 2024;191:261-266.
    >> Share

  723. ELEFTHERIADOU V, Delattre C, Chetty-Mhlanga S, Lee C, et al
    Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK.
    Br J Dermatol. 2024;191:216-224.
    >> Share

  724. LAIMER M
    Nonsense variant readthrough therapy for epidermolysis bullosa.
    Br J Dermatol. 2024;191:161-162.
    >> Share

  725. CAMPBELL F, Laws P
    Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
    Br J Dermatol. 2024;191:163.
    >> Share

  726. ALTRICHTER S, Gimenez-Arnau AM, Bernstein JA, Metz M, et al
    Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
    Br J Dermatol. 2024;191:187-199.
    >> Share

  727. WOODLEY DT, Hao M, Kwong A, Levian B, et al
    Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Br J Dermatol. 2024;191:267-274.
    >> Share

  728. HOWELLS L
    Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
    Br J Dermatol. 2024;191:e4.
    >> Share

  729. XU Y, Guo L, Wu S, Zhang T, et al
    Causal effect of elevated body mass index on hidradenitis suppurativa: a two-sample Mendelian randomization study.
    Br J Dermatol. 2024;191:290-292.
    >> Share

  730. HUANG Y, Pu W, Wang L, Ma Q, et al
    ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis.
    Br J Dermatol. 2024 Jul 15:ljae286. doi: 10.1093.
    >> Share

  731. BRUCE G, Rosala-Hallas A, Jones AP, Turner C, et al
    The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children - results from the TREAT trial.
    Br J Dermatol. 2024 Jul 15:ljae276. doi: 10.1093.
    >> Share

  732. WANG H, Wu Y, Bassetti JA, Wang Z, et al
    A gain-of-function variant in SREBF1 causes generalized skin hyperpigmentation with congenital cataracts.
    Br J Dermatol. 2024 Jul 15:ljae291. doi: 10.1093.
    >> Share

  733. LI A, Musters AH, Hyseni A, Gerbens LAA, et al
    Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-center cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
    Br J Dermatol. 2024 Jul 15:ljae289. doi: 10.1093.
    >> Share

  734. LALLAS K, Spyridonos P, Kittler H, Tschandl P, et al
    Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study.
    Br J Dermatol. 2024 Jul 12:ljae281. doi: 10.1093.
    >> Share

  735. DAVITI M, Papadimitriou I, Cinotti E, Lallas A, et al
    Atypical melanocytes of an Atypical Spitz Tumor observed with Optical Super-High Magnification Dermoscopy.
    Br J Dermatol. 2024 Jul 2:ljae277. doi: 10.1093.
    >> Share

  736. JIA Q, Cao Q, Peng C, Shui X, et al
    Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study.
    Br J Dermatol. 2024 Jul 2:ljae278. doi: 10.1093.
    >> Share

  737. KLEEMANN J, Schilling B
    Multicenter phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in japanese advanced melanoma patients: Immune resistance remains one of the major efforts in melanoma research.
    Br J Dermatol. 2024 Jul 2:ljae279. doi: 10.1093.
    >> Share

    June 2024
  738. SCHIELEIN L, Ziehfreund S, Biedermann T, Zink A, et al
    "When you do not feel comfortable in your skin, you cannot get out of it" - A Qualitative Interview Study exploring Psychosocial Impact and Coping Strategies among Patients with Prurigo Nodularis.
    Br J Dermatol. 2024 Jun 28:ljae274. doi: 10.1093.
    >> Share

  739. WOBSE M, Appenzeller S, Roth S, Siedel C, et al
    Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.
    Br J Dermatol. 2024 Jun 27:ljae256. doi: 10.1093.
    >> Share

  740. HAGENSTROM K, Klinger T, Muller K, Willers C, et al
    Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis.
    Br J Dermatol. 2024 Jun 27:ljae250. doi: 10.1093.
    >> Share

  741. VON KOBYLETZKI LB, Svensson A
    Generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis have different survival rates and health care needs.
    Br J Dermatol. 2024 Jun 25:ljae271. doi: 10.1093.
    >> Share

  742. ESPOSITO M, Yerly L, Shukla P, Hermes V, et al
    COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
    Br J Dermatol. 2024 Jun 25:ljae258. doi: 10.1093.
    >> Share

  743. DE SMEDT J, Van Kelst S, Janssen L, Marasigan V, et al
    High dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind, placebo-controlled study (ViDMe trial).
    Br J Dermatol. 2024 Jun 24:ljae257. doi: 10.1093.
    >> Share


  744. Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis.
    Br J Dermatol. 2024;191:e3.
    >> Share

  745. TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
    Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
    Br J Dermatol. 2024;191:143-144.
    >> Share

  746. XIE W, Kong X, Liu W, Liang G, et al
    Antifungal-resistant Trichophyton indotineae: transmission warrants priority attention and international collaboration.
    Br J Dermatol. 2024;191:146-147.
    >> Share

  747. HORISSIAN M, Samaan C, Cohrs A, Kirby J, et al
    Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021.
    Br J Dermatol. 2024;191:142-143.
    >> Share

  748. ABDOLRASOULI A, Hay RJ
    Antifungal-resistant Trichophyton indotineae: transmission is occurring outside previously identified endemic areas - are we prepared?
    Br J Dermatol. 2024;191:145-146.
    >> Share

  749. DANBY SG
    Debunking the myth that all emollients are equal opens the door for future atopic dermatitis prevention studies.
    Br J Dermatol. 2024;191:6-7.
    >> Share

  750. TULL TJ, Benton EC, Semkova K, Watson NA, et al
    Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.
    Br J Dermatol. 2024;191:138-140.
    >> Share

  751. GOLETZ S, Probst C, Komorowski L, Radzimski C, et al
    Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin beta4 subunit.
    Br J Dermatol. 2024;191:140-141.
    >> Share

  752. LIU Y, Liu J, Chen Y, Mo R, et al
    Potential digenic inheritance of SERPINB7 and SERPINA12 variants in Chinese patients with Nagashima-type palmoplantar keratosis.
    Br J Dermatol. 2024;191:136-138.
    >> Share

  753. LIANG L, Peng S, Huang S, Wang H, et al
    Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib.
    Br J Dermatol. 2024;191:148-149.
    >> Share

  754. KEARNEY N, Kirby B
    Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab.
    Br J Dermatol. 2024;191:5-6.
    >> Share

  755. SALAMON G, Strobl S, Field-Werners U, Diem A, et al
    Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
    Br J Dermatol. 2024;191:75-81.
    >> Share

  756. THACI D, Pinter A, Sebastian M, Termeer C, et al
    Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naive patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled p
    Br J Dermatol. 2024;191:36-48.
    >> Share

  757. HASCHE D, Hufbauer M, Braspenning-Wesch I, Stephan S, et al
    Cytokeratin-17 expression is commonly observed in keratinocytic skin tumours and controls tissue homeostasis impacting HPV protein expression.
    Br J Dermatol. 2024 Jun 15:ljae255. doi: 10.1093.
    >> Share

  758. MCMAHON M, Deacon DC
    Spatial sequencing reveals transcriptional variation between amelanotic and pigmented acral melanoma.
    Br J Dermatol. 2024 Jun 15:ljae253. doi: 10.1093.
    >> Share

  759. FISCHER G
    The impact of vulval lichen sclerosus in young people: a call for better awareness, individualised maintenance plans and revised guidelines.
    Br J Dermatol. 2024 Jun 15:ljae254. doi: 10.1093.
    >> Share

  760. BENCOMO T, Lee CS
    Gene expression landscape of cutaneous squamous cell carcinoma progression.
    Br J Dermatol. 2024 Jun 13:ljae249. doi: 10.1093.
    >> Share

  761. BARBAROT S, Aubert H, Vibet MA, Leray M, et al
    Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial.
    Br J Dermatol. 2024 Jun 12:ljae111. doi: 10.1093.
    >> Share

  762. FISCHER J
    Confetti Cure: Reversing the Genetic Kaleidoscope of Ichthyosis.
    Br J Dermatol. 2024 Jun 11:ljae248. doi: 10.1093.
    >> Share

  763. MITRA R, Fitzsimmons H, Hale T, Tan ST, et al
    Recent Advances in Understanding the Molecular Basis of Infantile Haemangioma Development.
    Br J Dermatol. 2024 Jun 7:ljae241. doi: 10.1093.
    >> Share

  764. VENABLES ZC, Wakkee M
    Basal cell carcinoma incidence trends - can we stop the surge?
    Br J Dermatol. 2024 Jun 5:ljae239. doi: 10.1093.
    >> Share

  765. LOUVEAU B, Nakouri I, Jouenne F, Baroudjian B, et al
    Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high throughput sequencing approach.
    Br J Dermatol. 2024 Jun 5:ljae233. doi: 10.1093.
    >> Share

  766. GUTTMAN-YASSKY E, Croft M, Geng B, Rynkiewicz N, et al
    The role of OX40L/OX40 axis signalling in atopic dermatitis.
    Br J Dermatol. 2024 Jun 5:ljae230. doi: 10.1093.
    >> Share

  767. FUJIMURA T, Yoshino K, Kato H, Fukushima S, et al
    Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial.
    Br J Dermatol. 2024 Jun 4:ljae231. doi: 10.1093.
    >> Share

    May 2024
  768. KISS O, Bahri R, Watson REB, Chike C, et al
    The impact of irritant challenge on the skin barrier and myeloid resident immune cells in post-menopausal women is modulated by hormone replacement therapy.
    Br J Dermatol. 2024 May 31:ljae226. doi: 10.1093.
    >> Share

  769. CHOI ME, Choi EJ, Lee JH, Won CH, et al
    Spatial transcriptome analysis of amelanotic acral melanoma reveals distant molecular determinants compared to pigmented acral melanoma.
    Br J Dermatol. 2024 May 30:ljae224. doi: 10.1093.
    >> Share

  770. SHEN CH, Yang YS, Lee IT, Chiang MH, et al
    Sodium-glucose cotransporter protein-2 inhibitors for diabetes and the reduced risk of inflammatory skin diseases.
    Br J Dermatol. 2024 May 29:ljae229. doi: 10.1093.
    >> Share

  771. BARBIERI A, Orloff J, Gulati N, Brown RM, et al
    Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1.
    Br J Dermatol. 2024 May 27:ljae170. doi: 10.1093.
    >> Share

  772. VAHER H
    Expanding the knowledge about the TNF-alpha induced GSDME-mediated pyroptosis in psoriasis.
    Br J Dermatol. 2024 May 23:ljae223. doi: 10.1093.
    >> Share

  773. LUO L, Cheng H, Liu Z, Olszewski P, et al
    Single-cell transcriptomic analysis identifies infiltrating plasmacytoid dendritic cells in psoriasis epidermis.
    Br J Dermatol. 2024 May 22:ljae210. doi: 10.1093.
    >> Share


  774. Correction to: Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
    Br J Dermatol. 2024 May 22:ljae212. doi: 10.1093.
    >> Share

  775. FRYSZ M, Patel S, Li MOY, Griffiths CEM, et al
    Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
    Br J Dermatol. 2024 May 22:ljae217. doi: 10.1093.
    >> Share

  776. HANRAHAN GB, Tsibris HC
    Mutational Landscape and Tumor Mutational Burden in Adult Patients with Malignant Melanoma Arising From Congenital Nevi.
    Br J Dermatol. 2024 May 21:ljae214. doi: 10.1093.
    >> Share

  777. MORREL B, Kampherbeek JHJ, Ten Kate-Booij MJ, van der Avoort IAM, et al
    Growing up with juvenile vulvar lichen sclerosus, the experiences and care needs of adult women with lichen sclerosus since childhood: a qualitative exploration.
    Br J Dermatol. 2024 May 21:ljae203. doi: 10.1093.
    >> Share


  778. Correction to: Breastfeeding decreases the risk of developing psoriasis through to early adulthood.
    Br J Dermatol. 2024 May 20:ljae208. doi: 10.1093.
    >> Share


  779. Contact allergies to dental material.
    Br J Dermatol. 2024;190:e66.
    >> Share


  780. Predicting the likelihood of hidradenitis suppurativa disease progression based on identified risk factors.
    Br J Dermatol. 2024;190:e67.
    >> Share


  781. The impact of atopic dermatitis on children and adolescents.
    Br J Dermatol. 2024;190:e65.
    >> Share


  782. Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review.
    Br J Dermatol. 2024;190:e64.
    >> Share

  783. PAVLENKO D, Akiyama T
    Cryosim-1: a cool solution for acute and chronic itch.
    Br J Dermatol. 2024;190:787.
    >> Share

  784. THANG CJ, Garate D, O'Leary S, Golovko G, et al
    Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study.
    Br J Dermatol. 2024;190:921-923.
    >> Share

  785. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.
    >> Share

  786. ZOUBOULIS CC, Passeron T, Pariser D, Wozniak MB, et al
    Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
    Br J Dermatol. 2024;190:836-845.
    >> Share

  787. KIM DY
    Mortality landscape of Behcet disease.
    Br J Dermatol. 2024;190:784.
    >> Share

  788. BAHAR F, DeCaprio JA
    Why do we distinguish between virus-positive and virus-negative Merkel cell carcinoma?
    Br J Dermatol. 2024;190:785-786.
    >> Share

  789. LIAO V, Cornman HL, Ma E, Kwatra SG, et al
    Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
    Br J Dermatol. 2024;190:798-810.
    >> Share

  790. LEE S, Wei ET, Selescu T, Babes A, et al
    Histamine- and pruritogen-induced itch is inhibited by a TRPM8 agonist: a randomized vehicle-controlled human trial.
    Br J Dermatol. 2024;190:885-894.
    >> Share

  791. GORDON ER, Trager MH, Kontos D, Weng C, et al
    Ethical considerations for artificial intelligence in dermatology: a scoping review.
    Br J Dermatol. 2024;190:789-797.
    >> Share

  792. CHOI SR, Shin A, Ha YJ, Lee YJ, et al
    All-cause and cause-specific mortality in patients with Behcet disease versus the general population.
    Br J Dermatol. 2024;190:858-866.
    >> Share

  793. JOHNSON O
    Living with nodular prurigo.
    Br J Dermatol. 2024;190:915.
    >> Share

  794. GREKOWITZ E, Metz M, Altrichter S, Bauer A, et al
    Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.
    Br J Dermatol. 2024;190:825-835.
    >> Share

  795. MARONESE CA, Marzano AV
    Identifying candidates for early intervention in hidradenitis suppurativa.
    Br J Dermatol. 2024;190:787-788.
    >> Share

  796. RAGAMIN A, Zhang J, Pasmans SGMA, Schappin R, et al
    The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Br J Dermatol. 2024;190:867-875.
    >> Share

  797. TORRE-CASTRO J, Rodriguez M, Alonso-Alonso R, Mendoza Cembranos MD, et al
    LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma.
    Br J Dermatol. 2024;190:876-884.
    >> Share

  798. KJAERSGAARD ANDERSEN R, Pedersen O, Eidsmo L, Jemec G, et al
    Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa (HS): results from a Cox proportional hazard regression analysis on disease progression among a cohort of 335 Danish patients with HS.
    Br J Dermatol. 2024;190:904-914.
    >> Share

  799. CHIESA FUXENCH ZC
    The burden of atopic dermatitis across paediatric populations: 'it's not just an itch that rashes'.
    Br J Dermatol. 2024;190:783-784.
    >> Share

  800. MISTRY K, Venables ZC
    A systematic review of Merkel cell carcinoma epidemiology highlights its rising incidence, poor prognosis and data heterogeneity.
    Br J Dermatol. 2024;190:782-783.
    >> Share

  801. MOHSEN ST, Price EL, Chan AW, Hanna TP, et al
    Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies.
    Br J Dermatol. 2024;190:811-824.
    >> Share

  802. OLSEN CM
    Ecological evidence for melanoma overdiagnosis in Denmark.
    Br J Dermatol. 2024 May 16:ljae206. doi: 10.1093.
    >> Share

  803. DU J, Dong C, Lin J, Lu X, et al
    MMP2hi Fibroblasts Regulate CD8+ T Cell Residency and Inflammation via CD100 in Psoriasis.
    Br J Dermatol. 2024 May 16:ljae205. doi: 10.1093.
    >> Share

  804. HAMMAS K, Nardin C, Boyer S, Michel C, et al
    Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
    Br J Dermatol. 2024 May 15:ljae201. doi: 10.1093.
    >> Share

  805. TANAHASHI K, Kono M, Yoshikawa T, Suzuki Y, et al
    Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin.
    Br J Dermatol. 2024 May 13:ljae193. doi: 10.1093.
    >> Share

  806. RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
    Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
    Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
    >> Share

  807. PARRAGA SP, Feldman SR
    Insulin resistance and psoriasis.
    Br J Dermatol. 2024 May 13:ljae199. doi: 10.1093.
    >> Share

  808. BOITOR RA, Varma S, Sharma A, Odedra S, et al
    Diagnostic accuracy of autofluorescence-Raman spectroscopy for surgical margin assessment during Mohs micrographic surgery of basal cell carcinoma.
    Br J Dermatol. 2024 May 13:ljae196. doi: 10.1093.
    >> Share

  809. PASSERON T, Reinhardt M, Ehst B, Weiss J, et al
    Secukinumab in adult patients with lichen planus: Efficacy and safety results from the randomised, placebo-controlled, proof-of-concept PRELUDE study.
    Br J Dermatol. 2024 May 13:ljae181. doi: 10.1093.
    >> Share

  810. ROBINSON J, Kibbi N, Rajan N
    Redefine "benign": A misnomer in the context of patients with genetic skin tumour syndromes.
    Br J Dermatol. 2024 May 10:ljae185. doi: 10.1093.
    >> Share

  811. GUNTHER C
    IL-17 blockade by secukinumab was not effective in controlling lichen planus in a randomized controlled clinical trial.
    Br J Dermatol. 2024 May 8:ljae186. doi: 10.1093.
    >> Share

  812. ZHANG S, Ran M
    Deceptive Pigment Changes in Neoadjuvant Sonidegib Therapy for Basal Cell Carcinoma.
    Br J Dermatol. 2024 May 4:ljae187. doi: 10.1093.
    >> Share

    April 2024
  813. MALLBRIS MJ, Jia B, Zhao Y, Kahlenberg JM, et al
    Concomitant Moderate to Severe Cutaneous Lesions Have Marked Impact on Quality of Life in Patients with Active Systemic Lupus Erythematosus: A Cross-Sectional Insight from Two Phase 3 Randomised Clinical Trials in Adults.
    Br J Dermatol. 2024 Apr 30:ljae183. doi: 10.1093.
    >> Share

  814. HALIOUA B, Skayem C, Merhand S, Ben Hayoun Y, et al
    Long-term consequences on stigmatization and disease burden during adulthood among patients with childhood or adolescence-onset atopic dermatitis.
    Br J Dermatol. 2024 Apr 29:ljae176. doi: 10.1093.
    >> Share

  815. O'REILLY M, Paolino A, Pathmarajah P, Ferguson J, et al
    Dupilumab in Chronic Actinic Dermatitis: a retrospective case series.
    Br J Dermatol. 2024 Apr 24:ljae180. doi: 10.1093.
    >> Share

  816. LI Y, He Y, Yang F, Liang R, et al
    GSDME-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation.
    Br J Dermatol. 2024 Apr 24:ljae179. doi: 10.1093.
    >> Share

  817. NIELSEN JB, Kristiansen IS, Thapa S
    Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?
    Br J Dermatol. 2024 Apr 24:ljae175. doi: 10.1093.
    >> Share

  818. LEEOLOU MC, Sarin KY, Fiorentino DF
    Filling the Prescription Gap: The Value of Community Support in Psoriasis Management.
    Br J Dermatol. 2024 Apr 18:ljae168. doi: 10.1093.
    >> Share

  819. HUANG D, Zhong X, Jiang Y, Kong L, et al
    Insulin Resistance Impairs Biological Agents Response in Moderate-to-Severe Plaque Psoriasis: Insights from a Prospective Cohort Study in China.
    Br J Dermatol. 2024 Apr 18:ljae147. doi: 10.1093.
    >> Share


  820. The association between vitamin D levels and psoriasis in people aged 40-79 years.
    Br J Dermatol. 2024;190:e54.
    >> Share


  821. Effectiveness and safety of immunoadsorption in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Br J Dermatol. 2024;190:e53.
    >> Share


  822. Predictors of response to treatment with biologics in people with moderate-to-severe psoriasis.
    Br J Dermatol. 2024;190:e55.
    >> Share


  823. A novel strategy for the treatment of melanoma.
    Br J Dermatol. 2024;190:e51.
    >> Share


  824. Practical guide for epidermolysis bullosa management in the first 4 weeks of life.
    Br J Dermatol. 2024;190:e52.
    >> Share


  825. The Patient Benefit Index for topical treatment (PBI-TOP): a new questionnaire to assess the treatment goals and preferences of people with psoriasis.
    Br J Dermatol. 2024;190:e56.
    >> Share


  826. Deciding on the final set of questions and groups of questions in the Patient-Reported Impact of Dermatological Diseases (PRIDD) tool.
    Br J Dermatol. 2024;190:e57.
    >> Share


  827. Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatment.
    Br J Dermatol. 2024;190:e58.
    >> Share


  828. UK trends in work-related contact dermatitis caused by nickel, chromium and cobalt.
    Br J Dermatol. 2024;190:e59.
    >> Share


  829. 'Gene creams' for genetic diseases?
    Br J Dermatol. 2024;190:e50.
    >> Share

  830. PASSERON T
    A pledge for a better care and consideration of patients with vitiligo.
    Br J Dermatol. 2024;190:614-615.
    >> Share

  831. SAMPOGNA F, Piaserico S
    Deucravacitinib: is there still a place or a need for a new oral agent?
    Br J Dermatol. 2024;190:610-611.
    >> Share

  832. HASAN SB, Bates J, Cannings-John R, Collier F, et al
    Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study.
    Br J Dermatol. 2024;190:775-777.
    >> Share

  833. KYUNG S, Woo S, Kim M, Lee H, et al
    Global burden of vaccine-associated alopecia, 1979-2023: a comprehensive analysis of the international pharmacovigilance database.
    Br J Dermatol. 2024;190:764-767.
    >> Share

  834. MOSS C
    Caring for babies born with epidermolysis bullosa.
    Br J Dermatol. 2024;190:608.
    >> Share

  835. RING HC, Thorsen J, Kirby B, Ingram JR, et al
    Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
    Br J Dermatol. 2024;190:769-771.
    >> Share

  836. FAKIH A, Tannous R, Lajnef M, Seneschal J, et al
    Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score.
    Br J Dermatol. 2024;190:712-717.
    >> Share

  837. HASHIMOTO T, Yamagami J
    Development of a novel treatment for pemphigus and confirmation of its efficacy: a randomized controlled trial of protein A immunoadsorption therapy.
    Br J Dermatol. 2024;190:609.
    >> Share

  838. RIVERA S, Dehner K, Flood A, Dykstra C, et al
    Adverse healthcare experiences are correlated with increased time to diagnosis in women with vulvar inflammatory dermatoses: a retrospective cohort survey.
    Br J Dermatol. 2024;190:761-762.
    >> Share

  839. VAN BEEK N, Eming R, Reuss A, Zillikens D, et al
    Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
    Br J Dermatol. 2024;190:657-667.
    >> Share


  840. The 2024 British Skin Foundation Research Awards are now available.
    Br J Dermatol. 2024;190:778.
    >> Share

  841. CHAIYABUTR C, Dawe R, Lesar A, Ibbotson SH, et al
    A retrospective comparison of early- and late-onset chronic actinic dermatitis: characteristics and management.
    Br J Dermatol. 2024 Apr 16:ljae101. doi: 10.1093.
    >> Share

  842. NASLUND-KOCH C, Skov L
    Shedding light on the smoke: Unraveling the impact of smoking cessation on psoriasis development.
    Br J Dermatol. 2024 Apr 15:ljae163. doi: 10.1093.
    >> Share

  843. PHILLIPS C, Russell E, McNiven A, McPherson T, et al
    A Qualitative Study of the Psychological Morbidity in Paediatric Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Br J Dermatol. 2024 Apr 12:ljae154. doi: 10.1093.
    >> Share

  844. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    >> Share

  845. SIMPSON EL, Eckert L, Gadkari A, Brown TM, et al
    Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
    Br J Dermatol. 2024 Apr 9:ljae056. doi: 10.1093.
    >> Share

  846. JONES OT, Matin RN, Walter FM
    Using artificial intelligence-based technologies to support the diagnosis and early detection of melanoma in primary care.
    Br J Dermatol. 2024 Apr 9:ljae094. doi: 10.1093.
    >> Share

  847. CAO Q, Li M
    GLMN variants cause skin hyperpigmentation: a promising potential therapeutic target.
    Br J Dermatol. 2024 Apr 8:ljae149. doi: 10.1093.
    >> Share

  848. ROCCUZZO G, Calvao J, Dobos G, Morsia E, et al
    Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
    Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093.
    >> Share

    March 2024
  849. KIM SR, Choi YG, Jo SJ
    Effect of smoking cessation on psoriasis vulgaris, palmoplantar pustulosis, and generalized pustular psoriasis.
    Br J Dermatol. 2024 Mar 27:ljae130. doi: 10.1093.
    >> Share

  850. SANDER N, Stolzl D, Fonfara M, Hartmann J, et al
    Blockade of IL-13 signaling improves skin barrier function and biology in patients with moderate to severe atopic dermatitis.
    Br J Dermatol. 2024 Mar 26:ljae138. doi: 10.1093.
    >> Share

  851. BENTZ P, Weisshaar E
    Biomarkers as key concepts in managing atopic dermatitis and psoriasis: Unlocking new ways of care for patient suffering from chronic hand dermatoses.
    Br J Dermatol. 2024 Mar 26:ljae127. doi: 10.1093.
    >> Share

  852. JOHNSON C, Liao W
    Food for thought: A comment on 'Breast-feeding decreases the risk of developing psoriasis through early adulthood'.
    Br J Dermatol. 2024 Mar 26:ljae135. doi: 10.1093.
    >> Share

  853. SOROKIN AV, Gelfand JM
    New Prospective Cohort Study and Mendelian Randomization Analysis Reveals a Link Between Psoriasis and Cardiovascular Risk Trough Elevated Plasma Triglycerides.
    Br J Dermatol. 2024 Mar 22:ljae129. doi: 10.1093.
    >> Share

  854. TALTY R, Richmond R, Micevic G
    Melanoma TIL therapy commences era of cell-based immunotherapies.
    Br J Dermatol. 2024 Mar 22:ljae126. doi: 10.1093.
    >> Share


  855. Correction to: Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis.
    Br J Dermatol. 2024 Mar 22:ljae112. doi: 10.1093.
    >> Share

  856. STRANDMOE AL, Bremer J, Diercks GFH, Gostynski A, et al
    Beyond The Skin: B Cells in Pemphigus Vulgaris, Tolerance and Treatment.
    Br J Dermatol. 2024 Mar 20:ljae107. doi: 10.1093.
    >> Share

  857. JIANG X, Yang C, Wang Z, Liang L, et al
    Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
    Br J Dermatol. 2024 Mar 15:ljae108. doi: 10.1093.
    >> Share


  858. AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma.
    Br J Dermatol. 2024;190:e46.
    >> Share


  859. Blood monitoring during psoriasis treatment with biologics.
    Br J Dermatol. 2024;190:e47.
    >> Share


  860. Safety of bimekizumab over 3 years in patients with psoriasis.
    Br J Dermatol. 2024;190:e38.
    >> Share


  861. International trends in the incidence of cutaneous squamous cell carcinoma and melanoma.
    Br J Dermatol. 2024;190:e40.
    >> Share


  862. Skin barrier dysfunction drives skin inflammation via formylpeptide receptor 1.
    Br J Dermatol. 2024;190:e45.
    >> Share


  863. 2024 British Skin Foundation Small Grants are NOW AVAILABLE.
    Br J Dermatol. 2024;190:603.
    >> Share


  864. Comparison of topical permethrin 5% and benzyl benzoate 25% for treating scabies.
    Br J Dermatol. 2024;190:e39.
    >> Share


  865. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Br J Dermatol. 2024;190:e42.
    >> Share


  866. The relationship between paediatric eczema and cognition.
    Br J Dermatol. 2024;190:e41.
    >> Share


  867. A guide to using the core outcome set for eczema.
    Br J Dermatol. 2024;190:e44.
    >> Share

  868. GARMAN KA, Thoreson N, Strong J, Hallaert P, et al
    Mycophenolate mofetil inhibits Merkel cell carcinoma growth.
    Br J Dermatol. 2024;190:593-595.
    >> Share

  869. CORNMAN HL, Whang KA, Ma E, Aggarwal P, et al
    Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort.
    Br J Dermatol. 2024;190:571-572.
    >> Share

  870. CLAIRE FULLER L, Sunderkotter C
    Scabies therapy update: Should 25% benzyl benzoate emulsion be reconsidered as a first-line agent in classical scabies?
    Br J Dermatol. 2024;190:459-460.
    >> Share

  871. NIELSEN W, Drucker AM
    The need and benefit of the Harmonising Outcome Measures for Eczema user's guide.
    Br J Dermatol. 2024;190:462-463.
    >> Share

  872. XIE W, Kong X, Zheng H, Mei H, et al
    Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant Trichophyton indotineae in China.
    Br J Dermatol. 2024;190:585-587.
    >> Share

  873. NANDA A, Chang YH, Cheng HC, Lai IT, et al
    Autosomal recessive plantar keratoderma with ragged periungual hyperkeratosis caused by a homozygous missense variant in KRT16.
    Br J Dermatol. 2024;190:588-590.
    >> Share

  874. COWPER R
    For itch and insanity.
    Br J Dermatol. 2024;190:568.
    >> Share

  875. BARLOW R, Ahmed A, Fellows J, Goulding J, et al
    Assessing and managing the mental health of people with vitiligo: a UK-wide consultation exercise.
    Br J Dermatol. 2024;190:574-576.
    >> Share

  876. MEYERSBURG D, Hoellwerth M, Brandlmaier M, Handisurya A, et al
    Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trial.
    Br J Dermatol. 2024;190:486-491.
    >> Share

  877. MOSCARELLA E, Di Brizzi EV, Alpi P, Arcelli A, et al
    Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.
    Br J Dermatol. 2024;190:578-579.
    >> Share

  878. DONHAUSER T, Gabes M, Ozkan E, Masur C, et al
    What do Hyperhidrosis Quality of Life Index (HidroQoL(c)) scores mean? Transferring science into practice by establishing a score banding system.
    Br J Dermatol. 2024;190:519-526.
    >> Share

  879. WAINMAN HE, Chandran NS, Frew JW, Garg A, et al
    Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Br J Dermatol. 2024;190:510-518.
    >> Share

  880. GEORGE CD, Lee T, Hollestein LM, Asgari MM, et al
    Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis.
    Br J Dermatol. 2024;190:465-476.
    >> Share

  881. NALDI L, Cassalia F
    Actinic keratosis epidemiology: the good, the bad and the ugly.
    Br J Dermatol. 2024;190:457-458.
    >> Share

  882. OYESIKU L, Dlova N, Ahmed S, Owen DR, et al
    Inclusive and equitable language for skin colour in the British Journal of Dermatology: acknowledging our past and laying the foundations to move forward.
    Br J Dermatol. 2024 Mar 13:ljae064. doi: 10.1093.
    >> Share

  883. AALA WJF, Hou PC, Hong YK, Lin YC, et al
    Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ Th2 cells which may contribute to pruritus in lesional skin.
    Br J Dermatol. 2024 Mar 13:ljae110. doi: 10.1093.
    >> Share


  884. Correction to: Malignancy risk in patients with atopic dermatitis: a population-based cohort study.
    Br J Dermatol. 2024 Mar 12:ljae093. doi: 10.1093.
    >> Share

  885. CANTISANI C, Taliano A, Longo C, Bortone G, et al
    Dynamic Optical Coherence Tomography and Reflectance Confocal Microscopy of Basal Cell Carcinoma of the Nipple-Areola Complex.
    Br J Dermatol. 2024 Mar 12:ljae104. doi: 10.1093.
    >> Share

  886. ARMATO U, Dal Pra I
    Discovering skin-rejuvenating matrikines - a basic and applied Dermatology new frontier.
    Br J Dermatol. 2024 Mar 12:ljae100. doi: 10.1093.
    >> Share

  887. CHEN GF, Xu S, White MA, Cohen JM, et al
    Association between atopic dermatitis and eating disorders: a cross-sectional study in the All of Us Research Program.
    Br J Dermatol. 2024 Mar 11:ljae103. doi: 10.1093.
    >> Share

  888. RA AG, Littlewood Z, Barton A, Keevil B, et al
    The use of serum methotrexate level as an assessment of biochemical drug adherence in psoriasis.
    Br J Dermatol. 2024 Mar 8:ljae096. doi: 10.1093.
    >> Share

  889. REHBINDER EM, Warnberg Gerdin S, Hoyer A, Bradley M, et al
    Frequent oil-baths and skin barrier during infancy in the PreventADALL study.
    Br J Dermatol. 2024 Mar 6:ljae091. doi: 10.1093.
    >> Share

  890. EL HACHEM M, De Marco R, Soria de Francisco JM, Audouze A, et al
    Ichthyosis: multinational European study on patient characteristics and body sites involved with impact on quality of life.
    Br J Dermatol. 2024 Mar 1:ljae082. doi: 10.1093.
    >> Share

    February 2024
  891. RIBERO S, Quaglino P, Roccuzzo G
    Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma.
    Br J Dermatol. 2024 Feb 29:ljae092. doi: 10.1093.
    >> Share

  892. RAMESSUR R, Dand N, Langan SM, Saklatvala J, et al
    Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research- an inter-disciplinary perspective.
    Br J Dermatol. 2024 Feb 29:ljae080. doi: 10.1093.
    >> Share

  893. GREVE AM, Wulff AB, Bojesen SE, Nordestgaard BG, et al
    Elevated plasma triglycerides increase risk of psoriasis: A cohort and Mendelian randomization study.
    Br J Dermatol. 2024 Feb 27:ljae089. doi: 10.1093.
    >> Share

    January 2024
  894. SAAD R, Duipmans J, Yerlett N, Plevey K, et al
    Neonatal Epidermolysis Bullosa: a clinical practice guideline.
    Br J Dermatol. 2024 Jan 4:ljae006. doi: 10.1093.
    >> Share

    December 2023
  895. FORKEL S, Schubert S, Corvin L, Heine G, et al
    Contact allergies to dental materials in patients.
    Br J Dermatol. 2023 Dec 20:ljad525. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016